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INTRODUCTION 
 
The Siddha System of Medicine is the ancient traditional system of medicine 
generated from Dravidian culture and it is believed to be one of the oldest medical 
systems in the known universe. It is a traditional healthcare science which is significant to 
Indian subcontinent especially Southern region. This science not only deals with 
medication and treatment but also it covers all the aspects of the social wellbeing and 
concreted in the fundamental basics of Nature and Spirituality. The word Siddha comes 
from the word Siddhi which means an object to attain heavenly bliss. The system has 
flourished well in India for many centuries. Although this system has declined in later 
years, in the wake of changing mode of life and Modern Medicine, it continues to sustain 
its influence on the masses because of its incomparable intrinsic merits. Siddha medicine 
can combat all types of diseases, especially the chronic diseases, which baffles and eludes 
even the modern sophisticated medicine. There were 18 important Siddhars in olden days 
and they developed this system of medicine for attain the holistic health of people. Hence, 
it is called Siddha system of Medicine.   
 
Siddhars were of the concept that a healthy soul can only be developed through a 
healthy body. So they developed methods and medication that are believed to strengthen 
their physical body and thereby their souls. 
 
Siddhars have listed the diseases of mankind as 4448 based on the Mukkutram i.e., 
Vali, Azhal, Iyyam. Among the 4448 diseases, the Psychological related 
diseases/problems are classified into 18 varieties by Siddhar Agasthiyar. The other 
imperative Siddhars Yugi Munivar and Theraiyar also describe the psychiatric diseases in 
their texts. 
 
VENNEER NOI.  
This disease is described in the texts of “Siddha Maruthuvam Pothu” by K. N. 
Kuppusami Muthaliyar and also “Noi Naadal Noi Muthal Naadal Thiraddu - Part - 2” by 
Dr. M. Shanmugavelu.  
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It is a condition that, debilitating disorder of Sukkila Thadhu (seventh physical 
constituent), within the seven Udal Thadhus (Physical Constitutes) of the human body. 
Deteriorating of the Sukkila Thadhu will leads to losses its natural luminous, colour, 
weight & heaviness; finally it is passed either with urine or before and after micturition.    
 
It may caused by having sexual contacts from very young age, excess lust on 
money and sex, anxiety and by hereditary.1,2      
 
The disease affects the sperm, ovum and accessory sexual organs (Prostate, 
bartholin and vaginal glands) are deteriorated. It causes structural and functional damages 
of the human being. The Common symptoms are weakness, dryness of tongue, tremor, 
headache, bad dreams, loss of interests in food, pain and tiredness shoulder and other 
organs. Tightened chest, blindness, hoarseness of voice, cough, dyspnoea, disturbed 
sleep, perspiration and constipation are other symptoms of this disease.3    
 
According to the modern science the Venneer Noi could be correlated with Dhat 
Syndrome.  
Dhat syndrome is a condition of strong sub-cultural beliefs associated with loss 
of semen found in the cultures of the eastern world and the resultant psychological 
symptoms has given the name4,5. Dhat syndrome where Dhat is the Sanskrit word from 
Dhātu dosha that means essence of semen8. Dhātu is a meaning of ‘metal’, and also 
‘elixir’ or ‘constituent part of the body’. Dhat is thought to be a culture-bound syndrome 
similar to jiryan (South-East Asia), prameha (Sri Lanka), and    shen-k'uei (China)9.  
 
The condition has no known organic aetiology. There is a belief that one drop of 
semen is equal to thousand drops of blood and thus, its loss is calamitous9. In the eastern 
cultural spirituality, semen is described as a "vital fluid". The discharge of this “vital 
fluid”, through nocturnal emission, masturbation, urine, or excess extra marital sexual 
contacts is associated with marked feelings of anxiety and dysphoria (It can also refer to a 
state of not being comfortable in one's current body)11,12.  
 
DSM IV mentioned that Dhat a folk diagnostic term used in India to refer to 
severe anxiety and hypochondriacal concerns associated with the discharge of semen, 
whitish discoloration of the urine, and feelings of weakness and exhaustion5.  
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According to ICD 10, mixed disorders of behaviour, belief and emotions which 
are of vague aetiology and nosological status and which occur with particular frequency 
in certain cultures. It is undue concern about the debilitating effects of the passage of 
semen4.  
 
The firm belief is that due to ‘unnatural’ loss of semen described it as being 
characterized by vague psychosomatic symptoms of weakness, emaciation, frailty, 
premature ageing, anxiety, poor appetite, guilt and sexual dysfunction, loss of masculine 
prowess and infertility.  And often the patient describes the loss of a whitish fluid while 
passing urine. Commonly they expose that the marked feelings of guilt associated with 
what the patient assumes is “excessive” masturbation are noted.6  
 
It is true culture bound sex neurosis. That has been frequently reported in the 
natives of Indian Sub-continent for the last many decades. The patients usually report 
experience mixture of physical, psychological, genital as well as sexual symptoms such as 
fatigue, weakness, loss of appetite, anxiety, guilty and etc. At times, patients also report 
sexual dysfunction which they attribute to passing of semen (Dhat) in urine as a direct 
consequence of his excessive indulgence in the masturbation, nocturnal emission or other 
sexual activity. Semen loss and consequent anxiety (interchangeable terms used for Dhat 
Syndrome) are not confined only to India some studies have been reported from Sri 
Lanka, Pakistan and other parts of Sub-continent as well.6,9,11 
 
  Dhat Syndrome is a commonest condition in the males from the adolescent to 
middle aged group. Even though it is universally observed syndrome, but it is obviously 
noted in high occurrence in Indian subcontinent. Based on the clinical experienced at the 
Out Patients Department (OPD) of National Institute of Siddha, it is observed that, 
significant number of male patients are coming with Dhat syndrome. According to the 
International Journal of Epidemiology 2014; 43: 2: 365 - 406 (Published: 22 December 
2013) the global prevalence rate of Dhat syndrome is 11.7% in India and Pakistan it is 
30%.12 These data inspires to carry out this study for the M.D (Siddha) Dissertation.  
 
For this study, the poly herbal formulation of  “Venpoosani Legiyam” as internal 
drug (Siddha Vaidhiya Thirattu) and “Ulunthu Thylam” (The Siddha Formulary of India – 
Part –I) for external application (massage the penis and scalp) to evaluate their efficacy in 
treating “Venneer Noi” (Dhat Syndrome).  
4 
 
In recent research, it has been found that, Venpoosani Legiyam improves overall 
health. As it is a tonic and gives strength to every body organ. It increases libido, and 
gives relief in variety of disorders. It is digestive, carminative, restorative, expectorant, 
and sedative. It is commonly used for general health tonic, weakness, spermatorrhoea and 
body heat condition. 
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AIM AND OBJECTIVES 
 
PRIMARY OBJECTIVE:   
 
To evaluate the efficacy of Poly herbal Siddha Drugs “VENPOOSANI LEGIYAM” 
(Internal medicine) and “ULUNTHU THYLAM” (External medicine) in the treatment of 
VENNEER NOI (DHAT SYNDROME) with and without psycho-education therapy. 
 
SECONDARY OBJECTIVE:   
 
v To make a detailed clinical evaluation of the disease by careful examination of 
Aetiology, Symptoms, Complication, Treatment and Prognosis 
 
v To study the Siddha and Modern aspects of Venneer Noi (Dhat Syndrome) 
 
v To study the Siddha basic principles towards the efficacy of trial medicines. 
 
v To carry out the Biochemical analysis of trial medicine (internal medicine) of 
Venpoosani Legiyam 
 
v To perform the physiochemical and phytochemical analysis of the trial medicine 
(internal medicine) of Venpoosani Legiyam 
 
v To accomplish the Aflotoxin analysis and microbial upload studies for the trial 
medicine (internal medicine) of Venpoosani Legiyam 
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REVIEW OF LITERATURE 
 
SIDDHA ASPECT OF VENNEER NOI 
 
VENNEER NOI  
 
Other names- Sukkila Neer, Thavala Neer and Thavala Mekam 
 
Definition: 
It is a condition that, debilitating disorder of Sukkila Dhātu (seventh physical 
constituent), within the seven Udal Dhātus (Physical Constitutes) of the human body. 
Deteriorating of the Sukkila Dhātu caused the losses its natural luminous, colour, weight 
and heaviness, then it is passing with urine and before or after maturation.1,2   
 
Root cause of the disease: 
It may caused by having sexual contacts from very young age, excess lust on 
money and sex, anxiety,  and by hereditary from father or mother or both.1,2  
 
Premonitory Sign and Symptoms      
There are frequent micturition, nocturnal emission, gradual emaciation and 
tremor.      
 
Signs and Symptoms  
Initially its shows the above mentioned premonitory signs and symptoms, then the 
frequent micturition become a thick thread like urination, due to this the thought that his 
vital energy is passing with urine and this may caused the following psychological 
problems like an anxious, depression, loneliness, shyness (shame) and embarrassment. 
And also patient suffers with sadness, emaciation, insomnia, nocturnal emission (semen 
release during dreams in the sleep at night) and fatigue of legs and hands. Further, 
physically patient having indigestion, nausea, vomiting, diarrhea or constipation tremor in 
both legs & hands and numbness of limbs. If not given the proper treatment at the time 
the condition going to worsen and increased sadness and depression finally patient may 
attempt suicide.   
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Siddha medical texts mentioned the Venneer noi / Thavalaneer noi / Sukkilaneer 
noi is could be compare with the Dhat syndrome. Siddha medicine is mentioned, various 
psychological and physiological functions of the body are attributed to the combination of 
seven elements (Saptha thathukal): first is Chaaram (plasma) responsible for growth, 
development and nourishment; second is Cheneer (blood) responsible for nourishing 
muscles, imparting colour and improving intellect; the third is Oon (muscle) responsible 
for shape of the body; fourth is Kozhuppu (fatty tissue) responsible for oil balance and 
lubricating joints; fifth is Enbu (bone) responsible for body structure and posture and 
movement; sixth is Majjai (bone marrow) responsible for formation of blood corpuscles; 
and the last is Sukkilam (semen) responsible for reproduction1,2. 
 
MEKA NEER 
 
The texts of “Noi Naadal Noi Muthal Naadal Thiraddu” and “Siddha 
Maruthuvam Pothu” mentioned the “Ven Neer Noi” under the “Meka Neer” or “Neerinai 
Perukkal Noikal” (Poly uric conditions). The Meka Neer is a condition that unnaturally 
excessive urination with loosen the strength of seven body constituents (Saptha 
Thathukal).2 
 
Root causes for the Meka Neer         
1  “Nfhijau; fytp Nghij 
 nfhOj;jkP dpiwr;rp Nghij 
ghJtha; nea;Ak; ghYk;  
 gupTl Zz;gP uhfpy;  
Nrhjghz; LUt kpf;f  
 Rf;fpy gpuNk fe;jhd;  
XJeP upopT Nru 
 Cz;nld twpe;J nfhs;Ns”      
                                   - Agathiar 2000- 
 
2.  “rupahf Nkfj;jh yghd thA 
  jhd;Giff;F NkNywpf; fghyr; #lhk;  
  ngupjhd Nkfj;jh yj;jp nte;J 
   Nghkg;gh jirnte;J uj;jk; tw;wpg;  
  gupthfpj; jrthAthy; ke;jq; nfhz;L  
  ngUe;jPdp kyge;jk; cjhd thA 
  tupthfpj; Njfnkyhk; tpleP uhNy 
  nka;aope;j Nkfnkd;w jpUg jhr;Nr”  
                                                                                - Siddha Maruthvuvam-    
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 Excessive intake of sweet and oily foods, farthest sexual acts, easily get sadness, 
constantly sit and lethargies are stimulates to amplify the important three Vaayukal (Mel 
Nokku, Keezh Nokku and Paravu Kaal). These augmented Vaayukkal intensify the 
Moolaatharam and this may inspire the Moola Kanal due to this reason Ven Neen Noi 
may caused.2          
 
Meka Neer could be divided in to twenty types. Based on the Mukktram (Tri 
Humour) ;  
Ø Vali Kutram - 04  
Ø Azhal Kutram - 06 
Ø Iya Kutram  - 10   
 
Under the Iya Noi, the following 10 types of Meka Neer are listed in the Siddha 
Texts.  
  “Mwhd rpNyl;Lkryk; gj;J jd;id 
   mud;nrhy;y Mj;jhs;jhd; Nfl;Fk; NghJ 
  thwhd thrhNkfe; njspNkf 
   %isA Uf;F Nkfj;Njh bsePu; Nkfk;  
  J}whd RuhRf;fpy Nkfq;fO ePu;NkfQ; 
   Rw;wkhk; gpurnkhL rhu Nkfk;  
  Njwhd ,iwr;rpah Nkfnkhd;W  
   nrg;gpdhu; rpNyl;Lkj;jpd; ryj;ijj;jhNd”. 
       
 - Noi Naadal Noi Muthal Naadal Thiraddu -  
 
1. Vaasa Neer 
2. Theli Neer 
3. Moolai Urukku Neer 
4. Ela Neer 
5. Kal Neer 
6. Ven Neer 
7. Kazhu Neer 
8. Then Neer 
9. Uppu Neer 
10. Eraichi Neer   
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Vennneer Noi 
“vd;wNjhu; Nkfe;jh dpwq;Fk; NghJ 
 Vw;wkhQ; Rf;fpyj;jp dpwNk NghYe; 
jd;wNjhu; jhspaplr; rhW NghYe;  
 jupj;JNk nkO$u;e;J rpWfp tPOq;  
fd;wNjh upijf;fha;r;rpw; fl;b Nghyf;  
 fdkhd <uy;Nghw; Nwha;e;J NghFk; 
Kd;wNjhu; fz;lryk; %d;wh khz;by;  
 Kaw;rpahf; nfhy;YQ;Rf;y Nkfe; jhNd” 
- Yugi Muni Vaithya Chinthamani- 
Njhaj;JW ePu;gj;jpdpy; 
  Njha;Rf;fpy ePu; Nfs; 
VAQ;rpW epiwahk; tpe;J 
  Ntdyhq;fd epwKk;  
NjhAk; girnkO fd;wpAQ; 
  nrhw;Whio ePu;tbthk;  
MAkb d/jpuyhk; 
  mtu;f; fhz;lJ %d;Nw”. 
- Noi Naadal Noi Muthal Naadal Thiraddu -  
 
Based on these stanza; urine become thick and reduced amount is excrete, it look 
like colour and heaviness of semen, it show like sticky wax and juice Thaazhai vizhuthu 
(areal root of Pandanas odoratissimus). If boiled it become solidify and appear like liver.  
 
 
Seats of the Tri Humours / Siddha patho-physiology    
 
 Due to internal and external causes of the living body, the Azhal humour raised 
and debilitates the Iyam humour. This leads to deteriorate the heaviness and colour of the 
semen and its pass with urine. If excessively loss of semen (Sukkila Dhadhu) it affects 
and gradually weaken all other six Udal Thadhukal.  
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Pulse (Naadi) variation  
 
1. “nghUshd thjj;jpy; gpj;jQ; Nru;e;J  
    nghUj;J Fzq;f S\;zthA rf;jp 
  nrupahik Gspj;Njg;gk; nghUky; ePupw; 
    rptg;Gkyk; gpbj;jYUj; jhJ el;lk ;  
  fUthd Njfkjp Yisr;ry; Nrhk;gy;  
    iffhy; jwpg;Gehf; frf;F kd;dk;  
  gupthd Cz;Fiwjy; UrpNghjy;  
    gyNehAk; tUj;jpitf;Fk; ghq;F jhNd”            
 
2. “rpwg;ghd gpj;jj;jpy; thj ehb 
    NrupYW jhJel;l Kjpu gPil 
   ciwg;ghfr; nrupahik Fd;kQ; #iy  
    cw;wRuq; fpuhzptapw; wpiur;ry; ke;jk;  
   miwg;ghd Xq;fhu GwePu;f; Nfhit  
    Mahrq; fpuf;fnkhL kaf;f %u;r;ir 
   Kiwf;fha;T tpltPf;f %y tha;T  
    Kulhd Neha;gyT KLFk; gz;Ng” 
 
3. “tifahd gpj;jj;jpy; tha;T $b  
    trkhdhy; typFd;kQ; #iy tha;T  
  gifahd the;jptpf;fy; mUt Ug;Gg;  
    gapj;jpaq;fs; nrupahik Gspj;j Vg;gk;  
  jifahj <uy;typ neQ;R NehTe;  
    jiyfpWf;F krjpahe; jhJel;lk ;  
  Jifahd %ytha;Tw; whY\;zQ; Nrhif  
    Jlu;e;JtUk; gygpzf;Fe; njhdpg;G jhNd” 
- Sathaga Naadi - 
 
   It’s meant that, Mixed Vali with Azhal, Azhal with Vali and excess Azhal with Vali 
caused the semen loss.    
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Clinical Features   
1. Hotness  
2. Nausea and Vomiting 
3. Indigestion  
4. Belching  
5. Bloating abdomen  
6. Colour change of urine  
7. Constipation  
8. Semen loss  
9. Body ache and pain 
10. Tiredness  
11. Bitter taste in tongue  
12. Numbness of limbs  
13. Loss of appetite  
14. Tastelessness 
15. Gastric ulcer  
16. Diarrhoea 
17. Sinusitis 
18. Execution  
19. Fainting  
20. Haemorrhoids 
21. Madness 
22. Giddiness   
23. Chest pain  
24. Weakness of the body 
25. Anaemia  
 
Treatment    
  Starts with purgative medicine for neutralised the amplified Azhal humour. Then 
give the medicines to improve the diminished Iyam become normalised. Cooling and 
nutritive medicine are select for the treatment.    
 Ilakam (lekiyam) based medicines and medicines prepared with gold, silver, coral 
and pearl are good for treat this condition.1  
12 
 
AYURVEDA 
 
Ayurvedic literature describing semen as a vital constituent of the human body 
dates back to 1500 BC. The disorders of ‘Dhatus’ have been elucidated in the Charak 
Samhita, which describes a disorder called ‘Shukrameha’ in which there is a passage of 
semen in the urine. Similar conditions have been described under various names from 
China (Shen K'uei), Sri Lanka (Prameha) other parts of South East Asia (Jiryan) 8 and 
Siddha medicine Venneer Noi. Some physicians believes Dhat syndrome to be either a 
culture-bound presentation of clinical depression, as a somatized set of symptoms, or a 
result of Western doctors misinterpretation of patients descriptions of their condition. 
 
 
13 
 
MODERN MEDICAL ASPECT OF VENNEER NOI  
(DHAT SYNDROME) 
 
Dhat Syndrome is characterized primarily with complaints of loss of semen 
through urine, nocturnal emission or masturbation, accompanied by vague symptoms of 
weakness, easy fatigability, palpitation, sleeplessness, low mood, guilt and anxiety. The 
condition has no organic aetiology. It may sometimes be associated with sexual 
dysfunction (impotence and premature ejaculation) and psychosocial disorders 
(depression, anxiety neurosis or phobia).9 
 
Dr. S. M. Yasir Arafat mentioned on his study in the journal of ‘Health Tips Ever’ 
that, the patients who presented with symptoms of Dhat Syndrome were mostly young, 
recently married, belonging to average or low socioeconomic status (perhaps a student, 
laborer or farmer by occupation), from rural area and from family with conservative 
attitudes towards sex.8 
 
Patients having Dhat syndrome can be further divided into five categories. 
1. Dhat alone – complaint of passage of Dhat in urine  
2. Dhat with multiple somatic symptoms  
3. Dhat with asthenia (physical or mental exhaustion) 
4. Dhat with co-morbid depression and anxiety  
5. Dhat with sexual dysfunction. 
 
Young males are most often affected, though similar symptoms have been 
reported in females with excessive vaginal discharge or leucorrhea, which is also 
considered a “vital fluid”. 6 
 
Dhat syndrome is a true culture bound sex neurosis quite common in natives of 
the Indian subcontinent. Culture bound syndromes (CBS) were defined by Littlewood and 
Lipsedge as ‘episodic and dramatic reactions specific to a particular community. In 1969, 
Yap invented the term CBS to delineate a rare and exotic group of disorders that cause 
little damage to humanity; however, they may consist of unpredictable and chaotic 
behaviour.52,55,56 
Empirical and clinical findings are reported for south Asia, where Dhat is seen as 
a significant clinical problem, although it has described some historical and cultural 
contexts. For Western countries and Australia, the data are fewer.38 
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This may due to with industrialisation and urbanisation, the anxiety about semen 
loss in the West diminished, and the same is likely to happen in southern Asia as well. If 
we understand Dhat as a culture-bound syndrome, the historical evidence indicates that it 
was prevalent in Europe, USA and Australia in the 19th century. In those countries it 
might have disappeared in response to changes in social and economic factors, whereas it 
is still prevalent in southern Asia. It could believe that the universality of symptoms of 
anxiety (in this case secondary to feared or actual loss of semen) has to be 
acknowledged.24  
 
It found that symptoms of semen-loss anxiety were reported from a range of 
cultures; found that in the West these symptoms were mainly reported during the 19th 
century. Although there are discrepancies in the data from modern-day India, and only 
descriptions exist of the symptoms in 18th- and 19th-century Western societies, it proves 
that Dhat syndrome is not culture-bound and it is certainly not an exclusive exotic 
neurosis of the Orient. Furthermore, Dhat and Dhat syndrome as described in research 
from the Indian subcontinent is not always a homogeneous entity, and although 
syndromes by definition are heterogeneous the symptoms described are more likely to be 
psychological or psychosomatic even though their attribution to Dhat may be culturally 
influenced.23 
 
Prince & Tcheng-Laroche (1987) pleaded that culture-bound syndrome status 
should not be assigned on the basis of the geographic distribution of the illness, nor on the 
basis of a local ‘label’, notions of cause or epidemiological features. More importantly, 
they felt that the meaning of illness for both individuals and their culture should not be 
confused with syndrome descriptions or used as criteria for international 
classification.39,40  
 
Beiser (1987) considers that some conditions will never fit into the illness 
discourse and must remain exotic or unclassifiable. We feel that it is possible to 
categorise these conditions, provided the emphasis is on pathology in its true bio-
psychosocial context, allowing the diagnostic flexibility. Kleinman’s caution of category 
fallacy became much more relevant in this context (Kleinman, 1980).20 
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Tseng (2001), cultures do influence psychopathology - through pathogenic, patho-
selective, patho-plastic, patho-elaborating, patho-facilitating and patho-reactive effects - 
but we believe that the interaction between the individual and the culture is extremely 
complex. Even if the culture is patho-facilitatory or patho-reactive, the individual’s 
disorder can be and will be influenced by other factors such as personality traits, peer and 
family support available to the individual and alternative explanations of the experience.27 
 
Due to debilitate of sukkilam (semen), it excretes with urine before and after 
maturation with loss of its natural glow, colour and heaviness. This may caused by having 
sexual contacts in early adolescent age or obsessive thoughts related to possessions of 
asserts or depressive moods and lack of interest or may hereditary. Preliminary symptoms 
are; frequent maturation, tremor, excess night emission and emaciation of body.  Clinical 
features are; recurrent thread likes maturation due to observed these by the patient he felt 
that he continuously losing his semen and owing to the psychological symptoms of , and 
get suffers with panic, depression, and having delusion for loss of semen. This may leads 
to anxiety, emaciation of body, insomnia, night emission, generalized tiredness, 
bashfulness and isolation. The physical symptoms are indigestion, nausea & vomiting, 
diarrhoea or constipation and tremor on limps. If it is not treat it may leads to suicide.   
 
The “Dhat Syndrome Symptoms Checklist (DSSC)” standardised and classified 
the following clinical feature for the Dhat Syndrome (S.K. Srivastsa, Applied and 
Community Psychology - Trends and directions, Volume 2, edition 2005,  page No. 596 
to 600.);55  
 
Physical 
1. Generalized weakness 
2. Backaches 
3. Localized ache and pain 
4. Ache and pain not localized 
5. Weakness of nerves 
6. Loss of hair 
7. Fatigue  
8. Abdominal distension 
9. Constipation 
10. Shrinkage penis 
11. Excessive Salivation  
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Somatic 
12. Restlessness 
13. Excessive sweating 
14. Blurred vision  
15. Poor sleep 
16. Singing of heart 
17. Numbness in the limbs   
18. Burning sensation of chest 
19. Acidity 
20. Dryness of mouth 
21. Palpitation 
 
Psychological 
22. Fear 
23. Guilty 
24. Shyness 
25. Embarrassment 
26. Anxiety 
27. Loss of confidence 
28. Nervousness 
29. Poor memory 
30. Low mood 
31. Suicidal thoughts 
32. Not being oneself (depersonalization) 
 
Sexual/ genital 
33. Burning micturition 
34. Penile discharge 
35. Thinness of seminal fluid 
36. Penile discharge before passing urine 
37. Premature ejaculation 
38. Penile discharge after passing urine 
 
Desire 
39. Lack of interest in sex 
40. Decrease desire for sex 
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Malhotra and Wig called ‘Dhat’ ‘a sexual neurosis of the Orient’. In China, 
anxiety following semen loss (Shen-K'uie) has been associated with epidemics of Koro, 
which is another culture bound syndrome in which the individual holds the belief that his 
penis is shrinking into his body and disappearing.39  
 
Tissot's paper in 18th century stating that even an adequate diet could waste away 
through seminal emission gained popularity amongst the emerging middle class and led 
Western Europe to an era of masturbating insanity.49 
 
The International Classification of diseases ICD-10 classifies Dhat syndrome as 
both a neurotic disorder (code F48.8) and a culture specific disorder (Annexe 2) caused 
by ‘undue concern about the debilitating effects of the passage of semen.’ It is a 
commonly recognized clinical entity in India and South East Asia and is also widespread 
in Nepal, Sri Lanka, Bangladesh and Pakistan3. 
 
The amendments to DSM–IV in that it now offers an outline for cultural 
formulation in which multi-axial diagnostic assessments are supplemented by a 
systematic review of the individual’s cultural background and the role of the cultural 
context in the expression and evaluation of symptoms and dysfunction, together with the 
effect that cultural differences might have on the relationship between the individual and 
the clinician. Cultural identity of the individual and cultural explanations of the 
individual’s distress - as well as factors related to psychosocial environment, levels of 
functioning and the relationship between the individual and clinician - are important. If all 
these factors are taken into account and used seriously in diagnoses then the scope for 
culture-bound syndromes becomes even more limited, even though this category is 
retained in DSM–IV.4 
 
Differential Diagnosis  
1. Chyluria 
Chyluria, also called chylous urine, is a medical condition involving the presence 
of chyle in the urine stream, which results in urine appearing milky white. The condition 
is usually classified as being either parasitic or non parasitic. It is a condition that is more 
prevalent among people of Africa and the Indian subcontinent. Chyluria appearance is 
irregular and intermittent. It may last several days, weeks or even months. There are 
several factors that trigger Chyluria recurrence. 
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2. Chlamydia infection 
Chlamydia infection might also be related to it because of similar symptoms in 
case of infection of the urethra (urethritis), which is usually symptomatic, causing a white 
discharge from the penis with or without pain on urinating dysuria. 
 
Treatment  
Understanding of Dhat Syndrome by Modern Medicine fails to impress most 
patients. Wig suggested emphatic listening, a non-confrontational approach, reassurance 
and correction of erroneous beliefs, along with the use of placebo, anti-anxiety and 
antidepressant drugs, wherever required. Other group advocated psycho-education and 
culturally informed cognitive behavioral therapy. Good response was reported with anti-
anxiety and antidepressant drugs as compared to psychotherapy. Depression symptoms of 
this syndrome showed effective response to selective serotonin reuptake inhibitors along 
with regular counseling.47 
 
The available intervention studies suggest that the management of Dhat syndrome 
involves sex education, relaxation therapy and medications. Sex education primarily 
focuses on anatomy and physiology of sexual organs and their functioning with reference 
to masturbation, semen, nocturnal emissions. It also involves functioning with 
genitourinary system independent of gastrointestinal tract, etc. Relaxation therapy mainly 
consists of Jacobson’s Progressive Muscular Relaxation Technique, which can be 
combined with biofeedback (so as to facilitate objective evidence and mastering of 
anxiety by the patient).27 
 
The most appropriate treatment is Psycho-education and psychotherapy for treat 
the Dhat Syndrome. Further increased intake of liquids in diet and quality of nutritional 
foods should be concerned.20  
 
Cognitive Behaviour Therapy is the mainstay of treatment. At other times 
counseling, anti-anxiety and antidepressant medications have been shown to be of use.42  
 
Regular exercise, yoga, meditation and enough leisure activities are support to 
reduce the severity of the Dhat syndrome.    
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PROPERTIES OF TRIAL DRUGS 
 
INTERNAL MEDICINE: 
Venpoosani Legiyam 
 
Ingredients  
 
1. VenpoosanikaaiChaaru – (Benincasa  hispida)  - 5200 ml (4 padi) 
2. ThaalaivizhuthuChaaru – (Pandanus odoratissimus) - 1300 ml (1 padi) 
3. Thennam poo Chaaru – (Cocos nucifera)   - 1300 ml (1 padi) 
4. PazhaChaaru – (Citrus limon)  - 1300 ml (1 padi) 
5. PasuPaal (Milk)  - 2600 ml (2 padi) 
6. Sarkarai  (Sugar) - (Saccharum officinarum)   - 350 g (10 palam) 
7. Seerakam - (Cumiuscyminum)   - 35 g (1 palam) 
8. Koththumalli - (Coriandrumsativum)  - 35 g (1 palam) 
9. Kostam - (Costus speciosus)  - 35 g (1 palam) 
10. Milaku - (Piper nigram)   - 35 g (1 palam) 
11. Maasikkaai - (Quercus infectoriaolivier)  - 35 g (1 palam) 
12. Elam - (Elettaria cardamomum)   - 35 g (1 palam) 
13. Saathikkai - (Myristica fragranshoutt)   - 35 g (1 palam) 
14. Saathipathiri - (Myristica fragranshoutt)  - 35 g (1 palam) 
15. Athimathuram - (Glycyrrhiza glabra)  - 35 g (1 palam) 
16. Thaalisam - (Abiess pectabilis)  - 35 g (1 palam) 
17. Nei (Ghee)  - 650 ml (½ padi) 
18. Thenn (Honey)   - 325 ml (¼ padi) 
 
Method of preparation  
 
Dissolve the jaggery in the milk and mix the juices of 1 to 4 items then filter it and 
boil this mixture up to threadlike stage (patham) after that slowly add the powders of the 
balance items 7 to 16 and mix up well, later add the ghee and honey and blend it well. 
Then store it in clean container. 
 
 Dose   :  5g two times a day    (Punnaikkai size) 
 Duration   : 48 days 
 Diet and Regiment (pathiyam) : Tamarinds (Puli) and Smoke (Pukai) 
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UlunthuThylam   (External Medicine) 
Ingredients  
 
1. Ulunthu  (Vigna munga)  - 1.400 lit 
2. Thanneer - (water)  - 5.600 lit 
3. Vellattuppaal - (goat milk)  - 1.4 lit  
4. Nalennai (Sesamum indicum) Seasamum - 1.4 lit 
5. Punnaikkaaivitaiparuppu (Calophyllum inophyllum) - 4 g  
6. Sathakuppai(Anethum graveolens) - 4 g 
7. Perarathai (Alpinia  galangal)  - 4 g 
8. Chukku (dried Gingeber officinale)  - 4 g 
9. Milaku (Piper nigram)  - 4 g 
10. Thippili (Piper longum)  - 4 g 
11. Vetpalaipattai (Writhtia tincoria)  - 4 g 
12. Athimathuram  (Glycerrhiza glabra)  - 4 g 
13. Inthuppu (sodium chloride impure)  - 4 g 
14. Vasampu – (Acorus calamus) - 4 g  
    
   
Method of Preparation 
Preparation of decoction by Ulunthu and Water well boiled till reduced in to 1.400 
litters and filter it. 
Finely powdered items of 5 to 14 and grind it to a paste with some quantity of 
VelaattuPaal. Mix this with the VelaattuPaal and make as decoction. Boil this to make as 
a Thylamand filter it, then keep in clean container.   
Dosage      :  Quantity sufficient (Q.S.)  
Duration      :  48 days 
 Method of Application :  Apply externally and massage   
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Properties of Internal and External Medicines 
 
1. VENPOOSANI 
Botanical Name : Benincasa hisbida 
English Name : Witer melon (Ashground) 
Family : Cucurbitaceae 
Organoleptic Character 
Taste   : Inippu 
Potency  : Thadpam 
Division  : Inippu 
 
General Property  
“ngUk;g+ rzpf;fha;f;Fg; gpj;jNkh Ll;fha;r;ry;  
 mUQ;rhu ePu;fl;lUfy;-kUe;jply;  
 gpj;jRuk; m];jpRuk; Nga;twl;rp NkfKk;Nghk; 
 nkj;j mdpyKWk; tps;” 
- Agasthiyar Gunavaagadam - 
Actions: 
· Diuretic 
· Styptic 
· Tonic 
· Alterative 
 
 
Chemical Composition  
Ø Linoleic acid (C18:2 ω-6),  
Ø Palmitic acid (C16:0),  
Ø Oleic acid (C18:1) and  
Ø Stearic acid (C18:0)  
 
2. THAALAI 
Botanical Name : Pandanus odoratissmus. Linn 
English Name : Screw-pine  
Family : Pandanaceae 
Organoleptic Character 
Taste   : Thuvarppu 
Potaeny  : Thadpam 
Division  : Inippu 
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General Property  
 “kbr;Nrhw;whd; kq;ifau;f;F khjhe;jg; G+g;ghk;  
  Ntbr;rg+ew;grpia tpisf;Fe;-jbj;jKiy 
  Rf;fpyj;ij nea;iaj; Jytpf;FQ; NrhignaDk;  
  mf;Fyj;ij ePf;Fk; mwp.”   
- Agasthiyar Gunavaagadam - 
Actions: 
· Refrigerant 
· Diaphoretic 
· Antispasmodic 
 
3. THENNAI 
Botanical Name : Cocos nucifera 
English Name : Coconut tree 
Family : Arecacea 
Organoleptic Character 
Taste   : Thuvarppu 
Potency  : Thadpam 
Division  : Kaarppu 
 
General Property  
 “Nkfk; mff;nfhjpg;G tPWtp uj;jgpj;jk;  
  Ntf mrpu;f;fuNeha; tPOgpukp – Njfj;jpy;  
  tpd;dk;ghypf;Fk; tplghfk; Nghfntd;why; 
  njd;dk;ghisg; G+itj; jpd;”.   
- Agasthiyar Gunavaagadam- 
Actions: 
· Nutitive 
· Stomachic 
· Refeigerat 
· Diureti 
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4. ELUMICHAI 
Botanical Name : Citrus limon. Linn 
English Name : Lime 
Family : Rutaceae 
Organoleptic Character 
Taste   : Pulippu 
Potency  : Vetppam 
Division  : Kaarppu 
General Property  
 “jhfk; FefNeha; jhohr; rpypgjNeha;  
  Ntfq;nfhs; cd;khjk; tPWgpj;jk; - khfz;Nzha 
  fd;dNdha; the;jpAk;Nghq; fl;Lth jpj;njhopypy;  
  kd;ndYkpr;rq;fdpia tho;j;J”.  
-  Agasthiyar Gunavaagadam- 
Actions: 
· Rubefacient 
· Carminative 
 
5. KARUMUBU 
Botanical Name :         Saccharum officinarum  Linn 
English Name : Sugar cane 
Family : Poaceae 
Organoleptic Character 
Taste   : Inippu 
Potency  : Thatppam 
Division  : Inippu 
General Property:  
  “fUk;gpuj nkj;jTz;lhw; fhZq; fgNeha; 
  tpUk;gpnty;y nkj;jTz;lhy; Nkfk; - jUkJePu;  
  cz;lh kijkpjkh Az;lhy;Nk fk;gpj;jk;  
  kpz;lhkw; rhe;jKWk; tps;”.  
- Agasthiyar Gunavaagadam- 
Actions: 
· Antiseptic 
· Demulcent 
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6. SEERAGAM 
Botanical name :Cuminum cyminum  Linn 
English name     :Anise, Ani seed. 
Family                :Apiaceae. 
Organoleptic characters: 
Taste        : Karppu, Inippu . 
Potency    : Tatpam 
Division   :Inippu. 
 General Property  
“thAnthLehrpNeha; td;gpj;jQ; NruhJ 
 fhak; nefpohJfz;FspUe;- J}akyh;f; 
 fhusfg; ngz;kapNyiffz;ljpj;jidAQ; 
 rPufj;ijePjpdKe; jpd;”. 
-mfj;jpau; Fzthflk; - 
Chemical constituents: 
 Cuminaldehyde, cuminin,1,3- β menthadien-7-al, 1,4-β menthadien-7-al,δ-
terpinene, β-pinene,7-1(O- β- D-galalacturonide), 3,5- dihydroxy flavones, glycosides of 
luteolin and apigenin. [Ref. Book: Medicinal plants-Edward Jarald] 
Actions: 
· Carminative 
· Stimulant 
· Stomachic 
· Astringent 
 
7. KOTHAMALLI 
Botanical name: Coriandrum sativm Linn 
English name:  Coriander 
Family :Apiaceae 
Organoleptic characters: 
Taste        :  Karppu 
Potency    : Seetha veepam 
Division   :Karppu 
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nghJFzk;: 
nfhj;jky;ypntg;gk; Fspu;fha;r;ry; gpj;jke;jQ; 
ru;j;jptpf;fy; jhfnkhLjhJel;lk;- fj;jpnaOk; 
thjtpfhu;klu; td;fu;j;jgptpuzk; 
G+jyj;jpy; yhjfw;Wk; Nghw;W. 
- mfj;jpau; Fzthflk.;  
Chemical constituents: 
  Essential oil, Linolool, monoterpene hydrocarbous ,  borneol, citrovellol, 
camphor, geraniol, geranyl acetalis, heterocyclic components, coriandrin, 
dihyhycoriandrine, coriandrones A-E, Flavonoids, Neochidilide, phenolic acids, sterols.  
                                                                 Ref. Book: Medicinal plants-Edward Jarald 
Actions: 
· Strong antifungitoxity 
· Stomachic 
· spasmolytic 
· carminative 
· Hydolipidemic 
· Insulin releasing 
· Microbicidal 
 
8. KOSTUM 
Botanical Name : Costus speciosus,(Koeng ex Retz.)Tree  
English Name     : Insulin tree  
Family                : Zinziberaceae. 
Organoleptic Charecters: 
Taste   :Kaippu, Viruviruppu. 
Potency  :Veppam. 
Division : Kaarppu. 
General Property  
 “ehl;bYW ntl;il eLf;fk; vDNeha;fs;  
  Nfhl;lnkdr; nrhd;dhy; FiyAq;fhz; - $l;bw; 
  RuNjhle; njhz;ilNeha; Njhyhj gpj;jk;  
  guNjrk; NghNk gwe;J”.    
- Agasthiyar Gunavaagadam- 
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Actions: 
· Anti- inflammatory,  
· Spasmolytic,  
· Muscle relaxant,  
· Tonic,  
· Stimulant. 
 
9. MILAGU 
Botanical Name : Piper nigrum 
English Name : Black pepper 
Family  : Piperaceae 
Organoleptic Character 
Taste  : Kaippu, kaarppu 
Devision : Veppam 
Division : Kaarppu 
General Property  
“rPjRuk; ghz;L rpNyj;kq; fpuhzpFd;kk;  
 thjk; mUrpgpj;jk; kh%yk; - XJrd;dp 
 ahrkg]; khuk; mld;Nkfk; fhrkpit  
 ehrq; fwp kpsfpdhy;”.  
- Agasthiyar Gunavaagadam- 
Chemical Constituents: 
 A volatile alkaloid Piperine or Pipirine 5-9%, Piperidine or Piperidin 5%, 
Abalsamic volatile essential 1-2%, fat7%.Mesocarp contains chavicin, a balsamic 
volatile oil, starch, gum, Piperrettine, Piperanine, PipericideSarmentine, Eugenol. 
  Ref: Indian Herbal Pharmacopoeia, P – 321. 
Actions: 
· Carminative 
· Pungent 
· Antiperiodic 
· Analgesic 
· Anti inflammatory 
· Antioxidant 
· Cyclooxygenase inhibitory activity 
  Ref: Indian Herbal Pharmacopoeia, P – 324 Database, Vol. – 190. 
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10. MASIKKAI 
Botanical Name :  Quercus infectoria  
English Name : Majuphal  
Family : Fagaceae 
Organoleptic Character 
Taste   :Thuvarppu 
Potency  : Thadpam 
Division  : Kaarppu 
General Property   
 “mf;fuq;fs; Nghf;fptpLk; khwhj ntg;gfw;Wk;  
  Nka;f;FWjp khrpf;fha; nkd;NkYk; - jf;fnjhU 
  ghyu;fz Neha;Nghf;Fk; gd;Nkf Ke;njhiyf;Fk; 
  Ntyida fz;Nzha; tpsk;G”.  
    - Agasthiyar Gunavaagadam- 
Actions: 
· Nutitive 
· Stomachic 
· Refeigerat 
· Diuretic 
 
11. EALAM 
Botanical name : Elettaria cardamomum  Linn 
English name     : Cardamom 
Family                : Zingiberaceae. 
Organoleptic characters: 
Taste        : Karppu . 
Potency   : Veppam 
Division  : Karppu. 
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nghJFzk;: 
“njhz;iltha;fTs; jhYFjq;fspy; 
Njhd;Wk; Nehajprhuk;gd; Nkfj;jhy; 
cz;ilNghy; vOq; fl;bfpupr;ruk; 
coiythe;jprpye;jptp\Q;Ruk; 
 
gz;il ntf;iftpjhfNeha; fhrKk; 
ghOQ; Nrhkg; gpzptpe;Jel;lKk; 
mz;ilaPistd; gpj;jk; ,itf;nfy;yhk; 
My khq;fko; VykUe;Nj” 
-Theraiyar Gunavaagadam - 
Chemical constituents: 
 1,8- cineole, α-terpinyl acetate, Limonene, sabinene, α-terpineol, α-pinene, 
linalool, 4,8,12- trimethyl , 4,8- dimethyl, 1,2,7,11- tridecatetraene 
 - Ref. Book: Medicinal plants-Edward Jarald] 
Actions: 
· Anti inflammatory 
· Analgesic 
· Anti spasmodic 
· Anti oxidant 
· Cholagogue 
 
12. SATHIKKAI 
Botanical Name : Myristica fragrans 
English Name : Nut Meg 
Family : Myristicaceae 
Organoleptic Character 
Taste   : Thuvarppu, kaarppu 
Potency  : Veppam 
Division  : Kaarppu 
General Property  
“jhJ el;lk; Ngjp rUthrp aQ;fpu Neha;  
 XJRthrq; fhrk; cl;fpuzp – NtNjh 
 byf;fha; tUk;gpzpNghk; Vw;wkay; gpj;jq;  
 Fyf;fh aUe;Jtu;f;Ff; $W”. 
- Agasthiyar Gunavaagadam- 
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Chemical Constituents: 
Myristicine 
 
Actions: 
· Carminative 
· Stimulant 
· Tonic 
· Aphrodisiac 
· Aromatic 
 
13. SATHIPATHIRI 
Botanical Name : Myristica fragrans 
English Name  : Mace 
Family : Myristicaceae 
Organoleptic Character 
Suvai   : Inippu 
Thanmai  : Thadpam 
Division  : Inippu 
General Property  
 “rhjpjUk; gj;jpupf;Fj; jhgr; Rue;jzpAk; 
  XJfpd;w gpj;jk; caUq;fhz; - jhJtpu;j;jp 
  Az;lhq; fpufzpNah Nlhjf; fopr;ryWk;  
  Gz;lhq; FiwNa gfu;”.  
       - Agasthiyar Gunavaagadam -  
Actions: 
· Carminative 
· Stimuant 
· Aphrodisiac 
· Hypnotic 
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14. ATHIMATHURAM 
Botanical name: Glycyrrhiza glabra Linn 
English name   : Liquorice 
Family               : Fabaceae 
Organoleptic Characters: 
Taste        : Inippu 
Potency   : Thatpam 
Division  : Inippu 
General Property  
“fj;jpaupKg;gpzpahy; tUGz; jhfq; 
fz;Neha;cd; khjk;tpf;fy; typntz; Fl;lk; 
gpj;jnkYk; GUf;fpfpupr;ruk; Mtu;j;j 
gpj;jkj %h;r;irtplghfk; ntg;ge; 
 
jj;jptUthjNrhzpjq;jhkhiy 
rUttplq; fhkpaNeha; jhJel;lq; 
Fj;jpUky; Mrpaq;fk; ,jo;Neha; ,e;J 
Fag;GZk;Nghk; kJ}fnkdf; $Wq; fhNy”. 
- Theraiyar Gunavagadam -  
Chemical constituents: 
 Glycyrrhizin, glycyrrhizic acid, GlabraninisA& B, Isoglabrolide, 
deoxoglabrolide, glabrolide, glycyrrhetol, Liquoric, Liquiritic, glycyrrhetic, glabranine, 
pinocembrin, prunetin, glucoliquitinapioside, prenyllico flavones A, echinatin.                     
                                   - Ref. Book: Medicinal plants-Edward Jarald 
 
Actions: 
· Anti hepatotoxic activity 
· Anti diuretic activity 
· Inhibit tumor producing activity 
· Anti viral 
 
15. ULUNTHU  
Botanical Name : Vigna munga.Linn 
English Name  : Black gram 
Family : Papilionaceae 
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Organoleptic Character 
Taste   : Inippu 
Potency : Thatppam 
Division : Inippu 
General properties;  
“nra;acSe; jpw;Fr; rpNyj;ktdp yw;gpwf;Fk;  
 nta;agpj;jk; Nghke;jk; tPWq;fhz;-nka;ajdpy;  
 vd;GUf;fp jPUk; ,Lg;Gf; fLgykhk;  
 Kd;G tpUj;jpAz;lha; Kd;”.         - mfj;jpau; Fzthflk; - 
Actions 
· Demulcent 
· Refrigerant 
· Galactagogue 
· Aphriodisiac 
· Nevine tonic 
 
16.  SATHAKUPPAI 
Botanical name       : Anethum graveolens Linn 
English name          : Garden dill 
Family                     : Apiaceae 
Organoleptic characters: 
Taste                       : Inippu, Karppu 
Potency                   : Veppam 
Division                  : Karppu 
General Property 
thjnkhL #jpfhthjk; rpuRNeha; 
NkhJnrtpNeha;fgNeha; %LRuk;- XJfpd;w 
%yf; fLg;GKjpg;gpdrk; NghFk; 
Qhyr; rjFg;igehL. 
- mfj;jpau; Fzthflk;  
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Chemical constituents: 
Carvone 
Limonene 
α-bergamotene 
α-pinene 
Anonylaldehyde 
 [Ref. Book: standardization of Medicinal plants] 
Actions: 
· Carminative 
· Diuretic 
· Stimulant 
· Stomachic 
· Antispasmodic 
 
17.  PUNAIKKALI 
Botanical Name :Mucuna pruiens.Linn 
Family :Fabaceae  
Organoleptic Character 
Taste   : Thuvarppu 
Potency  : Thatppam 
Division  : Inippu 
General Property  
 “jOjisehw; wj;NjhL rhupuj;jg; Nghf;Fk; 
  gOJGup fpd;wfug; ghDk; - mONjFe; 
  jhykpir tpe;JTkhQ; rhw;ww; fUk;G+idf; 
  fhyp tpijiaf; foW.  
- Agasthiyar Gunavaagadam – 
 Actions: 
· Astringent 
· Nevine Tonic 
· Aprodisiac 
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18. PERARATTAI 
Botanical Name : Alpinia galanga 
English Name : Greater Galagal 
Family : Zingiberaceae 
Organoleptic Character 
Taste   : Kaarppu 
Potency   : Veppam 
Division  : Kaarppu 
General Property  
 “muj;ij fgj;ij mWf;Fq;fhy; Xl;LQ; 
  rpuj;jpYWk; <isiar; rpijf;Fk; - ,iuj;JtUk;  
  gpj;jNjh lj;ijg; gpwtypg;ig khw;wptpLk;  
  cw;wru;t ty;tplk;Nghf; Fk;”.    
- Agasthiyar Gunavaagadam - 
Actions: 
· Expectoant 
· Febrifuge 
· Stomachic 
 
19.  CHUKKU 
Botanical Name : Zingiber officinale 
English Name : Dried ginger 
Family : Zingiberaceae 
Organoleptic Character 
Taste   : Kaarppu 
Potency   : Veppam 
Division  : Kaarppu 
General Property  
 “#iyke;jk; neQ;nrupg;G NjhlNkg; gk;koiy  
  %yk;,iu g;gpUky; %f;FePu; - thyfg 
  Njhlkjp rhue; njhlu;thj Fd;kePu;j; 
   Njhlk;Mkk; Nghf;FQ;Rf;F”.                                                                     
- Agasthiyar Gunavaagadam - 
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Chemical constituents: 
 Camphene, Phellandrene, Zingiberine, Cineol and Borneol, Gingerol a Yellow 
Pungent body, an Oleoresin-Ginger in the active principle, other resins and starch. B – 
Sesquiphellandrene, Gingerdiols, Gingerdiacetates are also present. 
   Ref: Indian Herbal Pharmacopoeia P – 443. 
Actions: 
Aromatic 
Carminative 
Stimulant 
Stomachic 
Digestive 
 
20.  THIPPILI  
Botanical Name : Piper longum 
English Name  : Long Pepper 
Family  : Piperacae  
Organoleptic Character 
Taste  : Kaarppu 
Potency : Veppam 
Division : Kaarppu 
General property  
“MrdNeha; njhz;ilNeha; Mtuz gpj;jKjy;  
 Ehrptpop fhjpitNeha; ehl;GONeha; - tPrpLtp 
 aq;fyhQ;r dQrpijAk; mk;gha; mopte;Jk;  
 nghq;fyhQ;r eq;ifau; Nfhl;Nghy;” 
      Theran Venpa 
                                           
Chemical Constituents: 
 Piperine (4 – 5%), Volatile Oil, Piperlonguminine,Piplartine, Sesamin, 
Terpenoids, Resin, Piperundecalidine. 
  Ref: Indian Herbal Pharmacopoeia revised – 2002, P – 310, 311. 
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Actions: 
· Stimulant 
· Carminative 
· Alterative 
 
21.  VETPALAI  
Botanical Name : Wrightia tinctoria. Roxb 
English Name  : Pala indigo plant 
Family  : Apocynaceae 
Organoleptic Character 
Taste  : Inippu 
Potency : Thatpam 
Division : Inippu 
General Property  
 “mf;fpdpia itj;jpUf;F khu;e;jth jk;Nghf;Fe;  
  jpf;Fbup Njhlj;ij jPu;j;JtpLk; - nrhf;ftpU 
  fl;ghiyf; $w;iwitj;j fhd klkapNy 
  ntl;ghiy ed;kUe;jhk; tps;”. 
-  Agasthiyar Gunavaagadam - 
Actions: 
· Aphrodisiac 
· Astringent 
 
22. VASAMBU 
Botanical Name : Acrous calamus. Linn 
Synonym   : Sweet flag 
Family  : Araceae 
Organoleptic Character 
Taste  : Kaarppu 
Potency : Veppam 
Division : Kaarppu 
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General Property  
 “ghk;ghjp eQ;rw; GjGz; typ tplghfq; Fd;kk; 
  #k;gh upuj;jgpj; jk;Kf ehw;wk;td; #iyrd;dp  
  tPk;ghk;ig fhrk; gpyPfQ; rpypgjk; tPwpUky;  
  jhk;ghq; fpUkp apitNaF khrpt rk;gpidNa”.  
- Theraiyar Gunavaagadam - 
Actions: 
· Stimulant 
· Carminative 
· Antiperiodic 
· Emetic 
· Nauseant 
· Disinfectant 
 
23.  NALLENNAI 
Botanical Name : Sesamum indicum 
English Name  : Gingili oil  
Family   Name           : Pedaliaceae 
Organoleptic Character 
Taste   : Inippu 
Potency : Veppam 
Division : Inippu 
General properties 
“Gj;jpeadf; Fspu;r;rp g+upg;G nka;g;GfQ;  
 rj;Jtq; fe;jp jdpapsik-nkj;jTz;lhq; 
fz;Nzha; nrtpNeha; fghytoy; fhr Neha; 
Gz;Nzha;g;Ngh nkdz;Nzha;Ngh nkz;nza;ahw; Nghw;W”. 
- mfj;jpau; Fzthflk;- 
 
Chemical Constituents:  
 Oleic and Linoleic Acid, Calcium, Phosphorus, Sodium Chloride, Lysine, 
Methionine, Free Fatty Acid, Oxalate and Aflatoxin B1 
37 
 
Actions: 
· Demulcent 
· Laxative 
· Nutritive 
· Emollient 
 
24. THEN (HONEY)    
It is a sweet food obtained made by bees using nectar from flowers. 
 
Actions:    
Laxative  
Astringent 
Expectorant 
It has been used in the treatment of wounds, cough, in burns. 
 
Chemical composition: 
Fructose, glucose, maltose, sucrose, tiny amounts of several compounds thought 
to function as antioxidants such as chrysin, pinobanksin, vitaminC, catalase, pinocembrin.  
 
Pharmacological activity: 
Antioxidant activity of honey and its role in preventing health disorder 
 
25.  INDHUPPU  
Sodium Chloride Impura 
 Taste  : Uvarppu 
 Potency : Veppam. 
 Division  : Kaarppu. 
            Actions:            Stomachic, Diuretic, Carminative. 
General Property: 
 “ml;lFd;k ke;jk; mrpu;f;fuQ;#u; rPjgpj;je;  
  Jl;litak; ehbg;Gz; Nlhlq;fs; - nfl;lky;f; 
  fl;Ltpl tpe;ijiaf; fhkpaNeha; tq;fug;ghd;  
  tpl;Ltpl tpe;Jg;ig tps;”.              
    - Gunapaadam Thaathu Seeve Vakuppu -   
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26. VELLATTU PAAL  (GOAT MILK) 
General properties 
“nts;shl;L ghYf;FNktpaew; wPgdkhe;  
Js;shL thjgpj;jQ; rhe;jkhk;-cs;s;iug;Gr; 
 rPjkjp rhuQ;rpNy\;kkWk; Gz;zhWk;  
 thj rpNy\;kKg;Ngh kha;e;J”. 
- Gunapaadam Thaathu Seeve Vakuppu – 
Chemical constituents: 
Carbohydrate (lactose), literature related to milk composition, fat, protein, vitamins, 
and minerals. 
 
27.  PASUMPAAL (COW’S MILK) 
Chemical constituents:  
Carbohydrate (lactose), literature related to milk composition, fat, protein, 
vitamins, and minerals. 
General Property  
 “ghyu; fpotu; goQ;Ruj;Njhu; Gz;zhsp 
  #iyau; Nkfj;Njhu; Ju;gyj;Njhu; VYkptu;  
  vy;yhu;f;F khFk; ,isj;jtu;f;FQ; rhjfkha; 
  ey;yha; gRtpd; ehl;L”.    
- Agasthiyar Gunavaagadam- 
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MATERIALS AND METHODS 
 
Standard operating procedure: 
Source of trial medicine: 
The raw drugs for the preparation of Venpoosani Legiyam and Ulunthu Thylam 
were purchased from a well reputed Siddha raw drug selling shops (Herbal Shops) and 
the purchased drugs were authenticated by the competent authority from Department of 
Medicinal Botany, National Institute of Siddha. The raw drugs were purified separately 
and then the trial drugs were prepared in Gunapadam Laboratory of National Institute of 
Siddha. 
 
Method of purification of raw drugs for internal medicine: 
(Ref: Chikitcharathna Theepam, Kannusaamy Pillai, Rathna Nayakar & Sons 2007) 
1. Venpoosani kaai Chaaru – (Benincasa hispida)   
Remove the external covering of the venpoosani kai and squeeze it and filter it 
then collect the juice in suitable vessel.  
2. Thaalai vizhuthu Chaaru 
Remove the external covering of the Thaalai vizhuthu and squeeze it and filter it 
then collect the juice in suitable vessel.  
3. Thennam poo Chaaru 
Remove the external covering of the young Thennam paalai and squeeze it and 
filter it then collect the juice in suitable vessel. 
4. Pazha Chaaru 
Cut the limes and squeeze it and filter it then collect in a suitable vessel.    
5. Milk  
After feed the calf clean the udder (Cow breast) by pure water then milking the 
milk in pure vessels after that wait for some time for disappear the froth then filter 
it.  
6. Sarkarai  (Sugar) - (Saccharum officinarum)   
Grind well and collect the fine particle by using sulakun (sulaku). 
7. Seerakam - (Cumius cyminum)     
Wash it well and remove the seeds and dry it.  
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8. Koththumalli - (Coriandrum sativum)   
Covered with pure cloth and make it as kilikatti aviththal then dry it under sun 
shine. 
9. Kostam - (Costus speciosus)    
Remove the foreign particles and dry it under sun shine. 
10. Milaku  - (Piper nigram)     
Soak it by fermented butter milk for 3 hours (01 saamam) then dry it. 
11. Maasikkaai - (Quercus infectoria olivier) 
Remove the foreign particles and dry it under sun shine. 
12. Elam - (Elettaria cardamomum)     
Remove the foreign particles and dry it under sun shine.   
13. Saathikkai - (Myristica fragrans)    
Remove the external covering and cut it small pieces then dry it under sun shine.  
14. Saathipathiri 
Remove the foreign particles and dry it under sun shine. 
15. Athimathuram 
Washed it in pure water and remove the external covering then cut it as small 
particles and dry it under sun shine. 
16. Thaaleesam 
Remove the foreign particles and dry it under sun shine. 
17. Ghee  
Boil the cow batter in a sand pot until evaporate the water and filter it. 
18. Honey        
Remove the foreign particles and filter it. 
 
Drug storage: 
 The trial drug Venpoosani Legiyam (Internal) was stored in cleaned and dried 
glass container with air tighten. Ulunthu Thylam was stored in cleaned and dried narrow 
mouthed glass bottles with air tighten. 
Dispensing:  
 The Legiyam was given in packets and Oil was given in pet bottles. 
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      Venpoosani kai                          Thazhai vizhuthu                    Thennam poo 
                                 
 
 
 
 
 
 
 
 
 
 
     Elumicham pazham                              Paal                                Sarkarai 
                  
 
 
 
 
        Seerakam                                   Malli                                   Kostam 
                 
 
 
 
 
42 
 
           Milaku                               Masikkaai                                 Elam 
                  
 
 
 
 
        Saathikkaai                         Saathipathiri                      Athimathuram 
                
 
 
 
 
        Thaalisam                                  Nei (Ghee)                            Then (Honey) 
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         Ulunthu                               Velaattu paal                              Nallennai  
             
 
 
 
   Poonaikkaali vithai                    Sathakuppai                       Perarathai 
                 
 
 
 
 
           Chukku                                    Thippili                          Vetpaalai pattai 
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                            Vasampu                                                                Inthuppu                                                         
                                               
 
                     
 
                                             
 
 
 
 
 Venpoosani Legiyam 
 
 
 
 
Ulunthuth Thylam 
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BIOCHEMICAL EVALUATION 
Experimental procedure:  
 5 g of Venpoosani Legiyam was taken in a 250 ml of clean beaker and 50ml  
of distilled water was added to it. Then it was boiled well for about 10 min. Then it is 
allowed to cool and filtered in a 100 ml volumetric flask and made up to 100 ml with 
distilled water. This preparation is used for the qualitative analysis of acidic/ basic 
radicals and biochemical constituents in it. 
Preparation of extract:  
5gm of Venpoosani Legiyam weighed accurately and placed in a 250ml clean 
beaker and 50ml of distilled water was added with it. Then it was boiled well for about 10 
minutes. Then it was allowed to cool and filtered in a 100ml volumetric flask and made 
up to 100ml with distilled water. The bio-chemical analysis of Venpoosani Legiyam was 
done at Biochemistry lab, National Institute of Siddha, Chennai-47. 
Preliminary test for Copper, Sodium, Silicate and Carbonate: 
Test for Silicate: 
A little (500mg) of the sample is shaken well with distilled water. 
A little (500mg) of the sample is shaken well with con. HCl / Con.  H2So4. 
Action of Heat:  
A small amount (500mg) of the sample is taken in a dry test tube and heated 
gently at first and then strong. 
Action of Heat:  
A small amount (500mg) of the sample is taken in a dry test tube and heated 
gently at first and then strong. 
Flame Test:  
A small amount (500mg) of the sample is made into a paste with con. HCl in a 
watch glass and introduced into non-luminous part of the Bunsen flame. 
Ash Test:  
A filter paper is soaked into a mixture of sample and dil. cobalt nitrate solution 
and introduced into the Bunsen flame and ignited. 
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TEST FOR ACID RADICALS 
Test for Sulphate: 
2ml of the above prepared extract was taken in a test tube and 2ml of 4% dil. 
ammonium oxalate solution was added. 
Test for Chloride:  
2ml of the above prepared extracts was added with 2ml of dil-HNO3 until the 
effervescence ceases off. Then 2 ml of silver nitrate solution was added. 
Test for Phosphate:  
2ml of the extract was treated with 2ml of con.HNo3 and 2ml of dil. ammonium 
molybdate solution.   
Test for Carbonate:  
2ml of the extract was treated with 2ml dil. magnesium sulphate solution 
Test for Nitrate: 
1 gm of the substance was heated with copper turning and concentrated H2SO4 
and viewed the test tube vertically down. 
Test for Sulphide:  
1gm of the substance was treated with 2ml of con. HCL 
Test for Fluoride & Oxalate:  
2ml of extract was added with 2ml of dil. Acetic acid and 2ml dil.calcium 
chloride solution and heated. 
Test for Nitrite:  
3drops of the extract was placed on a filter paper, on that-2 drops of dil.acetic 
acid and 2 drops of dil. Benzidine solution were placed. 
TEST FOR BASIC RADICALS 
Test for Lead:  
2ml of the extract was added with 2ml of dil. potassium iodine solution. 
Test for Copper:  
One pinch (50mg) of substance was made into paste with con. HCl in a watch 
glass and introduced into the non-luminous part of the flame. 
Test for Aluminium:  
In the 2ml of extract dil. sodium hydroxide was added in 5 drops to excess. 
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Test for Iron: 
 
To the 2ml of extract add 2ml of dil. ammonium solution 
To the 2ml of extract 2ml thiocyanate solution and 2ml of con HNo3 is added 
Test for Zinc:  
In 2ml of the extract dil. sodium hydroxide solution was added in 5 drops to 
excess and dil. ammonium chloride was added.  
Test for Calcium:  
2ml of the extract was added with 2ml of 4% dil. ammonium oxalate solution  
Test for Magnesium:  
In 2ml of extract dil.sodium hydroxide solution was added in drops to excess. 
Test for Ammonium: 
In 2ml of extract 1 ml of Nessler's reagent and excess of dil. sodium hydroxide 
solution were added. 
Test for Potassium: 
A pinch (25mg) of substance was treated  with 2ml of dil. sodium nitrite solution 
and then treated with 2ml of dil. cobalt nitrate in 30% dil. glacial acetic acid. 
Test for Sodium:  
2 pinches (50mg) of the substance was made into paste by using HCl and 
introduced into the blue flame of Bunsen burner. 
Test for Mercury:  
2ml of the extract was treated with 2ml of dil. sodium hydroxide solution. 
Test for Arsenic:  
2ml of the extract was treated with 2ml of dil. sodium hydroxide solution. 
Other constituents 
Test for Starch:  
2ml of extract was treated with weak dil. iodine solution  
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Test for Reducing Sugar:  
5ml of Benedict's qualitative solution was taken in a test tube and allowed to boil 
for 2 minutes and added 8 to 10 drops of the extract and again boil it for 2 
minutes.  
Test for the Alkaloids: 
2ml of the extract is treated with 2ml of dil. potassium iodide solution.    
2ml of the extract is treated with 2ml of dil. picric acid. 
Test for Tannic Acid:  
2ml of extract was treated with 2ml of dil. ferric chloride solution 
Test for Unsaturated Compound:  
In the 2ml of extract 2ml of dil. Potassium permanganate solution was added.  
Test for Amino Acid:  
2 drops of the extract was placed on a filter paper and dried well, and then 20ml of 
Burette reagent was added in it. 
 
PRELIMINARY PHYTOCHEMICAL SCREENING VENPOOSANI LEGIYAM 
The preliminary phytochemical screening test was carried out for each extracts of 
Venpoosani legiyam as per the standard procedure. 
1. Detection of alkaloids:  
Extracts were dissolved individually in dilute Hydrochloric acid and filtered. 
a) Mayer’s Test: Filtrates were treated with Mayer’s reagent (Potassium Mercuric 
Iodide). Formation of a yellow coloured precipitate indicates the presence of alkaloids.  
b) Wagner’s Test: Filtrates were treated with Wagner’s reagent (Iodine in Potassium 
Iodide). Formation of brown/reddish precipitate indicates the presence of alkaloids.  
c) Dragendroff’s Test: Filtrates were treated with Dragendroff’s reagent (solution of 
Potassium Bismuth Iodide). Formation of red precipitate indicates the presence of 
alkaloids. 
d) Hager’s Test: Filtrates were treated with Hager’s reagent (saturated picric acid 
solution). Presence of alkaloids confirmed by the formation of yellow coloured 
precipitate.  
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2. Detection of carbohydrates: 
Extracts were dissolved individually in 5 ml distilled water and filtered. The 
filtrates were used to test for the presence of carbohydrates. 
Molisch’s Test:  
To 2 ml of plant sample extract, two drops of alcoholic solution of α- naphthol are 
added. The mixture is shaken well and few drops of concentrated sulphuric acid is 
added slowly along the sides of test tube. A violet ring indicates the presence of 
carbohydrates.   
Benedict’s Test:  
Filtrates were treated with Benedict’s reagent and heated gently. Orange red 
precipitate indicates the presence of reducing sugars. 
Fehling’s Test:  
Filtrates were hydrolyzed with dil. HCl, neutralized with alkali and heated with 
Fehling’s A & B solutions. Formation of red precipitate indicates the presence of 
reducing sugars. 
 
3. Detection of glycosides:  
Extracts were hydrolyzed with dil. HCl, and then subjected to test for glycosides.  
Modified Borntrager’s Test:  
Extracts were treated with Ferric Chloride solution and immersed in boiling water 
for about 5 minutes. The mixture was cooled and extracted with equal volumes of 
benzene. The benzene layer was separated and treated with ammonia solution. 
Formation of rose-pink colour in the ammonical layer indicates the presence of 
anthranol glycosides.  
Cardiac glycoside (Keller-Killiani test):   
Extract was shaken with distilled water (5 mL). To this, glacial acetic acid (2 mL) 
containing a few drops of ferric chloride was added, followed byH2SO4 (1 mL) along the 
side of the test tube. The formation of brown ring at the interface gives positive indication 
for cardiac glycoside and a violet ring may appear below the brown ring. 
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Legal’s Test:  
Extracts were treated with sodium nitroprusside in pyridine and sodium 
hydroxide. Formation of pink to blood red colour indicates the presence of cardiac 
glycosides. 
4. Detection of Saponins 
Froth Test:  
Extracts were diluted with distilled water to 20ml and this was shaken in a 
graduated cylinder for 15 minutes. Formation of 1 cm layer of foam indicates the 
presence of saponins.  
Foam Test:  
0.5 gm of extract was shaken with 2 ml of water. If foam produced persists for ten 
minutes it indicates the presence of saponins.  
5. Detection of phytosterols  
Salkowski’s Test:  
Extracts were treated with chloroform and filtered. The filtrates were treated with 
few drops of Conc. Sulphuric acid, shaken and allowed to stand. Appearance of golden 
yellow colour indicates the presence of triterpenes. 
6. Detection of phenols Ferric Chloride Test:  
Extracts were treated with 3-4 drops of ferric chloride solution. Formation of 
bluish black colour indicates the presence of phenols.  
7. Detection of tannins Gelatin Test:  
The extract is dissolved in 5 ml of distilled water and 2 ml of 1% solution of 
Gelatin containing 10% NaCl is added to it. White precipitate indicates the presence of 
phenolic compounds.  
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8. Detection of flavonoids  
Alkaline Reagent Test:  
Extracts were treated with few drops of sodium hydroxide solution. Formation of 
intense yellow colour, which becomes colourless on addition of dilute acid, indicates the 
presence of flavonoids. 
Lead acetate Test:  
Extracts were treated with few drops of lead acetate solution. Formation of yellow 
colour precipitate indicates the presence of flavonoids.  
9. Detection of proteins and aminoacids 
Xanthoproteic Test:  
The extracts were treated with few drops of conc. Nitric acid. Formation of yellow 
colour indicates the presence of proteins. 
Ninhydrin Test:  
To the extract, 0.25% w/v ninhydrin reagent was added and boiled for few 
minutes. Formation of blue colour indicates the presence of amino acid.  
Biuret test:  
2 ml of filtrate is treated with 1 drop of 2% copper sulphate solution. To this 1 ml 
of ethanol (95%) is added, followed by excess of potassium hydroxide pellets. Pink 
colour ethanolic layer indicates the presence of protein. 
10. Detection of diterpenes Copper Acetate Test: 
Extracts were dissolved in water and treated with 3-4 drops of copper acetate 
solution. Formation of emerald green colour indicates the presence of diterpenes 
 11. Gum and Mucilage:  
To 1ml of extract add 2.5ml of absolute alcohol and stirring constantly. Then the 
precipitate was dried in air and examine for its swelling properties. Swelling was 
observed that will indicate presence of gum and mucilage. 
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12. Test for Fixed oils and Fats  
Spot test:  
A small quantity of extract is pressed between two filter papers. Oil stain on the 
paper indicates the presence of fixed oils.  
 13. Test for Quinones 
Extract was treated with sodium hydroxide blue or red precipitate indicates the 
presence of Quinones. 
The Preliminary phytochemical studies of aqueous extract of Venpoosani legiyam 
were done using standard procedures. The results were presented in tables. The present 
study reveals that the bioactive compounds were present in all the extracts of Venpoosani 
legiyam. 
 
PHYSIOCHEMICAL ANALYSIS OF -VENPOOSANI LEGIYAM 
1. Loss On Drying: 
  An accurately weighed 2g of Venpoosani Legiyam formulation was taken 
in a tarred glass bottle. The crude drug was heated at 1050C for 6 hours in an oven till 
a constant weight. Percentage moisture content of the sample was calculated with 
reference to the shade dried material. 
2. Determination of total ash: 
Weighed accurately 2g of Venpoosani Legiyam formulation was added in 
crucible at a temperature 6000C in a muffle furnace till carbon free ash was obtained. 
It was calculated with reference to the air dried drug.  
3. Determination of acid insoluble ash: 
Ash above obtained, was boiled for 5min with 25ml of 1M Hydrochloric 
acid and filtered using an ash less filter paper. Insoluble matter retained on filter paper 
was washed with hot water and filter paper was burnt to a constant weight in a muffler 
furnace. The percentage of acid insoluble as was calculated with reference to the air 
dried drug. 
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4. Determination of water soluble ash: 
Total ash 1g was boiled for 5min with 25ml water and insoluble matter 
collected on an ash less filter paper was washed with hot water and ignited for 15 min 
at a temperature not exceeding 4500C in a muffle furnace. The amount of soluble ash 
is determined by drying the filtrate.  
 
Determination of water soluble Extractive: 
5gm of air dried drug, coarsely powered Venpoosani Legiyam was macerated 
with 100ml of distilled water in a closed flask for twenty-four hours shaking frequently. 
Solution was filtered and 25 ml of filtrated was evaporated in a tarred flat bottom shallow 
dish, further dried at 1000 C and weighted. The percentage of water soluble extractive was 
calculated with reference to the air dried drugs.   
 
5. Determination of alcohol soluble extractive: 
2.5gm. of air dried drugs; coarsely powdered Venpoosani Legiyam was 
macerated with 50 ml. alcohol in closed flask for 24 hrs. With frequent shaking it was 
filtered rapidly taking precaution against loss of alcohol. 10ml of filtrate was then 
evaporated in a tarred flat bottom shallow dish, dried at 1000C and weighted. The 
percentage of alcohol soluble extractive was calculated with reference to air dried drug. 
 
 
DETERMINATION OF MICROBIAL LOAD 
 
The determination of microbial load as described below was carried out on sample 
as per the WHO guidelines (Anonymous 2007) was done by Regional Research Institute 
of Unani Medicine, RRIUM, Royapuram, Chennai 13.56 
 
Pre-treatment of the test material: 
 Depending on the nature of the crude herbal material grind, dissolve, dilute, 
suspend or emulsify it using a suitable method and eliminate any antimicrobial properties 
by dilution, sterilisation or filtration.  Either phosphate buffer pH 7.0 or fluid medium, 
used to suspend or dilute the test specimen.  Test procedure for the Enterobacteriaceae 
and certain other Gram-negative bacteria. 
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Detection of bacteria 
 Homogenise the pre-treated material appropriately and incubate at 30 - 37°c for a 
length of time sufficient for multiplication of the organisms.  Shake the container, transfer 
aliquots equivalent to 1 gm or ml of the homogenised material to 100ml of entero-bacteria 
enrichment broth Mossel and incubate at 35 – 37°c for 18 – 48 hours.  Prepare a 
subculture on a plate with culer red bile agar with glucose and lactose.  Incubate at 35 - 
37°c for 18-48 hours.  The material process of the test, if no growth of colonies of Gram - 
negative bacteria is detected on the plate. 
Test Procedure: 
Plate Count: 
 For bacteria use Petri dishes 9-10 cm in diameter.  To one dish add a mixture of 
1ml of the pre-treated herbal material and about 15ml of liquefied casein-soya bean digest 
agar at a temperature not exceeding 45°c. Alternatively, spread the material on the surface 
of the subdivide medium in a Petri dish.  If necessary, dilute the material to obtain an 
expected colony count of not more then 300.  Prepare two dishes using the same dilution, 
invert them and incubate them at 30-35°c for 48-72 hours, unless a reliable count is 
obtained in a short period of time.  Count the number of colonies formed and calculates 
the result using the plate with the largest number of colonies, up to a maximum of 300.  
For fungi use Petri dishes 9-10cm in diameter.  To one dish add a mixture of 1ml of pre-
treated material and about 15ml of liquefied saborated glucose agar with antibiotics at a 
temperature not exceeding 45°c alternatively, spread the pre-treated material as described 
above to obtain are expected colony count of not more than 100.  Prepare at least two 
distinguishing the same dilution and incubate them upright at 20-25°c for 5 days, unless a 
more reliable count in obtained in a shorter period of time.  Count the number of colonies 
formed and calculates the results using the dish with not more than 100 colonies. 
E. coli: 
 Transfer a quantity of the homogenised material in lactose both prepared and 
incubated to described above, containing 1g or 1ml of the material being examined to 
100ml of MacConkey agar and incubate at 43-45°c for 18-24 hours.  Prepare a subculture 
on plate with MacConkey agar and incubate at 43-45°c for 18-24 hours.  Growth of red, 
generally non-mucoid colonies of Gram-negative tods, sometimes surrounded by a 
reddish zone of precipitation, indicates the possible of E.Coli.  This may be confirmed by 
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the formation of indole at 43.5-44.5°c or by other biochemical reactions.  The material 
passes the test if no such colonies are detected or if the confirmatory biochemical 
reactions are negative. 
Salmonella: 
 Incubate the solution, suspension or emulsion of the pre-treated material prepared 
an described above at 35-37°c for 5-24 hours, as appropriate for enrichment.  
Primary test 
 Transfer 10 ml of the enrichment culture to 100 ml of tetrachionats bide brilliant 
broth and incubate at 42-43° for 18 – 24 hours.  Prepare subcultures on at least two of the    
following three agar media citrate agar, sylose, lysine deoxycholate agar, and birllen agar, 
in culture at 35 – 37° c for 24 – 48 hours. 
Secondary test 
 Prepare a subculture of any colonies showing the characteristics on the surface of 
triple sugar iron agar using the deep inoculation technique. This is done by first 
inoculating the needle and then, incubating at 35 – 37 c for 18 – 24 hours.  The test is 
positive for the presence of salmonella spp.  If a change of colour from red to yellow is 
observed in the deep culture ( but not in the surface culture), usually with the formation of 
gas with or without productions on hydrogen sulphide in the agar.  Confirmation is 
obtained by appropriate biochemical and serological tests.  The material being examined 
passes the test if cultures of the type described do not appear in the primary test, or if the 
confirmatory biochemical and serological tests are negative. 
Staphylococcus aureus: 
 Prepare an enrichment culture as described for Pseudomonas aerginosa.  Prepare a 
subculture on a suitable medium such as Baird – parker agar.  Incubate at 35 - 37° c for 
24-48 hours.  The material passes the test if no growth of microorganisms is detected.  
Black colonies of Gram positive cocci often surrounded by clear zones may indicate the 
presence Staphylococcus aureus.  For catalase - positive cocci, confirmation may be 
obtained, for exam by coagulase and deoxyribonuclese tests. 
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VENPOOSANI LEGIYAM 
PART - C: TEST PERFORMED 
Microbial load:  
The procedures recommended for analysis of microbial load as per the WHO 
guideline (WHO, 2007). 
Test for Aflatoxin:  
The procedures recommended for the detection of Aflatoxin as per WHO guidelines 
(WHO 2007).57   
Instrument Details:  
Name of the Instrument : CAMAG (CAMAG - Automatic TLC sampler, 
   Scanner and Visualiser) 
Spray Gas : N2 
Lamp used : Deuterium and Tungsten Lamp 
 The samples were processed as per procedures recommended in WHO 2007 and 
applied for the Thin Layer Chromatography and High Performance Thin Layer 
Chromatography study with suitable solvent systems. After development the plate was 
allowed to dry in air and examined under UV 366nm.   
Test for Aflatoxin analysis: 
 The sample (8µl) and Standard - G2, G1, B2 and B1 (20µl) were applied on TLC 
aluminium sheet silica gel 60 F 254 (E.MERCK) and plate was developed using the 
solvent system Chloroform: Acetone: Water (14: 2: 0.2). After development the plate was 
allowed to dry in air and examined under UV 366 nm. 
CLINICAL STUDY 
STUDY TYPE  :  An Open Clinical Trial 
STUDY PLACE  :  OPD of Ayothidoss Pandithar Hospital,  
       National Institute of Siddha, 
       Tambaram Sanatorium, Chennai – 600047 
STUDY PERIOD  :  2014– 2017 
SAMPLE SIZE  :  40 patients 
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SUBJECT SELECTION: 
         Patients reporting with symptoms of inclusion criteria were subjected to screening 
test and documentation. 
Inclusion criteria:   
Ø Age : 18 - 45 years 
Ø Sex : Males only  
Ø Weakness, anxiety, sleeplessness, mild depression and guilt which is attributed to 
semen loss. 
Ø Loss of semen through nocturnal emissions and masturbation frightens the 
individual as he believes it to be harmful to the body.  
Ø Report a white discharge in their urine which they feel is semen.  
Ø Mention that passing semen during defecation  
Ø Sexual dysfunction may or may not be present.  
Ø Willing to give specimen of blood and sperm for the investigations before and 
after treatment.  
Ø  Willing to participate in Psycho – education therapy sessions 
Ø  Willing to participate in trial and signing consent by fulfilling the condition of 
Proforma. 
Exclusion criteria:  
Ø Chyluria 
Ø Diabetes mellitus   
Ø Severe Cardiac Diseases 
Ø Severe Respiratory Diseases 
Ø Acute and chronic Renal Diseases 
Ø Needed for Surgical Treatment     
Ø Alcohol and Substance Abuse 
Ø Other severe Psychiatric Illness 
Ø Mentally Challenged  
Ø Physically Challenged  
Ø Severe Malignancy Diseases 
Ø Any other chronic Illness 
58 
 
Withdrawal criteria:  
Ø Intolerance to the drug and development of any serious adverse effect during drug 
trial. 
Ø Poor patient compliance & defaulters 
Ø Patient unwilling to continue the course of clinical study 
Ø Patient reluctant to continue the Psycho-education sessions  
Ø Any drastic changes occurring in hematological finding during treatment period. 
Ø Increase in severity of symptoms 
Ø Occurrence of any other systemic illness 
TESTS AND ASSESMENTS: 
1. Clinical assessment 
2. Siddha system assessment 
3. Routine investigations 
1.Clinical Assessment: 
Ø Conduct by use the Dhat Syndrome Symptoms Check-list  (DSSC) 
Ø Psycho – Educations Screening and Assessment Questionnaire 
2. Investigations based on Siddha system: 
1. Naadi 
2. Sparisam 
3. Naa 
4. Niram 
5. Mozhi 
6. Vizhi 
7. Malam 
8. Moothiram 
· Neerkkuri : 
· Neikkuri   : 
 
3.  INVESTIGATION: 
BLOOD 
· Hb 
· Total WBC Count 
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· Polymorphs 
§ Lymphocytes  
§ Eosinophils 
§ Monocytes  
§ Basophils  
· Total RBC count  
· ESR ½ Hr:       1 Hr: 
· Blood sugar : Fasting:        PP: 
· Serum cholesterol 
URINE 
· Albumin 
· Sugar(F)                    (PP) 
· Deposits 
RENAL FUNCTION TESTS 
             Blood Urea 
             Serum Creatinine 
             Uric acid 
LIVER FUNCTION TESTS 
              Serum total Bilirubin 
              Direct Bilirubin 
              Indirect Bilirubin 
              Serum Alkaline Phosphatases 
              SGOT  
              SGPT 
LIPID PROFILE: 
    HDL:  
    LDL:              
    VLDL:  
    Total Cholesterol  
    TGL:   
SEMEN ANALYSIS  
 Normal Semen analysis test  
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DATA COLLECTION: 
Required information will be collected from each patient by using the following 
forms; 
Forms:  
Form I            Screening and selection Proforma,  
Form I B Psychological assessment Performa  
Form II           History taking & Clinical assessment Proforma 
Form III          Laboratory investigation Proforma 
Form IV         Drug compliance form 
Form V Adverse Reaction / Pharmaco Vigilance form  
Form VI          Patient information sheet 
Form VII         Patient Consent form 
Form VIII       Withdrawal form 
Form IX      Dietary Advice form 
 
Study Enrolment: 
· Patients reporting at the OPD with symptoms of weakness, anxiety, sleeplessness, 
mild depression and guilt which is attributed to semen loss, and loss of semen 
through nocturnal emissions and masturbation frightens the individual as he 
believes it to be harmful to the body and also report a white discharge in their 
urine which they feel is semen are chosen for enrolment based on the inclusion 
and exclusion criteria. 
 
· The enrolled patients will be informed about the study, trial drug, possible 
outcomes and the objectives of the study in the language and terms understandable 
to them and getting consent in the Informed Consent form (Form VI). 
 
· Complete clinical history, complaints and duration, examination findings all 
would be recorded in the prescribed Proformas. 
 
· Screening Form- I and I.B will be filled up, Form –II and Form –III will be used 
for recording the patients, history, clinical examination of symptoms and signs 
and laboratory investigations respectively. If there is any abnormal laboratory 
reports obtained then excluded from this study. Patients would be advised to take 
the trial drug and appropriate dietary advice (Form IX)   would be given according 
to the patients, perfect understanding. 
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Conduct of the study: 
Three days before the treatment, purgation therapy had given with Meganatha 
Kulikai- 2 in the early morning with Inji chaaru (ginger juice) for normalising the vital 
humours. Then the trial Medicines “Venpoosani Legiyam” (internal) and “Ulunthuth 
Thylam” (external) was given for 48 days.  
Among the 40 patients, 20 patients were received trial the medicines only and the 
remaining (randomised) 20 patients were received the prescribed Psycho-education / 
Counselling therapy along with trial medicines.   
  The patients are requested to visit the hospital OPD once in 7 days for 48 days. In 
each and every visit the patients received trial medicines and also underwent clinical 
assessment and the prognosis were recorded with the supervision of the Faculty member.  
     The each randomised selected 20 patients (1, 2, 5, 7, 9, 12, 13, 15, 17, 19, 21, 22, 
25, 27, 29, 32, 34, 36, 37 and 39) were received the Psycho-education / Counselling 
session for six times per week from the 2nd visit for the trial medicine to 7th visit.   
Laboratory investigations were done before and after the trial. At the end of the 
trial, the patients were advised to visit the OPD for further 2 months for follow-up for any 
recurrence. Defaulters had not allowed to continue and withdrawn from the study with 
fresh case had being inducted. 
Adverse / serious effects management: 
In this study, no adverse events were observed during the course of the treatment 
and follow-up periods. 
 
 
DATA ANALYSIS: 
Data analysis: 
After enrolled the patients in the study, a separate file for each patient was 
maintained and all forms were kept in the file. Study number and patient’s number were 
entered on the top of the file for easy identification. Whenever the patients visit to OPD 
during the study period, the necessary entries was made at the assessment forms.  
The screening forms were filled separately. All forms were further scrutinized by 
Senior Research Officer (Statistics) for logical errors and incompleteness of data to avoid 
any bias. No modification in the results is permitted for unbiased reports. The software of 
SPSS will be used for data analysis.    
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Dhat Syndrome Symptoms Checklist (DSSC) 
(S.K. Srivastsa, Applied and Community Psychology - Trends and directions, Volume, 2, 
edition 2005,  page No. 596 to 600.)    
This questionnaire enquires about the problem of Dhat. I request you to read each 
question carefully and tick (√) Score of most suits to your response (s) considered to be 
most appropriate by you. Please answer all questions.  
 Symptoms 
Scoring 
00 01 02 03 04 
 Physical      
01 Generalized weakness      
02 Backaches      
03 Localized ache and pain      
04 Ache and pain not localized      
05 Weakness of nerves      
06 Loss of hair      
07 Fatigue      
08 Abdominal distension      
09 Constipation      
10 Shrinkage penis      
11 Excessive salivation      
 Somatic      
12 Restlessness      
13 Excessive sweating      
14 Blurred vision       
15 Poor sleep      
16 Singing of heart       
17 Numbness in the limbs        
18 Burning sensation of chest      
19 Acidity      
20 Dryness of mouth      
21 Palpitation       
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Scoring  
00 - Not at all     01 - Mildly        02 - Moderately         03 - Severe         04 - More severe. 
Scoring chart 
 
          0                              1                               2                            3                             4 
 Psychological      
22 Fear       
23 Guilty       
24 Shyness      
25 Embarrassment       
26 Anxiety      
27 Loss of confidence      
28 Nervousness      
29 Poor memory      
30 Low mood      
31 Suicidal thoughts      
32 Not being oneself (depersonalization)       
 Sexual/ genital      
33 Burning micturition       
34 Penile discharge      
35 Thinness of seminal fluid      
36 Penile discharge before passing urine      
37 Premature ejaculation      
38 Penile discharge after passing urine      
 Desire      
39 Lack of interest in sex      
40 Decrease desire for sex      
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Psycho – Education / Counselling Screening and Assessment Questionnaire 
 
Psychological and Counselling  
Brief Adult Outcome Questionnaire Version II (BAOO – II) 
The Brief questionnaire asks about some of the most commonly reported thoughts, 
feeling and behaviours among adults seeking behavioural health treatment. Please think 
about the past two weeks and answer the questions below to the best of your ability. This 
will help you and your therapist / doctor to plan your treatment and monitor your 
improvement.   
  How often did you Never Hardly 
ever 
Some 
times 
Often Very 
often 
01 Feel unhappy or sad      
02 Have little or no energy      
03 Have a hard time getting along with family, 
friends, or co-workers  
     
04 Feel hopeless about the future      
05 Have a hard time paying attention       
06 Feel unproductive at work or other daily 
activities 
     
07 Feel tense or nervous      
08 Have problem with sleep (too much or too 
little) 
     
09 Feel lonely      
10 Think about harming yourself      
11 Have someone express concerns about your 
loss of semen  
     
12 Have more than five times of passing semen 
in a one week time 
     
13 Have a problem at work, college, or home 
because of excess semen loss issue 
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Please take a moment to assess your last session to help us better serve your needs: 
 
 Please answer according to their 
relevance 
True Almost 
True 
Unsure Almost 
False 
False 
01 I felt we talked about the things that were 
important to me. 
     
02 I felt that the therapist/ doctor liked and 
understood me.   
     
03 I felt that the session has helpful.       
04 I felt confident that the therapist/ doctor and 
I worked well together 
     
 
 
Outcome: 
Primary Outcome 
1. Comparison before and after intervention with DSSC 
2. Categorization by the DSSC scoring   
· DSSC scoring  ≤ 40  - Good 
· DSSC scoring  41 to 80 - Moderate 
· DSSC scoring    81 to 120 - Mild 
· DSSC scoring    ≥ 121 - Nil 
 
Secondary Outcome  
Ø The effectiveness of Psycho-education by comparing before and after 
treatment   
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RESULTS OF PRECLINICAL STUDY 
1). BIO-CHEMICAL AND ELEMENTAL ANALYSIS OF TRIAL MEDICINE 
Qualitative Analysis 
SL. 
NO 
EXPERIMENT OBSERVATION INFERENCE 
1. Appearance of the sample 
Greenish Brown in 
Colour 
 
2. Solubility:  
a. A little of the sample is 
shaken well with distilled 
water. 
b. A little of the sample is 
Shaken well with con. Hcl 
 Con. H2SO4. 
 
Completely soluble 
 
 
 
Completely soluble 
 
 
 
 
 
Absence of 
Silicate 
3. Action of Heat: 
A small amount of the sample 
is taken in a dry test tube and 
heated gently at first and then 
Strong. 
 
White fumes not evolved 
Brown fumes not 
evolved 
 
Absence of 
Carbonate.                        
Absence of 
Nitrate. 
4. Flame  Test: 
A small amount of the sample 
is made into a paste with con. 
Hcl in a watch glass and 
introduced into non-luminous 
part of the Bunsen flame. 
 
White flame  is appeared 
 
 
Absence of 
Copper. 
5 Ash Test: 
A filter paper is soaked into a 
mixture of sample and cobalt 
nitrate solution and introduced 
into the Bunsen flame and 
ignited. 
 
No Yellow colour flame. 
 
Absence of 
Sodium. 
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Preparation of extract  
 5 gm of Venpoosani Legiyam was weighed accurately and placed in a 250 ml 
clean beaker. Then 50 ml distilled water was added and dissolved well. Then it is boiled 
well for about 10 minutes. It was cooled and filtered in a 100 ml volumetric flask and 
then it was made up to 100 ml with distilled water. This fluid was taken for analysis. 
SL. 
NO. 
EXPERIMENT OBSERVATION INFERENCE 
TEST FOR ACID RADICALS 
1. Test For Sulphate: 
a. 2 ml of the above prepared 
extract is taken in a test tube to 
this added 2ml of 4% ammonium 
oxalate solution. 
b. 2ml of the above prepared 
extract is added with 2 ml of dil-
Hcl is added until the 
effervescence ceases off. Then 
2ml of Barium chloride solution 
is added. 
Cloudy appearance 
present 
 
A white precipitate 
insoluble in con. 
Hcl is obtained 
Absent of Sulphate  
 
 
 
 
2. Test For Chloride: 
2 ml of the above prepared 
Extract is added with dil. HNO3 
till the effervescence ceases. Then 
2 ml of silver nitrate solution is 
added. 
Cloudy appearance 
present (Mild trace 
element) 
 
Presence of 
Chloride. 
3. Test For Phosphate: 
2 ml of the extract is treated with 
2ml of ammonium molybdate 
solution and 2 ml of con. HNO3 
 No Cloudy yellow 
appearance 
Absence of  
Phosphate.        
4. Test For Carbonate: 
2m1 of the extract is treated with 
2m1 magnesium sulphate solution 
No cloudy 
appearance 
Absence of 
Carbonate. 
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Test For Nitrate: 
1gm of the substance is heated 
with copper turnings and 
concentrated H2SO4   and viewed 
the test tube vertically down. 
 
Brown gas is not 
evolved 
 
 
Absence of Nitrate. 
 
 
 
6. Test For Sulphide: 
1 gm of the substance is treated 
with 2m1 of con. Hcl. 
 
No Rotten egg 
smelling gas 
evolved 
 
Absence of Sulphide. 
 
7. 
 
 
 
 
Test for Fluoride and oxalate 
2 m1 of The Extract Is Added 
With 2m1of Acetic Acid and 2 
m1 calcium Chloride solution and 
heated. 
 
No Cloudy 
appearance. 
 
 
Absence of  Fluoride 
& Oxalate 
8.  
 
 
 
Test for Nitrate 
   3 drops of extract is placed on a 
filter paper, on that 2 drops of 
acetic Acid and 2 drops of 
benzidine solution is placed. 
 
No characteristic 
Changes. 
 
 
Absence of nitrite. 
9. 
 
 
 
 
 
Test For Borate: 
    2 pinches of the substance is 
made into paste by using 
sulphuric acid and alcohol (95%) 
and introduced into the blue 
flame. 
 
 
 
 
Absence of borate. 
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II. TEST FOR BASIC RADICALS 
1 Test For Lead: 
2 m1of the extract is added with 
2m1of potassium iodide solution. 
 
 No Yellow 
precipitate 
is obtained 
 
Absence of Lead. 
2. Test for Copper: 
a. One pinch of substance is made 
into paste with con. Hcl in a 
watch glass and  introduced into 
the non-luminous part of the 
flame. 
b. 2 ml of extract is added with 
excess of ammonia solution. 
 
No Blue colour 
flame precipitate 
 
 
No Blue colour 
precipitate  
 
Absence of Copper. 
 
 
 
Absence of Copper. 
3. Test For Aluminium: 
Take the 2m1of the extract 
sodium hydroxide is added in 
drops to excess. 
 
No characteristic 
changes 
 
 
Absence of 
Aluminium. 
 
4. Test  For  Iron: (Ferrous) 
To the 2 ml of extract 2m1                                         
ammonium thiocyanate solution                           
and 2m1of con.HNO3 is added. 
 
 
Blood red colour 
Appearance 
 
 
 
 
Presence of Iron. 
 
 5. Test For Zinc: 
 To 2m1 of the extract sodium 
hydroxide solution is added in 
drops to excess. 
 
White precipitate is 
not Formed 
 
Absence of Zinc. 
 
6. Test For Calcium: 
2m1 of the extract is added with 
2m1 of 4% ammonium oxalate 
Solution. 
 
Cloudy appearance 
and white 
precipitate                       
is obtained 
 
Absence of Calcium. 
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7. Test For Magnesium: 
 To 2ml of extract sodium                                   
hydroxide solution is added in 
drops to excess. 
 
White precipitate is 
not obtained. 
 
Absence of 
Magnesium. 
8. Test For Ammonium: 
To 2ml of extract few ml of 
Nessler's reagent and excess of 
sodium hydroxide solution are 
added. 
 
No brown colour 
appeared. 
 
 
Absence of 
Ammonium. 
9. Test For Potassium: 
 A pinch of substance is treated 
with 2ml of sodium nitrite 
solution and then treated with 
2m1 of cobalt nitrate in 30% 
glacial acetic acid. 
 
No Yellowish 
precipitate is 
obtained 
 
 
 
Absence of 
Potassium. 
10. Test For Sodium: 
2 pinches of the substance is 
made into paste by using HCL 
and introduced into the blue flame 
of Bunsen burner. 
 
No Yellow colour  
Flame appeared. 
 
 Absence of Sodium. 
 
11. Test For Mercury: 
2 m1 of the extract is treated with 
2ml of sodium hydroxide 
solution. 
 
 
 Yellow precipitate                           
is not obtained 
 
 
 
Absence of Mercury. 
 
 
12. 
Test For Arsenic: 
2 m1 of the extract is treated with 
2m1 of sodium hydroxide 
solution. 
 
No brownish red 
Precipitate is 
obtained 
 
Absence of Arsenic. 
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III. MISCELLANEOUS 
1. Test for Starch: 
2 ml of extract is treated with weak 
iodine solution. 
No blue colour 
developed 
Absence of Starch. 
 
2. Test For Reducing Sugar: 
5. ml of Benedict's qualitative 
solution is taken in a test tube and 
allowed to boil for 2 minutes and 
added 8 to 10 drops of the extract 
and again boil it for   2 minutes. 
The colour changes are noted. 
 
 No Brick red 
colour developed 
 
Absence of Reducing 
sugar. 
3. Test For The Alkaloids: 
a. 2m1 of the extract is treated with 
2 ml of potassium Iodide solution.                       
b. 2m1 of extract is treated with 
2ml of picric acid. 
c. 2m1 of the extract is treated with 
2ml of phosphotungstic acid. 
 
Red colour 
developed 
 
Trace Yellow 
colour developed 
White precipitate 
developed 
 
Presence of 
Alkaloid. 
 
Trace of Alkaloid 
present. 
Presence of 
Alkaloid. 
4. Test for Tannic Acid: 
 2 ml of extract is treated with  
2ml of ferric chloride solution. 
 
Black precipitate 
is obtained 
 
Presence of Tannic 
acid. 
 5. Test for Unsaturated Compound: 
   To the 2ml of extract 2ml of 
Potassium Permanganate solution is 
added. 
Potassium 
Permanganate is  
decolourised 
Presence of 
Unsaturated 
Compound. 
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6. Test For Amino Acid: 
   2 drops of the extract is placed on 
a filter paper and dried well and 2 
ml of biuret reagent is added 
 
 
 
No Violet colour 
developed 
 
Absence of Amino 
acids. 
7. Test For type of Compound: 
  2ml of the extract is treated with 2 
ml of ferric chloride solution. 
 
Green colour 
developed 
 
 
No Red colour 
developed 
 
 
 
No Violet colour 
developed 
 
 
No blue colour 
 developed 
 
Presence of oxy 
quinole epinephrine 
and pyro catechol. 
 
Anti pyrine, Aliphatic          
amino acids and 
Meconic acid are 
absent. 
 
Apomorphine, 
Salicylate and 
Resorcinol are absent. 
 
Morphine, Phenol 
cresol and hydro 
quinone are absent 
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RESULT: 
 The Bio-chemical analysis of Venpoosani Legiyam had shown the presence of 
Chloride, Phosphate, Reducing Sugar, Iron, Tannic acid, oxy quinole epinephrine and 
pyro catechol, unsaturated compound and Alkaloids. 
 
2. PHYTOCHEMICAL ANALYSIS  
S.no Phytochemicals Test Name H2O ext. 
1. 
Alkaloids 
  
  
Mayer’s Test -ve 
Wagner’s Test -ve 
Dragendroff’s Test -ve 
Hager’s Test -ve 
2. 
Carbohydrates 
  
Molisch’s Test: +ve 
Benedict’s Test +ve 
Fehling’s Test -ve 
3. 
Glycoside 
  
Modified Borntrager’s Test +ve 
Cardiac glycoside (Keller-Killiani 
test) 
+ve 
Legal’s Test +ve 
4. 
Saponin  
   
Froth Test -ve 
Foam Test +ve 
5. Phytosterol Salkowski’s Test +ve 
6. Phenol Ferric Chloride Test +ve 
7. Tannins Gelatin Test -ve 
8. 
Flavonoids  Alkaline Reagent Test +ve 
Lead acetate Test +ve 
9. 
Proteins and amino 
acids 
Xanthoproteic Test +ve 
Ninhydrin Test -ve 
Biuret test +ve 
10. Diterpenes Copper Acetate Test +ve 
11. Gum and Mucilage Extract + alcohol +ve 
12. Fixed oils and Fats Spot test +ve 
13. Quinones NAOH + Extract +ve 
+ve/-ve present or absent if component tested 
The above stated physiochemical properties for the given sample certified to be present. 
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3)  PHYSIOCHEMICAL ANALYSIS OF -VENPOOSANI LEGHEYAM 
S.no Parameters Percentage 
1 Loss on drying 11.09% 
2 Total ash value 1.49% 
3 Acid insoluble ash Less than 1% 
4 Water soluble ash Less than 1% 
5 Water soluble extraction 54.84% 
6 Alcohol soluble extraction 35.08% 
 
The above stated physiochemical properties for the given sample certified to be present. 
 
RESULT OF DETERMINATION OF MICROBIAL LOAD 
Analysis of Microbial Load: 
S. 
No. 
Parameters 
Reference 
Limits as per 
WHO (2007) 
Results Remarks 
1 Total Bacterial Count 
(TBC) 
105CFU/gm 3x103cfu/ml  
Within 
permissible 
limits 
2 Total Fungal Count (TFC) 103CFU/gm Less than 10 cfu/ml 
3 Enterobacteriaceae 103 Absent 
4 Escherichia coli 10 Absent 
5 Salmonella Spp  Absent Absent 
6 Staphylococcus aureus Absent Absent 
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Result of Aflatoxin analysis Test: 
 
 
 
UV-366nm 
 
 
 
Densitometric chromatogram at UV-366nm  
Standard – G2, G1, B2 & B1; Test sample 
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HPTLC finger print of Standard at 366nm 
 
 
Rf value of Standard at 366nm  
 
 
HPTLC finger print of Test sample at 366nm 
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Rf value of Test sample at 366nm  
 
Note:  
Similar Rf values were seen in the standard and test sample, upon  derivatization 
with  isopropyl alcohol  and  conc. H2 SO4  (9:1), the band colour changed from bluish 
green to yellow in Track 1 (standard) where as no colour change was seen in the Track 2 
(TS) which indicated the absence of aflatoxins in the Test sample.  
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OBSERVATION AND RESULTS CLINICAL STUDY 
The observation and results were studied and tabulated under the following heading. 
1) Age Distribution 
2) Occupational Status 
3) Family History 
4) Diet Habits 
5) Thinai Reference 
6) Kaalam Distribution 
7) Yakkai Ilakkanam (Physical Constitution) 
8) Gunam Reference 
9) Duration of Illness 
10) Distributions of Muth Thodam (Tri Humours) 
11) Udal Kattukkal Reference 
12) En Vagai Thervugal 
13) Neerkkuri, Neikkuri Reference 
14) Haematology General report 
15) Haematology Biochemistry report 
16) Urine Analysis  
17) Sperm Analysis 
18) DSSC Score Before and After Treatment 
19) Results DSSC Score Before and After Treatment 
20) Results after OPD Treatment 
21) Result after Psycho-education / Counselling therapy 
22) Statistical Significance of Treatment (Clinical Trial) 
23) Statistical Significance of Psycho-education / Counselling  
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1) Age Distribution 
 
Sl. No Age No of Cases Percentage 
1 18 - 24 5 12.5 % 
2 25 - 31 12 30.0 % 
3 32 - 38 11 27.5 % 
4 39 - 45 12 30.0 % 
 
 
 
 
 
Observation: 
 The patients were selected from all age groups as given above and the maximum 
numbers of patients [12 (30%)] were in the age groups between 18 – 24 and 32 - 38. 
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2) Occupational Status 
Sl. No Nature of Work No. of Cases Percentage 
01 IT Professionals  04 10.0 % 
02 Electricians/ Technicians  11 27.5 % 
03 Business 04 10.0 % 
04 Farmers / Labourer works 15 37.5 % 
05 Driver  04 10.0 % 
09 Unemployee 02 05.0 % 
 
 
 
 
Observation:    
 The majority of patients in this study were in the group of Farmers and manual 
labour workers 15 cases (37.5%). 
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3) Family History 
 
Sl. No. Criteria No. of Cases Percentage 
   01 Family History (Relevant)           00         00 % 
   02 Family History (No relevant)           40         100 % 
 
Observation: 
 All the patients having no relevant family history in this regards of Ven Neer Noi 
(Dhat Syndrome).  
 
4) Dietary Habits 
 
Sl. 
No. 
Dietary Habits No. of Cases Percentage 
    1 Vegetarian            08          20 % 
    2 Non Vegetarian            32          80 % 
 
 
 
 
 
Observation: 
 32 (80 %) of the patients were having habits of Non-Vegetarians. 
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5) Thinai Reference 
 
Sl. 
No 
Thinai No. of Cases Percentage 
1 Kurinji (Hill Area) 01 02.5 % 
2 Mullai (Forest Area) 01 02.5 % 
3 Marutham (Fertile Land) 37 92.5 % 
4 Neithal (Coastal Area) 01 02.5 % 
5 Paalai (Desert Land) 00 00 % 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Observation: 
 92.5 % of the patients were from Marutham Nilam (Fertile land) and the 
remaining (2.5%) from Kurinchi Nilam (Hill Area), 2.5 % from Mullai Nilam (Forest 
Area) and 2.5 from Neithal Nilam (Coastal Area). No one of the patients was from 
Paalai Nilam (Desert Land). 
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6)  Kaalam Distribution  
 
Sl No Kaalam No. of Cases Percentage 
1 Kaar kaalam 00 00 % 
2 Koothir kaalamn 00 00 % 
3 Munpani kaalam 02 05 % 
4 Pinpani kaalam 38 95 % 
5 Elavenil kaalam  00 00 % 
6 Muthuvenil kaalam  00 00 % 
 
 
 
Observations  
 38 (95 %) patients received the treatment from the period of Pinpani kaalam, 02 
(5%) were received the treatment from Munpani kaalam.  
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7) Yaakai Ilakkanam (Physical Constitution) 
 
Sl. No Yaakai Ilakkanam No. of Cases Percentage 
1 Vaatha Udal 0 00 % 
2 Piththa Udal 0 00 % 
3 Kaba Udal 0 00 % 
4 Thontha Udal 40 100 % 
 
           
 
Observation: 
 40 (100 %) of the patients were constituents of the body is Thontha Udal . 
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8) Gunam (Quality and Characters) 
 
Sl. No Gunam No. of Cases Percentage 
1 Sathuva Gunam 00 00 % 
2 Rajo Gunam 40 100 % 
3 Thamo Gunam 00 00 % 
 
 
 
Observation: 
 All of the patients 40 (100 %) had “Rajo Gunam”. Patients were having Sathuva 
Gunam and Thamo Gunam not appeared.    
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09)  Duration of Illness 
 
Sl. No Duration of Illness No of Cases Percentage 
1. Below 01year 05 12.5 % 
2. Above 1 - 2 years 20 50.0 % 
3. Above 2 - 3 years 10 25.0 % 
4. Above 3 years 05 12.5 % 
 
 
 
 
Observation: 
 50 % (20) of the patients were suffering with the illness between above 01 year to 
02 years, 25% (10) were in the division of above 02 years to 03 years and 12.5 % (05) 
were below 01 year and above 3 years. 
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10) Distribution of Mukkutram 
 The derangements of Vaatham, Piththam and Kabam in Venneer Noi are as 
follows 
Vaatham 
 
Sl. No Classification of Vaatham No of Cases Percentage 
1 Praanan 00 00 % 
2 Abaanan 05 12.5 % 
3 Udhaanan 00 00% 
4 Samaanan 40 100 % 
5 Viyaanan 40 100 % 
6 Naagan 00 00 % 
7 Koorman 00 00 % 
8 Kirukaran 00 00 % 
9 Devathaththan 00 00 % 
10 Dananjayan 00 00 % 
 
Observations  
 Samanan and Viyaanan were affected in 40 (100 %) cases and Abanan were 
affected in 05 (12.5 %) cases.  
 
Piththam 
 
Sl. No 
Classification of 
Piththam 
No. of Cases Percentage 
1 Analakam  34 85.0 % 
2 Ranjakam 00 00.0 % 
3 Saathakam 00 00.0 % 
4 Prasakam 00 00.0 % 
5 Alosakam 03 07.5 % 
  
Observation: 
 Analakam - 34 (85 %) and Alosakam - 03 (07.5 %) were affected.  
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11) Udal Kattukkal 
 
Sl. No UdarKattukkl No of Cases Percentage 
1 Saaram 40 100.0 % 
2 Senneer 00 100.0 % 
3 Oon 00 00.0 % 
4 Kozhuppu 00 00.0 % 
5 Enbu 00 00.0 % 
6 Moolai 00 00.0 % 
7 Sukkilam 40 100.0 % 
 
Observation: 
 Among 40 patients, Saaram and Sukkilam were affected in all the cases. 12)  
 
Envagai Thervugal 
 
Sl. No Envagai Thervugal No. of Cases Percentage 
1 Naadi 
 
a. Vaatha piththam 08 20 % 
b. Piththa vaatham 28 70 % 
c. Kabha vaatham 02 05 % 
d. Kaba piththam 02 05 % 
2 Sparisam 00 00.0 % 
3 Naa 00 00.0 % 
4 Niram 00 00.0 % 
5 Mozhi 00 00.0 % 
6 Vizhi 00 00.0 % 
7 Malam 00 00.0 % 
 
 In Envagai thervugal, the Naadinadai seen in Venneer Noi patients were 
Pithavaatham was affected in 28 (70 %), Vaathapitham was affected in 08 (20 %), 
Kabhavaatham and Kabhapiththam were affected in same number as 02 (05 %).  The 
rest of the other elements of Envagai thervukal were not affected.  
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13)  Neerkkuri, Neikkuri Reference  
 
Sl. 
No 
Type of Test No. of Cases Percentage 
1 
Neerkkuri: 
“ Niram”  Pale yellow 40 100.0 % 
2 
Neikkuri: 
(Vaatham) “Aravana Neendal” 02 
 
05.0 % 
(Piththam)“Azhipol Paraviyathu” 01 02.5 % 
 
(Kabam) “Muththothu ninrathu” 
 
37 92.5 % 
 
             
 
Observations  
Neikkuri  
Among the 40 patients, Kabha neer was found for 37 (92 %) cases, Vatha neer 
was found in 02 (05%) and Piththa neer was found in 01 (03%) of the patients.
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14) General Parameters:   
Before treatment- Haematology 
S. No OP No Age / 
Sex 
B.Sugar mg/dl Hb 
gms% 
TC 
cu/mm 
DC % ESR  mm/hr T.RBC 
Million  FA PP P L Mix ½ hr 1 hr 
1. I 54876 41/M 72 91 14.0 10700 77 18 05 10 22 5.6 
2. I 54994 21/M 70 98 14.9 7400 54 40 05 02 04 5.4 
3. I 57150 40/M 104 102 15.1 8700 71 25 04 16 32 5.1 
4. I 59186 26/M 91 124 14.9 5000 58 36 06 02 04 5.5 
5. I 67704 35/M 107 128 15.7 7500 55 40 05 08 10 6.0 
6. I 66344 30/M 105 103 16.4 7100 60 35 05 02 06 5.2 
7. I 69530 25/M 102 109 15.8 8700 60 34 06 04 08 5.2 
8. G 81198 42/M 106 104 16.6 6000 75 21 04 10 18 5.3 
9. I 69360  20/M 93 123 16.1 11400 70 25 05 02 06 5.6 
10. I 69787 24/M 99 102 15.9 6800 60 30 10 04 08 5.6 
11. I 70432 44/M 97 110 15.0 6100 50 44 06 06 12 5.5 
12. I 69649 25/M 104 118 15.3 4200 55 40 05 02 04 5.0 
13. H 19244 33/M 108 129 15.4 6900 66 28 06 02 04 5.2 
14. I 64804 35/M 85 129 16.0 7700 60 33 07 08 16 5.7 
15. I 67741 45/M 97 115 14.3 5700 65 30 05 12 20 4.9 
16. I 72642 37/M 103 117 16.1 6100 57 37 06 02 04 5.4 
17. I 73943 40/M 98 111 15.0 6300 60 33 07 06 12 5.2 
18. I 72640 29/M 101 98 15.0 9800 62 32 06 02 04 5.2 
19. I 71749 38/M 94 135 16.2 7400 55 37 08 06 14 5.3 
20. I 74260 22/M 109 112 14.6 6400 50 41 09 06 12 5.2 
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14) General Parameters:  Before treatment- Haematology 
S. No OP No 
Age/ 
Sex 
B.Sugar mg/dl Hb 
gms% 
TC 
cu/mm 
 
DC % 
 
ESR  mm/hr    T.RBC           
Million 
FA PP P L Mix ½ hr 1 hr 
21. I 75150 40/M 103 117 16.1 6300 63 31 06 02 06 5.7 
22. I 74213 29/M 101 130 15.1 7700 60 33 07 12 14 5.0 
23. I 77344 29/M 85 103 15.6 5000 55 38 07 02 04 3.5 
24. I 75190 26/M 103 120 16.6 6500 63 31 06 04 08 5.2 
25. I 74820 35/M 105 123 16.7 5500 50 41 09 12 14 5.4 
26. I 74076 40/M 105 124 14.8 8300 58 39 03 06 10 4.8 
27. I 77019  29/M 107 135 15.0 5500 51 43 06 02 06 4.8 
28. I 75565 23/M 95 100 16.6 7000 61 31 08 12 14 5.7 
29. I 74271 32/M 108 125 15.7 10700 55 40 05 02 04 5.9 
    30. I 80234 41/M 92 95 16.4 4600 60 36 04 12 14 5.7 
31. I 80094 32/M 80 124 16.6 7900 60 33 07 02 06 5.6 
32. I 80098 40/M 89 106 14.3 5300 60 30 10 02 04 4.8 
33. I 76162  26/M 100 105 15.7 7200 58 36 06 02 04 5.4 
34. I 80524 41/M 103 107 16.1 7400 70 25 05 04 10 5.0 
35. I 80174 33/M 89 107 15.1 10600 65 30 05 02 04 5.1 
36. I 81946 36/M 82 130 15.2 8600 60 36 04 12 14 5.3 
37. F 78386 28/M 85 95 14.5 6300 60 38 02 08     14 5.0 
38. I 81785 30/M 108 120 15.3 8000 50 44 06 06 10 5.0 
39. E 19088 35/M 88 109 16.8 10200 70 25 05 06 12 5.7 
40. I 80114 44/M 106 126 14.6 10000 55 35 10 06 12 4.9 
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After treatment- Haematology 
S.No OP No 
Age/ 
Sex 
B.Sugar mg/dl Hb 
gms% 
TC 
cu/mm 
DC % ESR mm/hr T.RBC 
Million FA PP P L Mix ½ hr 1hr 
1. I 54876 41/M 99 98 13.6 6800 61 35 04 06 12 5.6 
2. I 54994 21/M 92 126 15.1 6800 50 41 09 02 04 5.4 
3. I 57150 40/M 94 128 15.2 9500 68 28 04 04 09 5.1 
4. I 59186 26/M 89 115 15.1 5600 61 33 06 06 12 5.4 
5. I 67704 35/M 99 126 15.7 7500 55 40 05 02 06 5.8 
6. I 66344 30/M 94 130 16.4 6300 50 43 07 02 04 5.2 
7. I 69530 25/M 106 110 15.8 7800 64 32 04 03 06 5.2 
8. G 81198 42/M 88 89 16.7 6600 69 27 04 02 04 5.5 
9. I 69360  20/M 92 122 16.1 10800 60 37 03 02 04 5.6 
10. I 69787 24/M 93 106 15.9 6600 66 29 05 04 04 5.3 
11. I 70432 44/M 92 114 14.9 6000 61 33 06 08 14 5.4 
12. I 69649 25/M 92 120 15.3 4300 61 35 04 02 04 5.1 
13. H 19244 33/M 82 130 15.4 8300 70 24 06 06 12 5.1 
14. I 64804 35/M 88 114 15.7 7900 60 32 08 04 10 5.6 
15. I 67741 45/M 92 109 14.2 4600 60 36 04 10 18 4.8 
16. I 72642 37/M 98 110 16.0 6400 60 34 06 03 06 5.4 
17. I 73943 40/M 87 102 14.8 7100 62 32 06 08 18 5.2 
18. I 72640 29/M 106 116 15.0 9400 63 31 06 02 04 5.2 
19. I 71749 38/M 100 135 16.1 8600 59 33 08 04 08 5.2 
20. I 74260 22/M 88 110 14.8 6200 60 36 04 06 12 5.3 
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After treatment- Haematology 
S.No OP No Age/ Sex 
B.Sugar mg/dl Hb 
gms% 
TC 
cu/mm 
DC % ESR  mm/hr 
T.RBC                       
Million 
FA PP P L Mix ½ hr 1 hr  
21. I 75150 40/M 95 96 15.1 6600 60 33 07 08 16 5.6 
22. I 74213 29/M 104 130 15.2 7800 62 30 08 08 16 5.3 
23. I 77344 29/M 93 103 15.6 4700 56 36 08 06 12 5.6 
24. I 75190 26/M 110 120 16.6 6700 65 30 05 10 12 5.2 
25. I 74820 35/M 97 125 16.7 6800 60 35 05 10 20 5.4 
26 I 74076 40/M 100 126 15.2 7800 60 36 04 10 14 5.2 
27. I 77019  29/M 106 124 15.4 5400 54 39 07 04 08 5.0 
28. I 75565 23/M 94 105 16.5 7400 59 35 06 10 12 5.0 
29. I 74271 32/M 110 128 16.0 7800 60 34 06 06 12 5.8 
   30. I 80234 41/M 104 105 16.3 4800 52 40 08 14 20 5.7 
31. I 80094 32/M 98 132 16.8 7900 60 32 08 06 12 5.6 
32. I 80098 40/M 95 112 15.0 7800 62 30 08 08 10 5.2 
33. I 76162  26/M 105 110 16.2 7800 60 34 06 08 12 5.6 
34. I 80524 41/M 105 110 16.2 7600 70 26 04 06 12 5.2 
35. I 80174 33/M 90 110 15.2 8600 67 30 03 06 12 5.2 
36. I 81946 36/M 90 128 15.2 8400 62 34 04 06 12 5.2 
37. F 78386 28/M 90 100 14.4 6900 59 35 06 08 16 4.9 
38. I 81785 30/M 105 118 16.0 8200 54 38 08 10 14 5.1 
39. E 19088 35/M 90 125 16.8 7800 64 31 05 10 16 5.6 
40. I 80114 44/M 105 130 14.9 10300 60 34 06 06 12 4.90 
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15). Before Treatment Biochemistry  
S. 
No 
OP/IP No Age/ 
Sex 
Lipid profile Liver Function Test RFT 
T.Ch
o 
Mgdl 
HD
L 
Mg
/dl 
LD
L 
Mg/
dl 
VL
DL 
Mg
/dl 
TG
L 
Mg/
dl 
T.
Bm
g/d
l 
D.
Bm
g/d
l 
I.B 
mg
/dl 
SG  
OT 
u/l 
SG
PT 
u/l 
AL
K 
u/l 
T.P 
Gm
s% 
Alb 
Gm
s% 
Glo 
Gm
s        
% 
Cal 
Mg/     
dl 
P 
Mg
/dl 
U.
A 
Mg
/dl 
U 
m
g/
dl 
Cr 
Mg
/dl 
1. I 54876 41/M 146 38 98 32 185 0.9 0.3 0.6 34 71 90 7.3 4.3 3.0 9.1 3.8 5.0 17 0.9 
2. I 54994 21/M 164 48 116 22 109 1.2 0.5 0.7 18 19 63 7.0 4.3 2.7 9.1 4.2 5.1 19 0.9 
3. I 57150 40/M 170 52 114 33 163 1.1 0.4 0.7 17 42 47 7.1 4.3 2.8 11.1 3.0 5.7 20 1.0 
4. I 59186 26/M 173 36 125 23 113 2.0 0.7 1.3 19 27 73 6.1 3.8 2.3 11.0 3.9 5.1 12 0.9 
5. I 67704 35/M 214 53 123 37 210 0.4 0.1 0.3 23 34 88 7.0 4.1 2.9 10.0 4.0 5.7 20 1.0 
6. I 66344 30/M 230 60 132 34 222 1.5 0.6 0.9 22 27 97 7.1 4.4 2.7 9.6 4.5 5.3 20 1.0 
7. I 69530 25/M 161 42 112 24 165 1.0 0.5 0.5 17 17 89 6.5 4.1 2.4 8.8 3.9 4.9 19 1.2 
8. G 81198 42/M 141 42 95 32 187 1.8 1.0 0.8 14 14 52 6.7 4.4 2.3 9.8 3.4 3.3 15 0.9 
9. I 69360  20/M 141 38 86 34 210 0.8 0.3 0.5 12 13 67 6.6 4.2 2.4 7.1 3.3 5.7 13 1.1 
10. I 69787 24/M 203 57 142 27 189 0.8 0.3 0.5 16 23 69 7.1 4.7 2.4 8.2 4.6 3.4 17 1.2 
11. I 70432 44/M 153 38 104 41 210 0.6 0.2 0.4 16 30 85 7.8 4.6 3.2 8.6 4.2 3.7 23 1.2 
12.. I 69649 25/M 151 45 103 34 172 0.6 0.2 0.4 13 16 48 7.2 4.7 2.5 8.7 4.7 5.8 13 1.0 
13. H 19244 33/M 125 36 98 42 208 0.5 0.2 0.3 14 33 79 6.2 4.2 3.0 7.1 4.2 5.1 20 1.0 
14. I 64804 35/M 147 41 103 27 156 0.6 0.2 0.4 19 31 73 7.4 4.3 3.1 8.1 4.5 5.9 15 0.8 
15. I 67741 45/M 174 47 123 25 125 0.8 0.3 0.5 18 16 60 7.2 4.6 3.6 8.4 4.8 3.5 24 1.0 
16. I 72642 37/M 178 51 118 22 176 1.3 0.6 0.7 13 18 72 6.9 4.6 2.3 10.7 3.3 4.5 20 0.9 
17. I 73943 40/M 182 48 97 24 122 1.6 0.6 1.0 39 33 50 6.6 4.1 2.5 8.1 3.3 5.5 23 1.0 
18. I 72640 29/M 213 47 127 38 187 0.7 0.3 0.4 14 17 58 8.0 4.9 3.3 8.4 3.4 3.8 16 0.9 
19. I 71749 38/M 204 62 130 32 167 1.3 0.6 0.7 16 15 74 7.4 4.4 3.0 8.5 4.6 7.5 41 1.0 
20. I 74260 22/M 213 54 123 34 172 0.6 0.2 0.4  11 20 59 7.1 4.5 2.6 9.1 4.7 2.6 13 1.1 
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Before Treatment Biochemistry  
 
S. 
No 
OP/IP 
No 
Age/ 
Sex 
Lipid profile Liver Function Test RFT 
T.Cho 
Mgdl 
HDL 
Mg/
dl 
LDL 
Mg/d
l 
VL
DL 
Mg
/dl 
TGL 
Mg/
dl 
T.B
mg
/dl 
D.
Bm
g/d
l 
I.B 
mg
/dl 
SG  
OT 
u/l 
SG
PT 
u/l 
AL
K 
u/l 
T.P 
G
ms
% 
Al
b 
G
ms
% 
Glo 
Gm
s        
% 
Cal 
Mg/     
dl 
P 
Mg
/dl 
U.A 
Mg/
dl 
U 
mg/
dl 
Cr 
Mg/
dl 
21. I 75150 40/M 162 57 79 29 44 0.9 0.4 0.5 17 21 54 7.4 4.3 3.1 9.3 4.9 3.0 18 1.1 
22. I 74213 29/M 187 55 112 22 111 1.0 0.4 0.6 17 27 58 6.8 3.8 3.0 9.1 4.1 3.4 17 1.0 
23. I 77344 29/M 202 37 122 24 121 0.9 0.4 0.5 20 16 67 7.4 4.2 3.2 8.8 4.9 3.1 35 1.0 
24. I 75190 26/M 182 30 80 49 149 1.3 0.5 0.8 13 13 61 6.2 3.2 3.0 9.2 4.4 3.1 13 1.2 
25. I 74820 35/M 176 36 112 35 134 0.5 0.2 0.3 17 25 54 7.1 3.8 3.3 9.0 4.8 5.3 10 0.9 
26. I 74076 40/M 132 39 83 13 63 0.3 0.1 0.2 17 26 124 7.3 4.4 2.9 9.0 4.4 6.2 17 1.1 
27. I 77019  29/M 218 50 124 52 158 0.7 0.3 0.4 14 15 42 6.2 3.7 3.3 9.2 5.2 5.7 24 1.1 
28. I 75565 23/M 195 38 101 17 86 1.4 0.6 0.8 12 15 63 7.0 4.0 3.0 10.2 3.4 4.6 15 1.1 
29. I 74271 32/M 186 37 107 23 115 0.5 0.2 0.3 34 40 100 7.0 4.0 3.0 9.8 3.4 4.6 20 1.1 
30. I 80234 41/M 168 36 88 32 160 0.8 0.3 0.5 08 10 56 6.0 4.0 2.0 9.7 3.5 3.8 21 1.3 
31. I 80094 32/M 145 34 86 50 148 0.7 0.3 0.4 14 20 69 7.9 4.9 3.0 9.3 3.9 5.1 17 1.1 
32. I 80098 40/M 183 46 107 20 128 0.8 0.5 0.3 13 11 38 7.9 4.4 3.5 9.0 4.4 5.5 24 1.1 
33. I 76162  26/M 199 44 122 21 105 1.2 0.7 0.5 17 15 50 7.6 4.2 3.4 9.2 4.7 4.6 24 1.1 
34. I 80524 41/M 219 60 119 39 196 0.6 0.2 0.4 21 31 64 7.8 3.9 3.9 10.6 3.2 5.5 23 1.2 
35. I 80174 33/M 227 53 124 13 66 0.9 0.3 0.6 20 40 73 7.1 3.6 3.5 9.8 4.8 4.0 32 1.1 
36. I 81946 36/M 165 41 91 52 158 0.3 0.1 0.2 14 17 71 7.8 4.6 3.2 9.9 4.0 4.4 29 1.1 
37. F 78386 28/M 165 48 91 21 106 0.5 0.2 0.3 10 06 60 6.8 3.8 3.0 10.2 4.0 3.4 14 1.2 
38. I 81785 30/M 200 54 114 37 183 0.9 0.4 0.5 12 17 55 7.7 4.4 3.3 8.9 4.3 3.7 27 0.9 
39. E 19088 35/M 188 30 90 33 144 1.0 0.4 0.6 26 35 53 6.8 3.7 3.1 9.0 4.1 3.4 32 1.2 
40. I 80114 44/M 156 32 102 30 150 0.6 0.2 0.4 32 35 46 6.3 3.3 3.0 9.0 4.2 3.1 26 1.0 
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Biochemistry after Treatment 
S. 
No 
OP/IP 
No 
Age/ 
Sex 
Lipid profile Liver Function Test RFT 
T.Ch
o 
Mg/
dl 
HD
L 
Mg/
dl 
LD
L 
Mg/
dl 
VL
DL 
Mg/
dl 
TG
L 
Mg/
dl 
T.
Bm
g/d
l 
DB
mg
/dl 
IB
mg
/dl 
SG
OT 
u/l 
S
G 
P
T 
u/l 
AL
K 
u/l 
T.P 
Gm
s% 
Alb 
Gm
s% 
Glo 
Gm
s        
% 
Cal 
Mg/     
dl 
P 
Mg
/dl 
U.
A 
M
g/d
l 
U 
mg
/dl 
Cr 
M
g/d
l 
1. I 54876 41/M 144 40 89 48 160 0.3 0.1 0.2 26 36 77 7.8 4.5 3.3 9.3 3.6 4.2 15 0.9 
2. I 54994 21/M 189 40 120 35 140 0.9 0.5 0.4 13 10 55 7.2 4.5 2.7 9.3 4.5 4.2 23 1.0 
3. I 57150 40/M 156 60 92 17 85 0.9 0.4 0.5 20 25 47 8.4 5.1 3.3 8.0 3.4 4.6 22 1.2 
4. I 59186 26/M 192 30 117 24 102 1.2 0.5 0.7 21 23 76 5.8 2.8 3.0 9.2 3.9 5.4 13 1.0 
5. I 67704 35/M 222 62 121 48 156 0.4 0.2 0.2 23 28 72 7.9 4.7 3.2 9.2 3.3 4.5 20 1.1 
6. I 66344 30/M 259 73 133 48 167 1.3 0.8 0.5 21 20 93 8.0 4.9 3.1 8.0 3.6 4.6 23 1.0 
7. I 69530 25/M 174 51 106 31 154 1.0 0.4 0.6 16 17 86 7.3 4.3 3.0 8.5 3.0 5.0 20 1.1 
8. G 81198 42/M 136 42 80 35 176 1.2 0.7 0.5 16 15 48 7.2 4.5 2.7 9.0 2.4 4.2 15 0.9 
9. I 69360  20/M 131 50 71 34 169 0.8 0.4 0.4 14 11 71 7.4 4.7 2.7 9.2 2.9 5.4 13 1.0 
10. I 69787 24/M 174 61 67 12 58 1.1 0.7 0.4 21 27 75 7.0 4.6 2.4 8.7 3.4 2.8 18 1.2 
11. I 70432 44/M 149 41 89 46 187 0.7 0.3 0.4 19 28 97 8.3 4.7 3.6 8.9 3.3 3.5 21 1.2 
12.. I 69649 25/M 173 60 101 39 196 0.7 0.3 0.4 25 33 51 7.4 4.7 2.7 7.5 3.1 4.7 22 1.2 
13. H 19244 33/M 133 36 77 46 167 0.6 0.2 0.4 24 35 88 7.2 4.2 3.0 8.0 3.6 5.1 12 1.0 
14. I 64804 35/M 141 42 87 40 156 0.4 0.3 0.1 28 28 67 7.3 4.3 3.0 8.0 2.5 4.6 13 0.9 
15. I 67741 45/M 210 61 122 36 160 0.9 0.4 0.5 19 10 52 7.9 4.8 3.0 9.6 3.8 3.7 21 1.0 
16. I 72642 37/M 177 50 111 19 159 1.2 0.6 0.6 15 19 80 7.5 4.6 2.9 8.4 2.4 2.2 29 1.0 
17. I 73943 40/M 169 41 100 22 113 1.2 0.6 0.6 27 34 57 6.8 4.2 2.6 7.6 3.3 5.1 28 1.0 
18. I 72640 29/M 222 44 135 54 131 0.7 0.3 0.4 17 14 73 7.9 4.7 3.2 9.0 2.8 4.2 15 1.0 
19. I 71749 38/M 186 53 108 22 111 1.2 0.6 0.6 20 17 101 7.5 4.5 3.0 8.3 4.5 2.6 24 1.0 
20. I 74260 22/M 202 52 140 32 156 0.6 0.3 0.3 12 10 84 7.0 4.4 2.6 9.2 4.2 5.2 16 1.1 
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Biochemistry after Treatment 
 
S. 
No OP/IP No 
Age/ 
Sex 
Lipid profile Liver Function Test RFT 
T.Cho 
Mgdl 
HDL 
Mg/d
l 
LD
L 
Mg/
dl 
VL
DL 
Mg
/dl 
TG
L 
Mg/
dl 
T.
Bm
g/d
l 
D.
Bm
g/d
l 
I.B 
mg
/dl 
SG  
OT 
u/l 
S
G
PT 
u/l 
AL
K 
u/l 
T.P 
G
ms
% 
Al
b 
G
ms
% 
Glo 
Gms        
% 
Cal 
Mg/     
dl 
P 
Mg
/dl 
U.
A 
M
g/
dl 
U 
m
g/
dl 
Cr 
M
g/d
l 
21. I 75150 40/M 187 52 97 27 160 0.8 0.3 0.5 20 17 84 7.2 3.5 3.5 9.8 4.3 7.2 20 1.1 
22. I 74213 29/M 187 55 98 22 111 1.0 0.4 0.6 18 30 78 6.8 3.8 3.0 9.1 4.1 3.4 20 1.0 
23. I 77344 29/M 202 37 112 24 121 0.6 0.3 0.3 28 12 83 7.4 4.2 3.2 8.8 4.9 3.1 30 1.0 
24. I 75190 26/M 182 30 80 49 179 1.2 0.6 0.6 15 16 80 6.2 3.2 3.0 9.2 4.4 3.1 15 1.2 
25. I 74820 35/M 140 52 86 29 168 0.4 0.2 0.2 20 30 86 6.2 4.2 2.0 10.1 3.2 5.9 17 0.9 
26. I 74076 40/M 224 46 136 57 136 0.3 0.1 0.1 17 28 115 7.3 4.6 2.7 8.5 4.3 7.5 18 1.1 
27. I 77019  29/M 186 34 87 22 92 0.4 0.3 0.1 14 16 41 6.8 4.4 2.4 9.6 4.2 5.1 24 1.1 
28. I 75565 23/M 186 34 87 22 92 1.2 0.6 0.6 15 12 89 6.8 4.4 2.4 9.6 4.2 5.1 16 1.1 
29. I 74271 32/M 196 24 89 29 152 0.5 0.2 0.3 30 32 105 6.7 4.0 2.8 9.0 3.2 5.1 22 1.1 
30. I 80234 41/M 157 34 90 34 172 0.7 0.3 0.4 08 11 62 6.2 4.2 2.0 9.4 3.6 4.2 19 1.1 
31. I 80094 32/M 160 38 80 47 161 0.9 0.4 0.5 17 18 75 6.2 3.4 2.8 9.8 3.2 5.1 19 1.1 
32. I 80098 40/M 164 40 89 27 101 0.6 0.3 0.3 14 15 80 6.0 3.8 2.2 9.1 3.2 4.8 26 1.1 
33. I 76162  26/M 209 38 137 30 150 1.2 0.7 0.5 20 15 80 7.3 4.2 3.1 8.4 4.9 4.7 25 1.1 
34. I 80524 41/M 190 69 100 40 160 0.6 0.2 0.4 21 30 80 6.2 3`2 3.0 9.8 3.4 4.7 25 1.2 
35. I 80174 33/M 221 53 135 31 153 0.9 0.4 0.5 21 35 82 7.1 3.6 3.5 9.0 3.4 4.5 30 1.1 
36. I 81946 36/M 167 47 82 40 150 0.4 0.2 0.2 16 18 88 6.6 3.8 2.8 10 4.2 5.1 30 1.1 
37. F 78386 28/M 145 39 84 31 154 0.6 0.3 0.3 12 10 68 7.7 4.6 3.1 8.8 4.2 4.5 11 1.0 
38. I 81785 30/M 196 42 117 47 168 0.9 0.4 0.5 14 16 80 7.4 4.3 3.0 7.9 4.5 3.1 30 0.9 
39. E 19088 35/M 188 30 90 33 144 0.6 0.3 0.3 30 32 80 6.8 3.7 3.1 9.0 4.1 3.4 23 1.1 
40. I 80114 44/M 156 32 102 30 150 0.5 0.2 0.3 27 32 80 6.3 3.3 3.0 9.0 4.2 3.1 34 1.0 
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16). Before treatment – Urine analysis 
S.NO OP/IP No Age/ 
Sex 
Alb 
Sugar 
Deposit Neerkkuri 
 
Neikkuri 
 F PP 
1. I 54876 41/M Nil Nil Nil 1-2Pc,1-2Ec Pale Yellow Slowly spread 
2. I 54994 21/M Nil Nil Nil 2-3Pc,1-2Ec Pale Yellow Slowly spread 
3. I 57150 40/M Nil Nil Nil 2-3Pc,2-4Ec Pale Yellow Slowly spread 
4. I 59186 26/M Nil Nil     Nil 2-4Pc,3-4Ec Pale Yellow Slowly spread 
5. I 67704 35/M Nil Nil Nil 2-3Pc,1-2Ec Pale Yellow Slowly spread 
6. I 66344 30/M Nil Nil Nil 2-3Pc,4-6Ec Pale Yellow Fastly spread 
7. I 69530 25/M Nil Nil Nil 1-2Pc,1-3Ec Pale Yellow Not  spread 
8. G 81198 42/M Nil Nil Nil 3-5Pc,2-4Ec Pale Yellow Slowly spread 
9. I 69360  20/M Nil Nil Nil 2-4Pc,2-3Ec Pale Yellow Fastly spread 
10. I 69787 24/M Nil Nil     Nil 4-5Pc,2-3Ec Pale Yellow Slowly spread 
11. I 70432 44/M Nil Nil Nil 2-3Pc,2-3Ec Pale Yellow Slowly spread 
12.. I 69649 25/M Nil Nil Nil 1-2Pc,2-4Ec Pale Yellow Not  spread 
13. H 19244 33/M Nil Nil Nil 2-4Pc,1-3Ec Pale Yellow Slowly spread 
14. I 64804 35/M Nil Nil Nil 3-5Pc,2-3Ec Pale Yellow Fastly spread 
15. I 67741 45/M Nil Nil Nil 2-4Pc,3-5Ec Pale Yellow Slowly spread 
16. I 72642 37/M Nil Nil Nil 2-4Pc,1-3Ec Pale Yellow Slowly spread 
17. I 73943 40/M Nil Nil Nil 2-3Pc,4-6Ec Pale Yellow Fastly  spread 
18. I 72640 29/M Nil Nil Nil 2-3Pc,2-3Ec Pale Yellow Slowly spread 
19. I 71749 38/M Nil Nil Nil 2-4Pc,2-3Ec Pale Yellow Slowly spread 
20. I 74260 22/M Nil Nil Nil 4-5Pc,6-8Ec Pale Yellow Slowly spread 
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Before treatment – Urine analysis 
S.NO OP/IP No 
Age/ 
Sex Alb 
Sugar 
Deposit 
 
Neerkuri 
 
Neikkuri 
F PP 
21. I 75150 40/M Nil Nil Nil 2-3Pc,2-3Ec Pale Yellow Slowly spread 
22. I 74213 29/M Nil Nil Nil 1-2Pc,2-3Ec Pale Yellow Slowly spread 
23. I 77344 29/M Nil Nil Nil 2-3Pc,2-Ec Pale Yellow Slowly spread 
24. I 75190 26/M Nil Nil Nil 2-3Pc,1-3Ec Pale Yellow Slowly spread 
25. I 74820 35/M Nil Nil Nil 2-3Pc,1-3Ec Pale Yellow Slowly spread 
26. I 74076 40/M Nil Nil Nil 1-2Pc,1-2Ec Pale Yellow Slowly spread 
27. I 77019  29/M Nil Nil Nil 2-3Pc,2-3Ec Pale Yellow Round shape 
28. I 75565 23/M Nil Nil Nil 2-4Pc2-3Ec Pale Yellow Not  spread 
29. I 74271 32/M Nil Nil Nil 1-2Pc,2-4Ec Pale Yellow Fastly  spread 
30. I 80234 41/M Nil Nil Nil 2-4Pc,2-4Ec Pale Yellow Slowly spread 
31. I 80094 32/M Nil Nil Nil 2-3Pc,4-5Ec Pale Yellow Fastly spread 
32. I 80098 40/M Nil Nil Nil 2-3Pc,1-2Ec Pale Yellow Slowly spread 
33. I 76162  26/M Nil Nil Nil 1-2Pc,2-4Ec Pale Yellow Slowly spread 
34. I 80524 41/M Nil Nil Nil 1-2Pc,2-3Ec Pale Yellow Bean shape 
35. I 80174 33/M Nil Nil Nil 6-8Pc,2-4Ec Pale Yellow Slowly spread 
36. I 81946 36/M Nil Nil Nil 2-3Pc,4-5Ec Pale Yellow Slowly spread 
37. F 78386 28/M Nil Nil Nil 4-6Pc,1-2Ec Pale Yellow Slowly spread 
38. I 81785 30/M Nil Nil Nil 2-4Pc,2-4Ec Pale Yellow Slowly spread 
39. E 19088 35/M Nil Nil Nil 2-4Pc,2-4Ec Pale Yellow Slowly spread 
40. I 80114 44/M Nil Nil Nil 2-4Pc,3-4Ec Pale Yellow Not  spread 
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After treatment – Urine analysis 
S.NO OP/IP No 
Age/ 
Sex 
Alb 
Sugar 
Deposit 
 
Neerkuri 
 
Neikkuri 
F PP 
1. I 54876 41/M Nil Nil Nil 1-2Pc,2-3Ec Pale Yellow Slowly spread 
2. I 54994 21/M Nil Nil Nil 2-3Pc1-2-Ec Pale Yellow Slowly spread 
3. I 57150 40/M Nil Nil Nil 2-4Pc,2-4Ec Pale Yellow Slowly spread 
4. I 59186 26/M Nil Nil Nil 4-5Pc,2-3Ec Pale Yellow Slowly spread 
5. I 67704 35/M Nil Nil Nil 1-2Pc,2-3Ec Pale Yellow Slowly spread 
6. I 66344 30/M Nil Nil Nil 2-4Pc,2-4Ec Pale Yellow Fastly spread 
7. I 69530 25/M Nil Nil Nil 2-4Pc,4-6Ec Pale Yellow Not spread 
8. G 81198 42/M Nil Nil Nil 2-4Pc,3-5Ec Pale Yellow Slowly spread 
9. I 69360  20/M Nil Nil Nil 1-3Pc,2-4Ec Pale Yellow Not spread 
10. I 69787 24/M Nil Nil Nil 2-3Pc,3-5Ec Pale Yellow Slowly spread 
11. I 70432 44/M Nil Nil Nil 1-3Pc,1-2Ec Pale Yellow Not  spread 
12.. I 69649 25/M Nil Nil Nil 3-5Pc,2-4Ec Pale Yellow Not  spread 
13. H 19244 33/M Nil Nil Nil 1-2Pc,1-2Ec Pale Yellow Slowly spread 
14. I 64804 35/M Nil Nil Nil 3-5Pc,6-8Ec Pale Yellow Fastly spread 
15. I 67741 45/M Nil Nil Nil 1-2Pc,2-3Ec Pale Yellow Slowly spread 
16. I 72642 37/M Nil Nil Nil 2-4Pc,2-4Ec Pale Yellow Tree  shape 
17. I 73943 40/M Nil Nil Nil 2-3Pc,1-2Ec Pale Yellow Sieve pattern 
18. I 72640 29/M Nil Nil Nil 2-6Pc,3-6Ec Pale Yellow Slowly spread 
19. I 71749 38/M Nil Nil Nil 1-2Pc 1-2Ec Pale Yellow Slowly spread 
20. I 74260 22/M Nil Nil Nil 2-3Pc,1-2Ec Pale Yellow Slowly spread 
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After treatment – Urine analysis 
S.NO OP/IP No 
Age/ 
Sex Alb 
Sugar 
Deposit 
 
Neerkuri 
 
Neikkuri 
F PP 
21. I 75150 40/M Nil Nil Nil 1-2Pc,1-2Ec Pale Yellow Slowly spread 
22. I 74213 29/M Nil Nil Nil 4-5Pc,2-4Ec Pale Yellow Sieve pattern 
23. I 77344 29/M Nil Nil Nil 6-7Pc,2-4Ec Pale Yellow Slowly spread 
24. I 75190 26/M Nil Nil Nil 1-2Pc,2-3Ec Pale Yellow Fastly  spread 
25. I 74820 35/M Nil Nil Nil 4-5Pc,4-5Ec Pale Yellow Not   spread 
26. I 74076 40/M Nil Nil Nil 2-3Pc,1-2Ec Pale Yellow Slowly spread 
27. I 77019  29/M Nil Nil Nil 2-3Pc,1-2Ec Pale Yellow Round shape 
28. I 75565 23/M Nil Nil Nil 1-2Pc,1-2Ec Pale Yellow Not  spread 
29. I 74271 32/M Nil Nil Nil 3-4Pc,2-3Ec Pale Yellow Round shape 
30. I 80234 41/M Nil Nil Nil 3-5Pc,2-4Ec Pale Yellow Slowly spread 
31. I 80094 32/M Nil Nil Nil 1-2Pc,2-3Ec Pale Yellow Sieve pattern 
32. I 80098 40/M Nil Nil Nil 1-2Pc,2-3Ec Pale Yellow Kidney shape 
33. I 76162  26/M Nil Nil Nil 4-5Pc,1-2Ec Pale Yellow Sieve pattern 
34. I 80524 41/M Nil Nil Nil 1-2Pc,2-3Ec Pale Yellow Slowly spread 
35. I 80174 33/M Nil Nil Nil 2-3Pc,2-3Ec Pale Yellow Slowly spread 
36. I 81946 36/M Nil Nil Nil 1-2Pc,1-2Ec Pale Yellow Slowly spread 
37. F 78386 28/M Nil Nil Nil 6-8Pc,4-6Ec Pale Yellow Pear  shape 
38. I 81785 30/M Nil Nil Nil 2-4Pc,3-5Ec Pale Yellow Slowly spread 
39. E 19088 35/M Nil Nil Nil 4-5Pc,3-5Ec Pale Yellow Sieve pattern 
40. I 80114 44/M Nil Nil Nil 2-4Pc,4-6Ec Pale Yellow Sieve pattern 
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17). Semen Analysis – Before Treatment  
 
S.NO 
 
OP NO 
 
AGE/SEX 
 
SPERM COUNT MILLOIN/ML 
 
MOTILITY % 
 
MORPHOLOGY 
    
BEFORE 
 
AFTER 
 
BEFORE 
 
AFTER 
 
BEFORE 
 
AFTER 
1. I 54876 41/M 52 54 70 70 50 50 
2. I 54994 21/M Nil 38 60 80 Nil 40 
3. I 57150 40/M 36 64 70 80 30 50 
4. I 59186 26/M Nil 76 Nil 70 Nil 40 
5. I 67704 35/M 12 39 80 80 50 50 
6. I 66344 30/M 16 38 70 70 50 50 
7. I 69530 25/M 18 56 70 70 40 50 
8. G 81198 42/M Nil 20 Nil 40 Nil 30 
9. I 69360 20/M 40 30 60 70 40 50 
10. I 69787 24/M 40 20 70 70 50 50 
11. I 70432 44/M 105 140 80 80 50 50 
12.. I 69649 25/M 12 54 50 60 20 40 
13. H 19244 33/M Nil 26 Nil 30 Nil 20 
14. I 64804 35/M 48 56 80 80 50 50 
15. I 67741 45/M 14 20 60 60 60 60 
16. I 72642 37/M 16 24 50 60 50 50 
17. I 73943 40/M 18 20 80 80 30 60 
18. I 72640 29/M 80 25 60 70 40 50 
19. I 71749 38/M 60 20 50 60 50 50 
20. I 74260 22/M 80 30 50 60 60 60 
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Semen Analysis Before Treatment 
 
S.NO OP/IP NO AGE/SEX SPERM COUNT/ML MOTILITY% MORPHOLOGY 
BEFORE AFTER BEFORE AFTER BEFORE AFTER 
21. I 75150 40/M 40 20 40 60 50 50 
22. I 74213 29/M 56 60 70 70 60 60 
23. I 77344 29/M 36 60 70 80 60 60 
24. I 75190 26/M 16 20 70 70 10 30 
25. I 74820 35/M 12 44 40 80 40 50 
26. I 74076 40/M 10 20 60 70 10 40 
27. I 77019 29/M 80 34 50 70 10 50 
28. I 75565 23/M 40 42 70 70 50 50 
29. I 74271 32/M 84 80 80 80 60 60 
30. I 80234 41/M 28 30 70 90 60 60 
31. I 80094 32/M 14 42 70 80 50 60 
32. I 80098 40/M 80 12 70 80 60 60 
33. I 76162 26/M 76 76 80 80 40 50 
34. I 80524 41/M 28 30 80 80 50 60 
35. I 80174 33/M 18 20 60 70 40 50 
36. I 81946 36/M 22 26 70 70 50 50 
37. F 78386 28/M Nil 12 Nil 60 Nil 10 
38. I 81785 30/M 14 20 60 70 60 60 
39. E 19088 35/M 08 08 60 60 50 50 
40. I 80114 44/M 38 38 70 70 50 60 
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Semen Analysis After Treatment 
S.NO OP NO AGE/SEX VOLUME/ML LIQUEFACTION TIME - MIN FRUCTOSE 
   BEFORE AFTER BEFORE AFTER BEFORE AFTER 
1. I 54876 41/M 2.0 2.0 30 30 +ve +ve 
2. I 54994 21/M 1.0 1.0 30 20 +ve +ve 
3. I 57150 40/M 2.0 2.0 30 30 +ve +ve 
4. I 59186 26/M 1.5 2.0 30 20 +ve +ve 
5. I 67704 35/M 1.0 1.5 30 30 +ve +ve 
6. I 66344 30/M 0.5 1.5 30 20 +ve +ve 
7. I 69530 25/M 1.0 2.0 30 30 +ve +ve 
8. G 81198 42/M 1.0 2.0 10 10 +ve +ve 
9. I 69360 20/M 0.5 2.0 20 20 +ve +ve 
10. I 69787 24/M 1.0 2.0 20 30 +ve +ve 
11. I 70432 44/M 1.5 2.0 30 30 +ve +ve 
12.. I 69649 25/M 1.0 3.0 30 30 +ve +ve 
13. H 19244 33/M 1.0 2.0 60 60 +ve +ve 
14. I 64804 35/M 1.0 1.5 30 30 +ve +ve 
15. I 67741 45/M 1.5 1.5 20 20 +ve +ve 
16. I 72642 37/M 1.0 1.5 20 20 +ve +ve 
17. I 73943 40/M 1.0 1.5 15 30 +ve +ve 
18. I 72640 29/M 1.5 2.0 20 20 +ve +ve 
19. I 71749 38/M 1.0 1.5 20 20 +ve +ve 
20. I 74260 22/M 1.0 2.0 15 15 +ve +ve 
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Semen Analysis After Treatment 
S.NO OP NO AGE/SEX VOLUME/ML LIQUEFACTION TIME- Min FRUCTOSE 
   BEFORE AFTER BEFORE AFTER BEFORE AFTER 
21. I 75150 40/M 2.0 2.0 30 30 +ve +ve 
22. I 74213 29/M 1.0 2.0 20 20 +ve +ve 
23. I 77344 29/M 2.0 2.0 20 20 +ve +ve 
24. I 75190 26/M 2.0 2.0 30 30 +ve +ve 
25. I 74820 35/M 3.0 2.5 30 30 +ve +ve 
26. I 74076 40/M 3.0 2.5 30 30 +ve +ve 
27. I 77019 29/M 3.0 2.5 30 20 +ve +ve 
28. I 75565 23/M 1.5 1.5 15 20 +ve +ve 
29. I 74271 32/M 1.5 1.5 15 15 +ve +ve 
30. I 80234 41/M 3.0 3.0 30 30 +ve +ve 
31. I 80094 32/M 3.0 2.0 30 30 +ve +ve 
32. I 80098 40/M 2.0 2.5 30 30 +ve +ve 
33. I 76162 26/M 2.0 2.5 30 30 +ve +ve 
34. I 80524 41/M 0.5 2.0 20 20 +ve +ve 
35. I 80174 33/M 2.0 2.0 30 30 +ve +ve 
36. I 81946 36/M 2.0 2.5 20 20 +ve +ve 
37. F 78386 28/M 2.0 2.0 30 20 +ve +ve 
38. I 81785 30/M 1.5 2.0 20 20 +ve +ve 
39. E 19088 35/M 1.0 2.0 20 20 +ve +ve 
40. I 80114 44/M 2.0 2.0 30 30 +ve +ve 
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18). DSSC Score Before and After Treatment 
 
 
 
S. No. OP/IP NO. NAME 
AGE / 
SEX 
BT AT 
 
Result 
1 I 54876 Mr. K.Chandran 41/M 84 15 Good 
2 I 54994 Mr. R. Shanmugam 21/M 91 15 Good 
3 I 57150 Mr. C. Suresh raj 40/M 69 10 Good 
4 I 59186 Mr. V. Kalithasan 26/M 70 20 Good 
5 I 67704 Mr. S. Shankar 35/M 88 18 Good 
6 I 66344 Mr. S. Ramu 30/M 75 25 Good 
7 I 69530 Mr. R. Rajesh 25/M 68 21 Good 
8 G 81198 Mr. C. Marish 42/M 75 37 Good 
9 I 69360 Mr. M. Mazar Akram 20/M 76 28 Good 
10 I 69787 Mr. S. Vinoth 24/M 91 41 Moderate 
11 I 70432 Mr. M. Kumar 44/M 73 48 Moderate  
12 I 69649 Mr. P. Satheeshkumar 25/M 65 31 Good 
13 H 19244 Mr. P. Ponraj 33/M 86 43 Moderate  
14 I 64804 Mr. M.K. Abdhul Razak 35/M 70 27 Good 
15 I 67741 Mr. K. Kanniyappan 45/M 81 41 Moderate  
16 I 72642 Mr. T. Dheenadayalan 37/M 71 43 Moderate 
17 I 73943 Mr. T. Manokaran 40/M 64 26 Good  
18 I 72640 Mr. P. Sinnadurai 29/M 60 37 Good 
19 I 71749 Mr. G. Gobi 38/M 72 35 Good 
20 I 74260 Mr. S.K. Pandiyan 22/M 84 15 Good 
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DSSC Score Before and After Treatment 
 
 
S. No. OP/IP NO. NAME 
AGE / 
SEX 
BT AT 
 
Result 
21 I 75150 Mr. A. Shivakumar 40/M 76 26 Good 
22 I 74213 Mr. K. Murugan 29/M 83 29 Good 
23 I 77394 Mr. R. Murugan 29/M 80 45 Moderate 
24 I 75190 Mr. G. Anandaraj 26/M 84 45 Moderate 
25 I 74820 Mr. S. Mathavan 35/M 88 45 Moderate 
26 I 74076 Mr. N. Kannan 40/M 65 37 Good 
27 I 77019 Mr. S. Majilmurugan 29/M 113 55 Moderate 
28 I 75565 Mr. J. Anzar Bhasha 23/M 112 38 Good 
29 I 74271 Mr. S. Balamurugan 32/M 135 46 Moderate 
30 I 80234 Mr. R. Syed Abu Ali 41/M 77 28 Good 
31 I 80094 R. Shanmugam 32/M 96 37 Good 
32 I 80098 Mr. V. Sundaramoorthi 40/M 107 51 Moderate 
33 I 76162 Mr. S. Sasitharan 26/M 72 24 Good 
34 I 80524 Mr. R. Jeysankar 41/M 57 33 Good 
35 I 80174 Mr. G. Perumal 33/M 87 30 Good 
36 I 81946 Mr. S. Venkadesan 36/M 78 38 Good 
37 F 78386 Mr. G. Manikandan 28/M 75 21 Good 
38 I 81785 Mr. S. Karthik 30/M 68 27 Good 
39 E 19088 Mr. M. Jeyaraman 35/M 80 54 Moderate 
40 I 80114 Mr. R. Poongavanam 44/M 61 22 Good 
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19). Results DSSC Score Before and After Treatment 
 
 
 
           
Observations 
 The Clinical improvements (DSSC Score) after the Clinical trial was 
observed of good improvement was in 28 (70 %) of the patients and moderate 
improvements were observed in 12 (30 %) of the patients.  
S. 
No 
Result No. of Patients Percentage 
 
01 
 
Good improvement 
 
28 
 
70 % 
 
02 
 
Moderate improvement 
 
12 
 
30 % 
 
03 
 
Mild improvement 
 
00 
 
00  % 
 
04 
 
Nil improvement 
 
00 
 
00 % 
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20). Psycho-education / Counselling improvements score Before and After 
Treatment 
 
 
S. 
No 
OP/IP 
NO 
NAME 
AGE / 
SEX 
BT AT 
 
Result 
 
Percentage 
1 I 54876 Mr. K.Chandran 41/M 37 10 27 73 
2 I 54994 Mr. R. Shanmugam 21/M 37 05 32 86 
3 I 67704 Mr. S. Shankar 35/M 28 08 20 71 
4 I 69530 Mr. R. Rajesh 25/M 30 14 16 53 
5 I 69360 Mr. M. Mazar Akram 20/M 33 23 10 30 
6 I 69649 Mr. P. Satheeshkumar 25/M 30 17 13 43 
7 H 19244 Mr. P. Ponraj 33/M 28 16 12 42 
8 I 67741 Mr. K. Kanniyappan 45/M 38 19 19 50 
9 I 73943 Mr. T. Manokaran 40/M 38 10 28 74 
10 I 71749 Mr. G. Gobi 38/M 29 12 17 59 
11 I 75150 Mr. A. Shivakumar 40/M 39 10 29 74 
12 I 74213 Mr. K. Murugan 29/M 37 14 23 62 
13 I 74820 Mr. S. Mathavan 35/M 29 12 17 59 
14 I 77019 Mr. S. Majilmurugan 29/M 37 13 24 65 
15 I 75565 Mr. J. Anzar Bhasha 23/M 30 14 16 53 
16 I 80098 Mr. V. Sundaramoorthi 40/M 36 11 25 69 
17 I 80524 Mr. R. Jeysankar 41/M 37 10 17 46 
18 I 81946 Mr. S. Venkadesan 36/M 40 10 30 75 
19 F 78386 Mr. G. Manikandan 28/M 38 10 28 74 
20 E 19088 Mr. M. Jeyaraman 35/M 32 05 27 84 
110 
 
21). Results of Psycho-education / Counselling improvements  
 
S. No Result No. of Cases Percentage 
01 ≥ 75 03 15 % 
02 60 - 74 08 40 % 
03 50 - 59 05 25 % 
04 40 - 49 03 15 % 
05 ≤ 39 01 05 % 
 
 
  Psycho-education / Counselling improvements pie chart  
 
 
 
 
Observations 
 The improvements after the 6 sessions of Psycho-education / Counselling 
were more than or equal of 75 % is observed in 03 (15 %) of the patients and 
between 74 – 60 % improvements were observed in 08 (40 %) of the patients and 59 
– 50 was 05 (25 %), 49 – 40 was 03 (15 %) and below or equal of 39 of score was 
noted in 01 (05 %) patient.   
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STATISTICAL ANALYSIS 
All collected data were entered into MS Excel software using different 
columns as variables and rows as patients. SPSS software was used to perform 
statistical analysis. Basic descriptive statistics include frequency distributions and 
cross-tabulations were performed. The quantity variables were expressed as Mean ± 
Standard Deviation and qualitative data as percentage. A probability value of <0.05 
was considered to indicate as statistical significance. Paired‘t’ test was performed for 
determining the significance between before and after treatment.  
 
 
22). Paired Sample Statistics (VCSS Score Before Treatment and After 
Treatment) 
 
 Mean ± Std t Value p value 
Before Treatment (40) 80.2 ± 15.7 19.71 < 0.0001 
After Treatment (40) 33.4 ± 11.3 
 
 
Observation 
The mean± standard deviation of DSSC score at before and after treatment 
were 80.20±15.7 and 33.40±11.30 respectively which is statistically extremely 
significant (t=19.71, p=0.0001).  
 There is a highly significant difference between before and after treatment on 
DSSC Score ie. 58 % reduction in DSSC Score after the trial. 
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23). Statistical Significance of Psycho-education / Counselling 
 
 Mean ± Std t Value p value 
Before Counselling(20) 33.75 ± 5.0  
13.48 
 
< 0.0001 
After Counselling (20) 12.15 ± 4.36 
 
 
Observation 
The mean± standard deviation of VCSS score at before and after treatment 
were 33.75±5.0 and 12.15±4.36 respectively which is statistically extremely 
significant (t=13.48, p=0.0001).  
  
 There is a highly significant difference between before and after the Psycho-
education / Counselling therapy for Randomised selected 20 patients among the total 
40 patients on sessions improvement chart ie. 64 % reduction in counselling session 
Chart score after the trial. 
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DISCUSSION 
 The Dhat Syndrome) is one of the most affected psychological related 
problems in the male from the teen agers to middle aged group especially in Indian 
subcontinent. Majority of them are not seeking the help to proper health care 
providers. They have the social stigma in related to this sexual neurotic condition. 
Large numbers of patients perceive even the natural physiological function as 
abnormal. The masturbation which is practiced world over by majority of males and 
significant number of females is perceived as unnatural and abnormal practice. 
Masturbation is perceived as detrimental to mental and physical health. The Dhat 
syndrome is rampant among the Indian population and leads to large number of 
physical and psychological symptoms. Majority of these individuals visit self claimed 
sex specialists and traditional faith healers. The contact with these health providers 
not only strengthen their misconception and false beliefs, but also compel the patients 
to pay huge cost of investigations and drugs which are not only non-effective but also 
hazardous. This may leads to them as a patient in physically and mentally. In many 
Hospitals of Modern and Siddha OPD medical practitioners daily seeing some of male 
patients try to speak some private matters related to their sexual linked physical and 
psychological problems. Many times it was missed by the doctors due to their heavy 
workload and think about it was not a serious issue. Hence these kinds of patients get 
more worsen their problems and become a mentally affected patient.  
  
 The trial drugs was prepared in Gunapadam lab of National Institute of 
Siddha after the authentication of the raw drugs by Assistant professor of medicinal 
botany NIS and CCRS Arumbakkam, Chennai. The trail drug was prepared by 
standard operating procedure as mentioned in the Protocol. 
  
 The Bio chemical analysis was done at the biochemistry lab of NIS and the 
results were documented. The Bio-chemical analysis of Venpoosani Legiyam had 
shown the presence of Chloride, Phosphate, Carbonate, Calcium, Potassium, Nitrite, 
Iron, Tannic acid, starch and Alkaloids. 
  
 The clinical study was conducted with a well-defined protocol and a proper 
proforma after the approval of Institutional Ethical Committee.For this dissertation 
study, 40 patients were selected and Patients were treated in the OP Department of 
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Sirappu Maruthuvam, in Ayothidoss Pandithar Hospital - National Institute of 
Siddha, Tambaram Sanatorium, Chennai –600 047. 
 
 Based on various criteria, the data were collected and tabulated. The criteria 
were family history, age distribution, occupation, dietary habits and incidence of the 
disease with reference to thinai, seasonal variation, clinical manifestations and 
assessment of the improvement in the prognosis of the disease with the trial drug. 
 
 In Siddha System, it is necessary to bring the vitiated humours to 
equilibrium. Hence before the treatment Meganatha Kulikai with Inji charu 
(Gingeber officinale) juice was given for Viresanam (Purgation) in the early 
morning to normalize the vitiated humours. During the treatment, the patients were 
advised to follow pathiyam (Dietary regimen). 
 
Internal Drug : Venpoosani Legiyam - 5gm two times per day with milk 
   External Drug : Ulunthuth Thylam for external application (massage on 
                                   penis) 2 times per day           
 Duration of Drug: 48 days 
 
 40 male patients were for this study, among 40 patients, age group 25 to 31 
years and 12 (30%) patients between 39 to 45 were equally in 12 in number (30 %),  
patients between 32 to 38 years, 11 (27.5 %) patients between 18 to 24 years, 05 
(12.5%). Venneer Noi commonly appears at young and middle age. In this present 
study, considerable numbers of patients were reported (24 patients) between the age 
of 25-31 and 39 - 45 among study sample. 
 
 The majority of patients in this study were Farmer / Labour workers 15 (37.5 
%), Electrical / Technical workers 11 (27.5%). It is reflected from other studies done 
in dhat Syndrome in other countries. 
 
 The bulk of patients in this study were Non-vegetarian 32 (80%) remaining 8 
(20%) patients were vegetarian. 
 
 In this present study shows, considerable numbers of patients were reported 
from Marutham (37 patients), Neithal, Kurinji, Mullai thinai were each 1 patient. 
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 Highest number of patients 38 (95%) were admitted during Pinpani Kaalam 
(Maasi & Panguni) and 02 patients (05%) were admitted during Munpani Kaalam 
(Markazhi & Thai).   
  
 Most of patients 20 (50%) were affected in duration of above 1 to 2 years, 15 
(25%) patients were affected by the illness from 2 to 3 years, below 1 year and 
above 3 years duration  were in same number 5 (12.5%) . 
   
 Laboratory investigations were done for all the cases before and after 
treatment. There were no variations in hepatic, renal and other parameters.  
  
 The outcome of this study was clinically observed by DSSC Score, which 
showed encouraging results of good improvement in 28 patients (70%), moderate 
improvement in 12 patients (30%).  
 
 Among the 40 patients randomized selected 20 patients received further 
Psycho-education / Counseling, apart from the trail medicine. This Psycho-
education / Counseling results shown 80 % (16 patients) is good improvement.  
  
 Patients who have having the night duty work, exposed to very poor result 
and respond, may be this is the affect of thookkaminai (not enough sleep) and more 
stressful life style. Based  on Siddha Literature who not keep the Thinasariyai (Daily 
regimen) haven’t maintain their good health, this may reflect these patient.      
  
 Patients who were received both treatments had revealed very good result 
and quick revilement than the only trail medicine taken group. Based on this it is 
shown Medicine combined with Psycho-education / counseling therapy is more 
effective and appropriate to treat the Venneer Noi (Dhat Syndrome).    
   
 In this study, no adverse events were observed during the course of the 
treatment. At the time of discharge, all the patients were advised to attend Out 
Patient Department of Sirappu Maruthuvam of NIS for further follow-up 3 months. 
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SUMMARY 
 
 The disease Venneer Noi was taken for the clinical study with Venpoosani 
Legiyam as internal medicine and Ulunthuth Thylam as external application 
(massage on penis). For the clinical study, 40 cases were selected based on the 
approved protocol. 
 
 This study has been approved by IEC of NIS [Date of IEC Approval& its 
number: NIS/IEC/9-2014-15/16-26.08.2015]. Animal studies were carried out after 
obtaining approval from the Institutional Animal Ethical Committee (IAEC) and the 
trial was registered in Clinical Trial Registry of India (Trial REF/2016/06/011548). 
Hence the study is safely executed on patients and there was no adverse drug 
reactions noted during the study period. 
 
 Out of the 40 cases were treated at OPD, of Ayothidoss Pandithar Hospital of 
National Institute of Siddha, Chennai-47. Randomly selected 20 cases were received 
Psycho-education therapy / counselling therapy. The detailed study on Venneer Noi 
with reference to its aetiology, pathogenesis, investigations, clinical features, 
diagnosis and treatment with trial drugs was done.  
 
 The results were observed by DSSC score. Among the 40 cases treated, 70 % 
cases had shown Good improvement, 30% cases had shown Moderate improvement. 
Randomised selected 20 patients were received additionally Psycho-education / 
counselling therapy. This revealed 80% of the patients had above 50% 
improvement. Combined trial medicine and Psycho-education / Counselling therapy 
shown more significant improvements.     
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CONCLUSION 
 
The present clinical study confirms the efficacy of the trial drugs “Venpoosani 
Legiyam (internal medicine) and Ulunthu Thylam (external medicine)” which is 
Siddha Poly herbal formulation. It was found to be good resulting on Venneer Noi 
patients in reducing clinical symptoms like fatigue, weakness, anxiety, loss of 
appetite, guilty, sadness, semen passing with urine and sexual dysfunction etc.  The 
literature evidence for this drug is Siddha Maruthuvam Pothu, Page No 524, 2016 (8th 
Edition), Published by Department of Indian Medicine and Homeopathy, 
Arumpakkam, Chennai – 600106. 
.  
 The quantitative outcome of DSSC score shows there is significant reduction 
between before and after treatment. The qualitative outcome shows there is 70 % of 
cases had shown good improvement and the rest 30 % of cases had shown moderate 
improvement. 
  
 Further the Psycho-education / Couselling therapy had shown more impressive 
result of reduction of symptoms of Venneer Noi (Dhat Syndrome). It shows the better 
improvement more than 50 % was 16 (80 %) patients.  
  
 According to this result it could be the evidence the Psycho-education / 
Counselling therapy is further given the support to improve the condition of Venneer 
Noi (Dhat Syndrome). The Modern Medical concept of Anxiety related somatic 
complaints or Culture bound syndrome also has to be proven.The clinical trial 
conducted in selected patients was satisfactory and the results were encouraging. 
However a study with large number of patients is required to find out the ideal dose 
response. 
 
 From the above results, the trail drugs “Venpoosani Legiyam” (Internal 
Medicine) and “Ulunthuth Thylam” (External Medicine) are responded well in the 
treatment of Vennee Noi. 
 
 The costs of the trail medicines are comparatively low. These drugs are 
easily available and the dosage is also convenient.  
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An open clinical trial of poly herbal Siddha drugs “VENPOOSANI LEGIYAM” 
(Internal medicine) and “ULUNTHU THYLAM” (External medicine) in the treatment 
of VEN NEER NOI (DHAT SYNDROME) with and without Psycho-education 
therapy.  
Principal Investigator: Dr. Vallipuram Anavarathan                                                              
 
FORM I - SCREENING & SELECTION PROFORMA 
 
 
1. SERIAL NO:      2. OP /IP NO:                              
3. NAME:            4. AGE/GENDER:    
5. OCCUPATION:           6. INCOME:  
INCLUSION CRITERIA 
· Age : 18 - 45 years           
   YES / NO 
· Sex : Male             
   YES / NO 
· Weakness, anxiety, sleeplessness, mild depression and guilt which is  
attributed to semen loss.        YES / NO 
· Loss of semen through nocturnal emissions and masturbation frightens  
the individual as he believes it to be harmful to the body.     YES / NO 
· Report a white discharge in their urine which they feel is semen.    YES / NO 
· Mention that passing semen during defecation      YES / NO 
· Sexual dysfunction may or may not be present.       YES / NO  
· Willing to give specimen of blood and Sperm for the investigations before and  
after treatment           YES / NO 
·   Willing to participate in trial and signing consent by fulfilling the condition 
 of Proforma.        YES / NO 
· Willing to attend OPD for the trial                YES / NO 
· Willing to give specimen of blood for the investigation              YES / NO 
· Willing to participate the Psycho-education sessions         YES / NO 
· Willingness for consent        YES / NO 
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EXCLUSION CRITERIA 
· Chyluria         YES / NO 
· Diabetes mellitus         YES / NO 
· Severe Cardiac Diseases      YES / NO 
·  Severe Respiratory Diseases      YES / NO 
· Acute and chronic Renal Diseases     YES / NO 
· Needed for Surgical Treatment         YES / NO 
· Alcohol and Substance Abuse       YES / NO 
· Other severe psychiatric Illness     YES / NO 
· Mentally Challenged        YES / NO 
· Physically Challenged       YES / NO 
· Severe Malignancy Diseases      YES / NO 
· Any other chronic Illness      YES / NO 
 
ADMITTED TO TRIAL IN OPD 
YES  NO  
    
  Serial NO:  
Date:        
Station: 
 
Signature of the Investigator: 
 
 
Signature of the Faculty:                                               Signature of the HOD: 
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NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL, CHENNAI – 600 047. 
 
 
An open clinical trial of poly herbal Siddha drugs “VENPOOSANI LEGIYAM” 
(Internal medicine) and “Ulunthu Thylam” (External medicine) in the treatment of 
VEN NEER NOI (DHAT SYNDROME) with and without Psycho-education therapy. 
Principal Investigator: Dr. Vallipuram Anavarathan                                                              
FORM II-A – HISTORY TAKING PROFORMA 
 
STUDY  NO:                  OP / IP NO: 
NAME:                AGE / GENDER: 
ADDRESS:                CONTACT NO : 
                RELIGION :  H / C / M / O. 
OCCUPATION:                INCOME: 
MARITAL STATUS :       1. Married 2. Unmarried 
DATE OF INTIAL ASSESSMENT:  
COMPLAINTS & DURATION:   
PERSONAL HISTORY: 
PERSONAL HABITS YES NO IF YES SPECIFY DURATION AMOUNT/Qty 
Smoking     
Tobacco Chewing     
Alcohol     
Narcotic  Drug Addiction     
  
HISTORY OF PREVIOUS ILLNESS AND TREATMENT TAKEN: 
 
 
FAMILY HISTORY:  
Whether this problem runs in family? 1. Yes            2. No    
If yes, mention the relationship of affected 
person(s) 
1._________________ 
 
 
2._________________ 
 
DIETARY STYLE: 1. Vegetarian    2. Non-vegetarian 
 
DEPARTMENT OF SIRAPPU MARUTHUVAM 
121 
 
FORM II B  
GENERAL EXAMINATION: 
1. Body weight [kg]    :                      
2. Height [cms]                       :                        
3. Body Temperature [F]       :   
4. Blood Pressure (mm/Hg)  :      
5. Pulse Rate /min.        : 
6. Heart Rate / min.         : 
7. Respiratory Rate /min.  :   
SYSTEMIC EXAMINATION 
1. Cardiovascular system  :  
2. Respiratory system  :  
3. Gastro-intestinal system  :  
4. Central Nervous system  :  
5. Urogenital system   :  
6. Endocrine system              :  
SIDDHA SYSTEM OF EXAMINATION 
1. THEGI (BODY CONSTITUTION): 
1.  Vatha udal 
2.  Pitha udal 
3.  Kaba udal 
4.  Thontha udal 
2. NILAM (LAND WHERE THE PATIENT LIVED MOST):  
1. Kurinji (Hilly terrain) 
2. Mullai (Forest range) 
3. Marutham (Plains) 
4. Neithal (Coastal belt) 
5. Paalai (Aridregion) 
3. KAALAM: 
1.  Kaar kaalam    (Aavani-Purattasi) 
2.  Koothir kaalam     (Ippasi-Kaarthigai) 
3.  Munpani kaalam     (Maargazhi-Thai) 
4.  Pinpani kaalam       (Maasi-Panguni) 
5.  Ilavenil kaalam       (Chithirai-Vaigasi) 
6.  Muthuvenil kaalam (Aani-Aadi) 
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4. GUNAM: 
1. Sathuvam  
2. Rasatham 
3. Thamasam 
 
5. PORIPULANKAL (SENSORY ORGANS):          
                  
  
 
 
 
6.KANMENDRIYANKAL (MOTOR ORGANS) : 
        
7.KOSANGAL (SHEATH):                
 
 
 
 
 
 
  
8. SEVEN UDAL THAATHUKKAL (SEVEN SOMATIC COMPONENTS) 
 
            Thathukkal Before treatment After treatment 
Saaram Normal  /Affected Normal  /Affected 
Senneer  Normal  /Affected Normal  /Affected 
Oon Normal  /Affected Normal  /Affected 
Kozhuppu Normal  /Affected Normal  /Affected 
Enbu Normal  /Affected Normal  /Affected 
Moolai Normal  /Affected Normal  /Affected 
Sukkilam / Suronitham Normal  /Affected Normal  /Affected 
Poripulankal Before treatment After treatment 
Mei (Skin) Normal  / Affected Normal  / Affected 
Vai (Tongue) Normal  / Affected Normal  / Affected 
Kann (Eye) Normal  / Affected Normal  / Affected 
Mooku (Nose) Normal  / Affected Normal  / Affected 
Sevi (Ear) Normal  / Affected Normal  / Affected 
Kanmenthiriyankal Before treatment After treatment 
Kai(Upper limb)  Normal  /Affected Normal  /Affected 
Kaal (Lower limb) Normal  /Affected Normal  /Affected 
Vai (Oral cavity) Normal  /Affected Normal  /Affected 
Eruvai (Anal region) Normal  /Affected Normal  /Affected 
Karuvai (Uro-Genital region) Normal  /Affected Normal  /Affected 
              Kosankal Before treatment After treatment 
Annamaya kosam Normal  /Affected Normal  /Affected 
Pranamaya kosam  Normal  /Affected Normal  /Affected 
Manomaya kosam  Normal  /Affected Normal  /Affected 
Vignanamaya kosam  Normal  /Affected Normal  /Affected 
Ananthamaya kosam Normal  /Affected Normal  /Affected 
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9. UYIR THAATHUKKAL: [THREE HUMORS] (VALI/ AZHAL/ IYYAM) 
A) VALI 
Vali 
1st 
day 
8th 
day 
15th 
day 
22nd 
day 
29th 
day 
36th 
day 
42nd 
day 
48th 
day 
Praanan         
Abaanan         
Samaanan         
Udhaanan         
Viyaanan         
Naagan         
Koorman         
Kirukaran         
Devathathan         
Dhananjeyan         
 
B) AZHAL 
 
Azhal 
1st 
day 
8th 
day 
15th 
day 
22nd 
day 
29th 
day 
36th 
day 
42nd 
day 
 
48th 
day 
Analakam         
Ranjakam          
Saathakam          
Prasakam          
Aalosakam         
 
C) IYYAM 
 
Iyam 1st 
day 
8th 
day 
15th 
day 
22nd 
day 
29th 
day 
36th 
day 
42nd 
day 
 
48th 
day Avalambagam         
Kilethagam         
Pothagam         
Tharpagam         
Santhigam         
124 
 
10. ENVAGAI THERVU: [EIGHT TYPES OF EXAMINATION] 
 
I. NAADI: [PULSE PERCEPTION] 
 
NAADI 1
st  
day 
8th 
day 
15th 
day 22
ndday 29thday 36
th  
day 
42nd 
day 
48th 
day 
         
 
II. SPARISAM: [PALPATION] 
 
Day SPARISAM 
01st  day  
08th day  
15th  day  
22nd  day  
29th  day  
36th  day  
42nd day  
48th day  
 
III. NAA: [TONGUE] 
 
NAA 1
st 
day 
8th 
day 15
thday 22
nd 
day 
29th 
day 
36th 
day 
42nd 
day 
48th day 
 
         
 
IV. NIRAM: [COMPLEXION]   
1. Vadham         
     2. Pitham 
      3. Kabam  
V. MOZHI: [VOICE] 
      1. High Pitched 
      2. Low Pitched 
      3. Medium Pitched 
 
VI. VIZHI: [EYES] 
 
VIZHI 1
st 
day 
8th 
day 
15th 
day 
22nd 
day 29
thday 36
th  
day 
42nd 
day 
 
48th 
day 
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VII. MALAM: [BOWEL HABITS / STOOLS] 
Mala kunam Before treatment After treatment 
Niram   
Irugal   
Ilagal   
Others   
 
VIII. MOOTHIRAM [URINE EXAMINATION] 
NEERKKURI: 
 
Neerkkuri Before treatment After treatment 
Niram   
Manam   
Edai   
Nurai   
Enjal   
 
NEIKKURI:  
Neikkuri Before treatment After treatment 
Aravana needathu/ 
Snake like pattern 
 
  
Azhipol paraviyathu 
Annular/Ringedpattern 
 
  
Muththothu ninrathu  
Pearlbeadepattern   
Other patterns   
11. CLINICAL EXAMINATION:        
Dhat Syndrome Symptoms Checklist: 
Scoring  
 
00 - Not at all 
01 - Mildly  
02 - Moderately   
03 - Severe  
04 - More severe 
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Sl. 
No Symptoms 
Scoring 
00 01 02 03 04 
 Physical      
 01 Generalized weakness      
02 Backaches      
03 Localized ache and pain      
04 Ach and pain not localized      
05 Weakness of nerves      
06 Loss of hair      
07 Fatigue      
08 Abdominal dissention      
09 Constipation      
10 Shrinkage penis      
11 Excessive salivation      
 Somatic      
 12 Restlessness      
13 Excessive sweating      
14 Blurred vision       
15 Poor sleep      
16 Singing of heart       
17 Numbness in the limbs        
18 Burning sensation of chest      
19 Acidity      
20 Dryness of mouth      
21 Palpitation       
 Psychological      
 22 Fear       
23 Guilty       
24 Shyness      
25 Embarrassment       
26 Anxiety      
27 Loss of confidence      
28 Nervousness      
29 Pour memory      
30 Low mood      
31 Suicidal thoughts      
32 Not being oneself (depersonalization)       
 Sexual/ genital      
 33 Burning Micturition      
34 Penile discharge      
35 Thinness of seminal fluid      
36 Penile discharge before passing urine      
37 Premature ejaculation      
38 Penile discharge after passing urine      
 Desire      
 39 Lack of interest in sex      
40 Decrease desire for sex      
Dhat Syndrome Symptoms Checklist  (DSSC) 
Before treatment 
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Dhat Syndrome Symptoms Checklist  (DSSC) 
After treatment 
Sl. 
No Symptoms 
Scoring 
00 01 02 03 04 
 Physical      
 01 Generalized weakness      
02 Backaches      
03 Localized ache and pain      
04 Ach and pain not localized      
05 Weakness of nerves      
06 Loss of hair      
07 Fatigue      
08 Abdominal dissention      
09 Constipation      
10 Shrinkage penis      
11 Excessive salivation      
 Somatic      
 12 Restlessness      
13 Excessive sweating      
14 Blurred vision       
15 Poor sleep      
16 Singing of heart       
17 Numbness in the limbs        
18 Burning sensation of chest      
19 Acidity      
20 Dryness of mouth      
21 Palpitation       
 Psychological      
 22 Fear       
23 Guilty       
24 Shyness      
25 Embarrassment       
26 Anxiety      
27 Loss of confidence      
28 Nervousness      
29 Pour memory      
30 Low mood      
31 Suicidal thoughts      
32 Not being oneself (depersonalization)       
 Sexual/ genital      
 33 Burning Micturition      
34 Penile discharge      
35 Thinness of seminal fluid      
36 Penile discharge before passing urine      
37 Premature ejaculation      
38 Penile discharge after passing urine      
 Desire      
 39 Lack of interest in sex      
40 Decrease desire for sex      
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FORM II C – PSYCHO-EDUCATION ASSESSMENT FORM 
BEFORE TREATMENT 
PSYCHO – EDUCATION SCREENING AND ASSESSMENT 
QUESTIONNAIRE 
 
PSYCHOLOGICAL AND COUNSELLING 
 
Brief Adult Outcome Questionnaire Version II (BAOO – II) 
The Brief questionnaire asks about some of the most commonly reported 
thoughts, feeling and behaviors among adults seeking behavioral health treatment. 
Please think about the past two weeks and answer the questions below to the best of 
your ability. This will help you and your therapist / doctor to plan your treatment and 
monitor your improvement.    
 
 How often did you NeverHardly 
ever 
Some 
times 
Often Very 
often 
01 Feel unhappy or sad      
02 Have little or no energy      
03 Have a hard time getting along with 
family, friends, or coworkers  
     
04 Feel hopeless about the future      
05 Have a hard time paying attention       
06 Feel unproductive at work or other daily 
activities 
     
07 Feel tense or nervous      
08 Have problem with sleep (too much or too 
little) 
     
09 Feel lonely      
10 Think about harming yourself      
11 Have someone express concerns about 
your loss of semen  
     
12 Have more than five times of passing 
semen in a one week time 
     
13 Have a problem at work, college, or home 
because of excess semen loss issue 
     
 
Please take a moment to assess your last session to help us better serve your needs:  
 
 Please answer according to their 
relevance 
True Almost 
True 
UnsureAlmost 
False 
False 
01 I felt we talked about the things that were 
important to me. 
     
02 I felt that the therapist/ doctor liked and 
understood me.   
     
03 I felt that the session has helpful.       
04 I felt confident that the therapist/ doctor 
and I worked well together 
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FORM II C – PSYCHO-EDUCATION ASSESSMENT FORM 
AFTER TREATMENT 
PSYCHO – EDUCATION SCREENING AND ASSESSMENT 
QUESTIONNAIRE 
 
PSYCHOLOGICAL AND COUNSELLING 
 
Brief Adult Outcome Questionnaire Version II (BAOO – II) 
The Brief questionnaire asks about some of the most commonly reported 
thoughts, feeling and behaviors among adults seeking behavioral health treatment. 
Please think about the past two weeks and answer the questions below to the best of 
your ability. This will help you and your therapist / doctor to plan your treatment and 
monitor your improvement.    
 
 How often did you NeverHardly 
ever 
Some 
times 
Often Very 
often 
01 Feel unhappy or sad      
02 Have little or no energy      
03 Have a hard time getting along with 
family, friends, or coworkers  
     
04 Feel hopeless about the future      
05 Have a hard time paying attention       
06 Feel unproductive at work or other daily 
activities 
     
07 Feel tense or nervous      
08 Have problem with sleep (too much or too 
little) 
     
09 Feel lonely      
10 Think about harming yourself      
11 Have someone express concerns about 
your loss of semen  
     
12 Have more than five times of passing 
semen in a one week time 
     
13 Have a problem at work, college, or home 
because of excess semen loss issue 
     
 
Please take a moment to assess your last session to help us better serve your needs:  
 
 Please answer according to their 
relevance 
True Almost 
True 
UnsureAlmost 
False 
False 
01 I felt we talked about the things that were 
important to me. 
     
02 I felt that the therapist/ doctor liked and 
understood me.   
     
03 I felt that the session has helpful.       
04 I felt confident that the therapist/ doctor 
and I worked well together 
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Psycho-Education / Counselling: 
Weekly one session (totally 6 sessions)  
· Apply the Basic Psychological counselling technique with give the essential 
anatomical and physiological education related to Dhat Syndrome. 
· Use cognitive behavioural therapy and behaviour modification techniques.  
 
 Visit         Date        Psycho- Education Sessions 
Day 08   
Day 15   
Day 22   
Day 29   
Day 35   
Day 42   
 
 
Date:          
Station: 
 
Signature of the Investigator: 
 
Signature of the Faculty:                                                           Signature of the HOD 
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An open clinical trial of poly herbal Siddha drugs “VENPOOSANI LEGIYAM” 
(Internal medicine) and “ULUNTHU THYLAM” (External medicine) in the treatment 
of VEN NEER NOI (DHAT SYNDROME) with and without Psycho-education 
therapy. 
 
Principal Investigator: Dr. Vallipuram Anavarathan  
 
1. SERIAL NO:       
2. OPD NO:                              
3. NAME:             
4. AGE/GENDER: 
 
FORM-III - LABORATORY INVESTIGATIONS 
 
BLOOD INVESTIGATIONS NORMAL VALUES 
BEFORE TMT 
( DATE) 
AFTER TMT 
(DATE) 
Hb (gm/dl) 12-15   
T.WBC (cells/cu.mm) 4000-11000   
DIFFERENTIAL 
COUNT (%) 
Polymorphs 40-75   
Lymphocytes 20-40   
Monocytes 2-10   
Eosinophils 1-6   
Basophils 0-1   
T.RBC (million cells / cu.mm) M:4.0-5.5  
 
 
 
ESR (mm/hour) ½ hr. 06 - 12   
  1 hr. 12 - 20   
 
Blood 
glucose 
(mg/dl) 
Fasting 70-110   
PP 80-140   
Random 80-120   
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RFT (mg/dl) 
Blood Urea 16-50   
Serum Creatinine 0.6-1.2   
LFT (mg/dl) 
Total bilirubin 0.2-1.2   
Direct bilirubin 0.1-1.2   
Indirect bilirubin 0.2-0.7   
SGOT 0-40   
SGPT 0-35   
Alkaline 
Phosphatase 80-290   
 
ROUTINE SEMEN ANALYSIS  
 
GENERAL EXAMINATION 
 
Place of collection:-  
Specimen Collected at:-  
Specimen Examined at:-  
Abstinence: - 2 - 7 days 
 
 
URINE INVESTIGATION BEFORE TMT( DATE) AFTER TMT ( DATE) 
Albumin   
Fasting sugar   
PP sugar   
Deposits   
Test Description Biological Ref. 
Interval Observed 
Value 
Before 
Treatment 
After 
Treatment 
PHYSICAL EXAMINATION    
Volume   1.5 ml or more   
pH   7.2 or more   
Colour  Opalescent, Greyish 
white 
  
Liquefaction  Completes within 15 
mts 
  
Viscosity   < 2 cms thread   
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Date:          
Station: 
 
 
Signature of the Investigator: 
 
 
Signature of the Faculty:                                                           Signature of the HOD: 
CHEMICAL EXAMINATION    
Fructose Test  Positive   
MICROSCOPIC 
EXAMINATION  
   
Sperm vitality             > 58 %   
Sperm count (Millions / ml)  15 millions/ml or more   
Sperm count per ejaculate  More than 40 millions   
Sperm Motility  within before 60 mts   
a) Rapid forward Progression        > 25 %   
b) Sluggish forward Progression     
Total forward Progression (a+b)         > 32 % (a + b)   
c) Non Progressive        < 20 %   
d) Non Motile             0   
SPERM MORPHOLOGY (Pap 
Stain) 
   
Normal Sperms          > 4%   
Abnormal Head     
Abnormal Neck    
Abnormal Tail     
OTHERS :    
Immature Germ Cells     
Leucocytes     
Epithelial Cells     
Red Blood Cells     
Candida/Trichomonads     
MISCELLANEOUS 
CHARACTERS 
   
Agglutination of Sperms   Not Present   
Crystals  Not seen   
Grams Staining  No organisms seen.   
Interpretation  Normozoospermia   
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An open clinical trial of poly herbal Siddha drugs “VENPOOSANI LEGIYAM” 
(Internal medicine) and “ULUNTHU THYLAM” (External medicine) in the treatment 
of VEN NEER NOI (DHAT SYNDROME) with and without Psycho-education 
therapy. 
 
Name of Principal Investigator: Dr. Vallipuram Anavarathan   
FORM-IV – CONSENT FORM 
“I have read the foregoing information, or it has been read to me. I have had 
the opportunity to ask questions about it and any questions I have asked have been 
answered to my satisfaction.  
            I consent voluntarily to participate as a participant in this study and understand 
that I have the   right to withdraw from the study at any time without in any way it 
affecting my further medical care”. 
"I have received a copy of the information sheet/consent form". 
Date:  
Signature of the participant 
In case of illiterate participant 
 
        “I have witnessed the accurate reading of the consent form to the potential 
participant, and the individual has had the opportunity to ask questions. I confirm 
individual has given consent freely.”                                                   
Date: 
 
Signature of a witness  
(Selected by the participant bearing no connection with the survey team)  
   
       
 
 
Left thumb Impression of the Participant 
 
Date:          
Station: 
Signature of the Investigator: 
 
 
Signature of the Faculty:                                                           Signature of the HOD 
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FORM – IV xg;Gjy; gbtk; 
Ma;thsuhy; rhd;wspf;fg;gl;lJ 
 
ehd; ntz;zPu; Neha; (Dhat Syndrome) vd;Dk; Nehapd; Ma;itf; 
Fwpj;j midj;J tpguq;fisAk; Nehahspf;Fg; GupAk; tifapy; 
vLj;Jiuj;Njd; vd cWjpaspf;fpNwd;.  
Njjp      ifnahg;gk;  
,lk;     ngau; 
 
Nehahspapd; xg;Gjy; 
vd;dplk; ,e;j kUj;Jt Ma;tpd; fhuzj;ijAk; kUe;jpd; jd;ik 
kw;Wk; kUj;Jt topKiw gw;wpAk; njhlu;e;J vdJ cly; 
,af;fj;jijf; fz;fhzpf;fTk; mjid ghJfhf;fTk; gad;gLk; kUj;Jt 
Ma;T$l gupNrhjidfs; gw;wp jpUg;jp mspf;Fk; tifapy; Ma;T 
kUj;Jtuhy; tpsf;fpf; $wg;gl;lJ. 
ehd; ,e;j kUj;Jt Ma;tpd;NghJ vg;nghOJ Ntz;LkhdhYk; 
,e;j Ma;tpypUe;J vd;id tpLtpj;J nfhs;Sk; cupikia 
njupe;jpUf;fpNwd;. ehd; vd;Dila Rje;jpukhd Nju;T nra;Ak; 
cupikiaf; nfhz;L ntz;zPu; Neha;f;fhf (Dhat Syndrome) kUe;jhf 
ntz;G+rzp Nyfpak; (cs; kUe;J) kw;Wk;) cSe;J ijyk; (ntsp; 
kUe;J) kUe;Jfspd; gupfupg;Gj; jpwidf; fz;lwpAk; kUj;Jt Ma;tpw;F 
vd;id cl;gLj;j xg;Gjy; mspf;fpNwd;.  
 
 
 
 
 
 
Ma;thsu; ifnahg;gk; : 
 
tpupTiuahsu; ifnahg;gk:;    Jiwj; jiytu; ifnahg;gk; : 
Njjp:      
,lk;:      
ifnahg;gk;:  
ngau;: 
rhl;rpf;fhuu; ifnahg;gk;:  
ngau;:  
cwTKiw: 
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therapy.  
Name of the Principal Investigator: Dr. Vallipuram Anavarathan   
  
FORM V - WITHDRAWAL FORM 
 
1. SERIAL NO OF THE CASE:    
2. OP / IP NO:     
3. NAME:      
4. AGE:         
5. GENDER:                          
6. DATE OF TRIAL COMMENCEMENT:  
7. DATE OF WITHDRAWAL FROM TRIAL:  
8. REASONS FOR WITHDRAWAL: 
Long absence at reporting:               Yes/ No 
Irregular treatment:                           Yes/ No 
Shift of locality:                                     Yes/No 
Increase in severity of symptoms:     Yes/No 
Development of severe adverse drug reactions:   Yes/No 
Development of adverse event:                                              Yes/No 
(If YES, give the details of adverse reaction in Form VII -B – Adverse      Reaction 
Form / Pharmaco Vigilance Form) 
 
 
Date:          
Station: 
 
Signature of the Investigator: 
 
Signature of the Faculty:                                                          Signature of the HOD 
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An open clinical trial of poly herbal Siddha drugs “Venpoosani Legiyam” (Internal 
medicine) and “Ulunthu Thylam” (External medicine) in the treatment of Ven Neer 
Noi (Dhat Syndrome) with and without Psycho-education therapy. 
 
.     FORM-VI– INFORMATION SHEET 
 
Name of Principal Investigator :  Dr. Vallipuram Anavarathan 
Name of the Institute    :  National Institute of Siddha, 
                                                       Tambaram Sanatorium, 
                                                         Chennai- 600047. 
 
 
INFORMATION SHEET FOR PATIENTS PARTICIPATING IN THE OPEN 
CLINICAL TRIAL: 
 
I, Dr. Vallipuram Anavarathan reading M.D (Siddha) at National Institute of 
Siddha, Tambaram Sanatorium, is doing a trial on the study of VEN NEER NOI 
(DHAT SYNDROME). Dhat Syndrome is a most common psychological problem in 
the Indian subcontinent it has general weakness, lack of energy and concentration, 
impaired sexual functions, and vague somatic troubles, often associated with an 
anxious or dysphoric mood state. In this regard, I am in a need to ask you few 
questions. I will maintain confidentiality of your comments and data obtained. There 
will be no risk of disclosing your identity and no physical, psychological or 
professional risk is involved by taking part in this study. Taking part in this study is 
voluntary. No compensation will be paid to you for taking part in this study. 
 
           You can choose not to take part. You can choose not to answer a specific 
question. There is no specific benefit for you if you take part in the study. However, 
taking part in the study may be of benefit to the community, as it may help us to 
understand the problem of defaulters and potential solutions. 
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If you agree to be a participant in this study, you will be included in the study 
primarily by signing the consent form and then you will be given the internal 
medicine Venpoosani Legiyam (Internal medicine-5gm, Twice a Day with milk for 48 
days) and Ulunthu Thylam (External medicine), if you wish to undergo the Psycho-
education therapy will be provided to you assuring that you will not be definitely hurt 
in any course of treatment. 
 
  The information I am collecting in this study will remain between you and the 
principal investigator (myself).  
             
If you wish to find out more about this study before taking part, you can ask 
me all the questions you want or contact Dr. Vallipuram Anavarathan, PG Scholar 
cum principal investigator of this study, attached to National Institute of Siddha, 
Chennai-47. You can also contact the me at, National Institute Siddha, Chennai 
600047, Tel no: 9962723482, for rights and participation in the study. 
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FORM-V jfty; gbtk; 
 
ntz;zPu; §¿¡öì¸¡É (Dhat Syndrome) kUe;jhf> ntz;g+rzp 
§Ä¸¢Âõ (¯û ÁÕóÐ) ÁüÚõ ¯ÙóÐò ¨¾Äõ (¦ÅÇ¢ 
ÁÕóÐ) ¬¸¢Â º¢ò¾ ÁÕóÐ¸Ç¢ý ÀÃ¢¸Ã¢ôÒò ¾¢È¨Éì 
¸ñ¼È¢Ôõ ÁÕòÐÅ ¬öÅ¢ü¸¡É ¾¸Åø ÀÊÅõ. 
 
Ó¾ý¨Á ¬Ã¡öîº¢Â¡Ç÷ ¦ÀÂ÷: Dr. Å. «ÉÅÃ¾ý 
¿¢ÚÅÉò¾¢ý ¦ÀÂ÷ : §¾º¢Â º¢ò¾ ÁÕòÐÅ ¿¢ÚÅÉõ, 
                        ¾¡õÀÃõ º¡Éð§¼¡Ã¢Âõ, ¦ºý¨É- 47. 
 
   §¾º¢Â º¢ò¾ ÁÕòÐÅ ¿¢ÚÅÉò¾¢ø Àð¼ §ÁüÀÊôÒ ÀÂ¢ýÚ 
ÅÕõ ¿¡ý Dhat syndrome (ntz;zPu; §¿¡ö) ±ýÛõ §¿¡Â¢ø 
ÁÕòÐÅ ¬Ã¡öîº¢Â¢ø ®ÎÀðÎû§Çý.  
 
   º¢ò¾ ÁÕòÐÅò¾¢ø ntz;zPu;§¿¡ö (Dhat syndrome) ±ýÛõ 
§¿¡Â¡ÉÐ ¯¼ø, ¯Ç¿Ä¨ÉÀ¡¾¢ìÌõ ´Õ §¿¡Â¡Ìõ. þó¾ 
§¿¡Â¢ø ¸¨ÇôÒ, þÂÄ¡¨Á, ¯¼ü§º¡÷×, ºì¾¢Â¢ý¨Á, À¾ð¼õ, 
¸ÕòàýÈ ÓÊÂ¡¨Á, À¾¸Ç¢ôÒ, ¿¢ò¾¢¨ÃÂ¢ý¨Á, ÁÉî§º¡÷×, 
ÁÉì¸Äì¸õ, ÌüÈ×½÷×, «¾¢¸ ÍÂÀ¡Ä¢ýÀõ «ÛÀÅ¢ò¾ø 
ãÄõ Å¢óÐ ¦ÅÇ¢§ÂÈø, þÃÅ¢ø ¸ÉÅ¢ø Å¢óÐ ¦ÅÇ¢§ÂÈø 
¬¸¢Â ÌÈ¢Ì½í¸û ¸¡½ôÀÎõ. þÐ ÁüÈÅ÷¸ÙìÌô ÀÃÅ ÜÊÂ 
§¿¡ö «øÄ. þó¾ ¬Ã¡öîº¢ ºõÁó¾Á¡¸ º¢Ä §¸ûÅ¢¸¨Ç 
§¸ð¸×õ, ÀÃ¢§º¡¾¢ì¸×õ, §¾¨ÅÂ¡É ¬öÅ¸ ÀÃ¢§º¡¾¨ÉìÌõ 
¾í¸¨Ç ¯ðÀÎò¾×õ ¯û§Çý. 
 
   þó¾ ¬Ã¡öîº¢ìÌ ¾¡í¸û Å¢ÕôÀò¾¢ý §ÀÃ¢ø ¯ðÀÎõ 
Àðºò¾¢ø ¯ûÁÕó¾¡¸ «‰Å¸ó¾¢ §Ä¸¢Âõ 5¸¢ «Ç× À¡ø 
«ÛÀ¡Éò¾¢ø 2 §Å¨Ç (¸¡¨Ä Á¡¨Ä) ¯½×ìÌô À¢ý 48 
¿¡ð¸ÙìÌ ¯ð¦¸¡ûÇ §ÅñÎõ. ¦ÅÇ¢ ÁÕó¾¡¸ ¯ÙóÐò 
¨¾Äõ 48 ¿¡ð¸ÙìÌ ¦ÅÇ¢§Â ¾¨ÄÂ¢Öõ ¬ñÌÈ¢Â¢Öõ ¾¼Å 
§ÅñÎõ. ¦ÅÇ¢ §¿¡Â¡Ç÷¸û 7 ¿¡ð¸ÙìÌ ´ÕÓ¨È 
ÁÕòÐÅÁ¨ÉìÌ ÅÃ§ÅñÎõ.  
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þÐ ºõÀó¾Á¡É ¾í¸ÇÐ «¨ÉòÐ Å¢ÅÃí¸Ùõ Ã¸º¢ÂÁ¡¸ 
¨Åì¸ôÀÎõ ±É ¯Ú¾¢ «Ç¢ì¸¢§Èý. þ¾¢ø ÀÂ½ôÀÊ Ó¾Ä¢Â 
±ó¾ ¯¾Å¢ ¦¾¡¨¸Ôõ ÅÆí¸ôÀ¼ Á¡ð¼¡Ð.þó¾ ¬Ã¡öîº¢Â¢ý 
§À¡Ð ¯¼ÖìÌ §ÅÚ À¡¾¢ôÒ ²üÀÎõ Àðºò¾¢ø §¾º¢Â º¢ò¾ 
ÁÕòÐÅÁ¨ÉÂ¢ø ¾ì¸ Á¡üÚ º¢¸¢î¨º «Ç¢ì¸ôÀÎõ. þó¾ 
¬Ã¡öîº¢Â¢ø ¾í¸¨Ç ¯ðÀÎò¾¢Â À¢ÈÌ ¯í¸ÙìÌ Å¢ÕôÀÁ¢-
ø¨Ä¦ÂÉ¢ø ±ô§À¡Ð §ÅñÎÁ¡É¡Öõ Å¢Ä¸¢ ¦¸¡ûÇ ÓØ 
¯Ã¢¨Á ¯ûÇÐ 
 
þó¾ ¬Ã¡öîº¢ ºõÀó¾Á¡¸ ÁüÈ Å¢ÀÃí¸ÙìÌõ §¿¡Â¢ý 
¾ý¨Á ÀüÈ¢Ôõ Ó¾ý¨Á 
¬Ã¡öîº¢Â¡ÇÃ¡É Dr.Å.«ÉÅÃ¾ý Àð¼ §Áü ÀÊôÀ¡Ç÷ º¢ÈôÒ 
ÁÕòÐÅ À¢Ã¢× «Ï¸×õ. ¨¸ô§Àº¢ ±ñ.9962723482. §ÁÖõ 
þó¾ ¬Ã¡öîº¢ìÌ IEC º¡ýÚ ¦ÀÈôÀðÎûÇÐ.   
 
 þó¾ ÁÕóÐ ntz;zPu; §¿¡öf;fhf (Dhat syndrome) º¢ò¾ 
ÁÕòÐÅò¾¢ø ÜÈôÀðÎûÇÐ.  ²ü¸É§Å ¯À§Â¡¸ò¾¢ø ¯ûÇ 
þÐ §À¡ýÈ ÁÕóÐ þÐÅ¨Ã §¿¡Â¡Ç¢¸Ç¢¼õ ±ó¾Å¢¾ Àì¸ 
Å¢¨Ç×¸¨ÇÔõ ²üÀÎò¾Å¢ø¨Ä. §ÁÖõ ¯½× Ó¨ÈÂ¢ø §¸¡Æ¢ 
þ¨Èîº¢, «¾¢¸ ¸¡Ãõ, ÒÇ¢ôÒ Ó¾Ä¢Â¨Å¸¨Ç ¾Å¢÷òÐ þîº¡ 
Àò¾¢Âõ ¸¡ìÌÁ¡Ú «È¢×Úò¾ôÀÎ¸¢ÈÐ    
 
 
Signature of the Patients:  
 
 
Date:             Station: 
      
  
 
Signature of the Investigator: 
 
 
 
Signature of the Faculty:                                                       Signature of the HOD: 
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therapy. 
 
Name of Principal Investigator: Dr. Vallipuram Anavarathan  
 
FORM –VII- DRUG COMPLIANCE FORM 
NAME: 
SERIAL NO: 
DRUG: 
On 01st  day-Date:  Drugs issued: (Gms) Drugs returned:    (Gms) 
On 08th  day-Date:   Drugs issued: (Gms) Drugs returned:    (Gms) 
On 15th day-Date:              Drugs issued: (Gms) Drugs returned:    (Gms) 
On 22nd day-Date:           Drugs issued: (Gms) Drugs returned:    (Gms) 
On 29th day-Date:             Drugs issued: (Gms) Drugs returned:    (Gms) 
On 36th day-Date:              Drugs issued: (Gms) Drugs returned:    (Gms) 
On 42nd day-Date:              Drugs issued: (Gms) Drugs returned:    (Gms) 
 
 
DEPARTMENT OF SIRAPPU MARUTHUVAM 
   Day    Date         Morning   Evening   Day    Date    Morning   Evening 
Day 01    Day 25    
Day 02    Day 26    
Day 03    Day 27    
Day 04    Day 28    
Day 05    Day 29    
Day 06    Day 30    
Day 07    Day 31    
Day 08    Day 32    
Day 09    Day 33    
Day 10    Day 34    
Day 11    Day 35    
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Date:          
Station: 
 
Signature of the Investigator: 
 
 
Signature of the Faculty:                                         Signature of the HOD: 
 
 
 
Day 12    Day 36    
Day 13    Day 37    
Day 14    Day 38    
Day 15    Day 39    
Day 16    Day 40    
Day 17    Day 41    
Day 18    Day 42    
Day 19    Day 43    
Day 20    Day 44    
Day 21    Day 45    
Day 22    Day 46    
Day 23    Day 47    
Day 24    Day 48    
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An open clinical trial of poly herbal Siddha drugs “VENPOOSANI LEGIYAM” 
(Internal medicine) and “ULUNTHU THYLAM” (External medicine) in the treatment 
of VEN NEER NOI (DHAT SYNDROME) with and without Psycho-education 
therapy. 
 
Name of the Principal Investigator: Dr.Vallipuram Anavarathan  
    
FORM VIII – ADVERSE REACTION FORM / PHARMACO VIGILANCE FORM 
 
SERIAL NO:                                                                                                           
OP/IP NO: 
NAME:                                                             AGE:                     GENDER: 
DATE OF TRIAL COMMENCEMENT: 
 
   Date DESCRIPTION OF ADVERSE REACTION    REMARKS 
   
 
 
 
 
 
 
 
Date:                                                                              
Station:  
 
Signature of the Investigator: 
 
 
Signature of the Faculty:                                                        Signature of the HOD 
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FORM IX – DIETARY ADVICE FORM 
 
§º÷ì¸ ÜÊÂ ¯½×¸û ¾Å¢÷ì¸ §ÅñÊÂ¨Å¸û 
 
ÓÕí¨¸ôÀ¢ïÍ 
«Å¨ÃôÀ¢ïÍ 
¸¡Ãð 
À£ðåð 
¸Ã¢º¡¨Ä 
¦À¡ýÉ¡í¸ñ½¢ 
Á½ò¾ì¸¡Ç¢             
ÓÕí¨¸ì¸£¨Ã 
Àº¨Äì¸£¨Ã 
º¢Ú¸£¨Ã                 
¸È¢§ÅôÀ¢¨Ä  
¦¸¡ò¾ÁøÄ¢ 
¿ø¦Äñ¦½ö 
À¡ø 
Á¡Ð¨Ç 
¬ôÀ¢û  
§ÀÃ£î¨º 
¾¢Ã¡ð¨º 
±ÖÁ¢î¨º 
¿¡Åø 
ºô§À¡ð¼¡ 
¯Ä÷ ¾¢Ã¡ð¨º 
     §Å¸¨Åò¾    
      ¸¡ö¸È¢¸û 
 
§¸¡Æ¢ì¸È¢ 
¸ÕÅ¡Î 
 ÒÇ¢ôÒô ¦À¡Õð¸û  
¦À¡Ã¢ò¾, ÅÚò¾ ¯½×¸û 
ÒÇ¢ôÒò ¾Â¢÷, §Á¡÷ 
mjpf vz;iz Nru;e;j czTfs; 
°Ú¸¡ö  
¦Àñ§À¡¸õ 
§À¡¨¾ô¦À¡Õð¸û 
Ò¨¸ôÀ¢Êò¾ø 
ÁÐ «ÕóÐ¾ø  
 
Date:             Station: 
 
Signature of the Investigator: 
 
Signature of the Faculty:                                                       Signature of the HOD: 
DEPARTMENT OF SIRAPPU MARUTHUVAM 
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